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As a large part of all health-related research is focused on cancer, and with several diagnostic 
and therapeutic procedures continuously emerging, the fact that this disease remains mostly 
uncured often seems overwhelming. Cancer is a disease with extremely heterogenous causes 
and biologic backgrounds, and multiple mechanisms have been identified as cancer-
promoting, acting on several stages of the tumour progression. Among numerous other 
networks, cancer cells use their own death in order to signal an urgency for survival to their 
neighbouring cells. It has been observed that while a cancer cell is undergoing apoptosis, it 
can release signals which upon receipt by surrounding cells can promote the growth of 
tumour. Apoptosis is a form of programmed cell death with diverse roles in the tumour 
microenvironment and emerging data indicate that, besides its role in tumour suppression, 
it can also promote oncogenic proliferation. Highly aggressive tumours such as Burkitt 
Lymphoma (BL) show high levels of apoptosis, which has a diagnostic and prognostic value 
for classifying and staging the disease. The network of regeneration and tissue repair 
mechanisms driven by cell-death has been named as the “onco-regenerative niche” by our 
group, and it is hypothesized that amongst other elements, extracellular vesicles (EVs) are 
key mediators of apoptotic cell-derived tumour microenvironment signals.  
EVs are membrane delimited structures secreted by cells, containing multiple types of 
bioactive material, including markers of the tissue they originate from. They are released by 
almost all cells and during several phases of the cell life cycle. EVs show numerous 
applications in diagnostics, and there is an increasing interest in their biological functions. 
However, mainly because of their small size and heterogeneity, there are challenges 
associated with their analysis, and although EVs are gaining popularity in clinical diagnostic 
practice, the guidelines for analytic procedures have not been established to date. Because 
the vesicles are much smaller than cells and fall in the category of nanoparticles, the methods 
which can be applied for their analysis are dedicated to smaller entities or are special 
adaptations of other methods routinely used for larger particles such as cells. Here, we 
report on EVs released by apoptotic BL cells (Apo-EVs) in relation to their potential use as 
cancer biomarkers in lymphoma. 
The hypothesis of this project examines the Apo-EVs as to their distinct structural and 
biochemical characteristics which can be used in the context of disease diagnosis and 
monitoring. As Apo-EVs can reach the main blood circulation, the analysis of Apo-EVs in 
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patients can provide with information about the stages and the progression of the disease. 
The two main axes this work move around on are firstly, the structural and biochemical 
analysis of the Apo-EVs in order to examine their special molecular characteristics which 
render those different from other EVs which are not related to apoptosis and secondly, the 
study of how Apo-EVs interact with cells present in the blood and whether their cargo can 
be transferred to the second. Those two sets of studies can provide a better understanding 
of Apo-EVs and their roles, aiming at contributing towards the development of a disease 
monitoring platform. 
This project is focused on analytical platforms and techniques which can be applied to the 
nano-scale for imaging EVs in pre-clinical research and with the potential for application on 
patient samples. In particular, EVs released in vitro by Burkitt Lymphoma cells undergoing 
apoptosis upon UV irradiation are used throughout this study. Basic physical properties of 
Apo-EVs such as structure, size distribution, surface charge and membrane fluidity are 
discussed using Cryo Electron Microscopy (EM) and tomography, Nanoparticle Tracking 
Analysis, Dynamic Light Scattering and fluorescence anisotropy respectively.  For phenotypic 
analysis we apply immunocapture and flow cytometry, immunogold labelling on 
transmission EM, fluorescence microscopy and quantitative PCR.  
The second part of the analysis consists of a study of the interaction of Apo-EVs with blood 
components such as platelets, leukocytes and red cells, in order to understand their effects 
in the circulation and therefore their potential for analysis in blood samples. For this purpose, 
cells and platelets from human blood were co-incubated with Apo-EVs in order to examine 
the uptake and the possibility of Apo-EV cargo delivery intracellularly.  
Looking at the differences between Apo- and non-Apo-EVs, the Apo-EVs have a larger 
diameter, while structurally, the two populations are not different. However, we have 
identified distinct Apo-EV markers such as active caspase 3 and histone-3, or DNA and small 
non-coding RNA-Y. There is also a strong interaction of EVs with platelets and leukocytes but 
not with red cells, indicating potential mechanisms of transfer of EV cargo in the circulation. 
It was also found that this interaction does not only concern the surface of the cells, but EVs 
can enter the platelets or cells, which supports the hypothesis that their special biochemical 
cargo can be transferred inside those cells. 
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It is concluded that for the characterization of the heterogenous Apo-EV populations, 
comparison of results from of each method is essential for choosing the appropriate 
combination of analytical tools. Finally, we consider that the monitoring free circulating Apo-
EV or blood cells with which they have interacted is a promising approach to improve cancer 
diagnosis, prognosis and evaluation of therapeutic response. 
 
  




Although researchers have studied cancer biology and anti-tumour therapies for a long time, 
it is in many cases observed that this disease remains uncured. One of the reasons why 
cancer is still prevalent is that the building blocks of the tumour, the cells, have developed 
mechanisms and networks via which they promote their growth and escape destruction. 
Among other factors, cancer cell death can drive tumour growth. This ‘paradox’ happens 
because while cells begin to die (with a process called apoptosis), they are able to release 
tumour-promoting signals which eventually reach neighboring cells and cause them to grow, 
sustaining the cancer. It is also true that for some types of cancer, large numbers of dying 
cells are related to high aggressiveness, therefore apoptosis can be an indication of how the 
disease progresses in a patient. One channel the dying cells use to deliver survival messages 
to their fellow cancer cells is via apoptotic cell-derived extracellular vesicles (Apo-EVs). The 
EVs are small membrane particles which are released by almost all cells in the body, and are 
loaded with messages from the parental cell which are eventually delivered to the recipient 
cells. The EVs which are obtained as a cell is undergoing apoptosis are therefore, the Apo-
EVs. 
The aim of this work is to enrich our knowledge on the Apo-EVs with the ultimate goal to use 
Apo-EVs found in blood as a cancer indicator. Therefore, two different paths have been 
followed: in the first, we examine what unique characteristics the Apo-EVs have which can 
be potentially used as biomarkers, and the second is to study how these EVs interact with 
the blood cells once they escape the site of the tumour and reach the main blood circulation. 
The results showed that there are three main biomolecules which were highlighted as unique 
for the Apo-EVs compared to other EVs, and in addition, it was indicated that the vesicles 
can fuse with platelets and white blood cells in the blood, which can imply that their cargo is 
transferred to them. Those results can be useful for future studies in which the Apo-EVs can 
be applied on a number of tumours which show high levels of cell death, as those levels can 
reflect the severity of the disease. 
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1.1. Extracellular vesicles 
The presence of sub-cellular functional factors in the blood was first reported in 1946, when 
pellets from ultracentrifuged blood plasma exhibited coagulation properties. Although the 
authors referred to the material responsible for this effect as ‘particulate fraction containing 
breakdown material of blood components’, this was the first time extracellular vesicles (EVs) 
were introduced in the literature (Chargaff and West, 1946). Two decades later, pellets from 
plasma centrifugation were shown to contain vesicular structures referred to as ‘platelet 
dust’ (Wolf, 1967). The interest in the vesicles has since been constantly increasing, and the 
field of vesicle research currently includes a large number of researchers worldwide.  
EVs are membrane particles released from cells, in which cellular material is encapsulated 
within a lipid bilayer. While it remains unknown whether all cell lineages have the ability to 
release EVs, various cell types have been found to be capable of doing so, with a few 
examples being the mast cells, neurons, dendritic cells, platelets, endothelial and epithelial 
cells and B-lymphocytes, among others (Théry, Zitvogel and Amigorena, 2002). Although 
there is a number of questions related to their functions and the purposes the EVs serve, the 
process of EV release appears to be conserved in evolution, leading to the assumption that 
the EVs contribute significantly to homeostasis and disease (Colombo, Raposo and Théry, 
2014). The diameter of the vesicles ranges from a few nanometers (nm) up to microns, 
depending on the subtype, and they have been isolated from the majority of human body 
fluids such as blood, urine, breastmilk or ascites in disease. Based on the observation that 
they are physiologically secreted from cells at constitutive levels, the initial explanation for 
their presence was that cells use EVs to eliminate unwanted proteins and side-products of 
the metabolic process from their interior to the extracellular space. Nowadays, it is believed 
that EVs also mediate communication signals among cells both in physiological and 
pathological situations (tumours, neurodegenerative diseases) (Hannafon and Ding, 2013).  
The biochemical composition of the EVs is relatively complex, as their structure incorporates 
material from the parental cell such as proteins, lipids and nucleic acids (Figure 1-1). Some 
proteins are commonly found in the majority of EVs, such as kinases, heat-shock proteins or 
actin, while others vary in levels of expression or are only present in specific tissues or disease 
as for instance the MHC class II from antigen-presenting cells (Théry, Zitvogel and Amigorena, 
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2002) or CEA (carcinoembryonic antigen) and HER-2 from colon and breast tumours 
respectively (Dai et al., 2005; Barok et al., 2018). A second component is the lipids which 
form the EV membrane, mainly structured with phospholipids such as phosphatidylcholine 
(PC), saturated fatty acids, sphingomyelin and various levels of cholesterol. Interestingly, the 
EV membranes show a distinct difference from the cell membranes in the localization of the 
phospholipid phosphatidylserine (PS). In healthy cells, this lipid is normally found in the inner 
monolayer via an active PS asymmetry maintenance system (see below) and is exposed on 
the outer surface upon initiation of apoptosis, platelet activation or other processes  (Nagata 
et al., 2016), (Shlomovitz, Speir and Gerlic, 2019); however, EVs seem to have exposed PS 
under normal conditions and there are two main theories explaining this observation. The 
first comes from the perspective of the thermodynamics of the lipid arrangement on the 
membrane and this is because the EV membranes have a higher degree of curvature 
compared to plasma cell membranes, which leads to mechanically induced ‘lipid-packing 
defects’ in which hydrophobic lipid heads such as the negatively charged PS can be found in 
the outer leaflet (Kastelowitz and Yin, 2014). The second possible explanation is attributed 
to the lack of flippase and active scramblase in EVs, enzymes which maintain asymmetry in 
the composition of lipids on the cell membrane by actively transferring lipids to the relevant 
side of the bilayer (Hugel et al., 2005), (Barclay et al., 1997). Therefore, with the majority of 
EVs exposing PS, Annexin V, a protein capable of binding on aminophospholipids with high 
affinity can act as a detection or capture probe, as indicated by the capturing of EV on beads 
coated with Annexin V (Dachary-Prigent et al., 1993; Shih et al., 2016). Apart from proteins 
and lipids, EVs are also nucleic acid-bearing entities with the most prevalent acids being RNA 
and especially small molecules such as miRNA, mRNA or rRNA. DNA is detected in some 
cases, often in EVs deriving from apoptotic cells but also in other smaller vesicles (Ehnfors et 
al., 2009; Cai et al., 2015). With the above evidence, it is implied that the transfer of genetic 
material from EV releasing cells to recipient cells via EVs can have potential effects in the 
intercellular communication and progression of several diseases. In conclusion, there is a 
basic biochemical pattern which most EVs have in common, however, this composition can 
be altered significantly under special conditions such as inflammation or tumour, which 
offers researchers a powerful tool for diagnostic analyses. In other words, detecting changes 
in the expression levels of proteins, lipids or nucleic acids of EVs can indicate potential 
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pathology which may not be detectable by other clinical means (Colombo, Raposo and Théry, 
2014). 
 
Figure 1-1. Schematic representation of the categories of EVs and biochemical composition. The EVs are a sum 
of membrane particles released by cells through different mechanisms (exosomes, microvesicles or Apo-EVs). The 
common characteristics of all types of vesicles is the general structure, i.e. the lipid bilayer, the membrane and 
intravesicular proteins and the genetic material.  
 
The generally recognised intracellular pathway for EV formation and secretion involves a 
process initiating in endosomal compartments where cellular components accumulate as 
part of a recycling/degradation process. Early vesicles (multivesicular bodies, MVBs) are 
formed by the inward budding of the endosomal membrane, enclosing part of the cytosol 
including proteins and also lipids. Some of these early MVBs finally fuse with the endosomal 
membrane in order to undergo degradation, while others are distinctively labelled for fusion 
with the plasma membrane and release of their load (smaller vesicles) to the extracellular 
Maria Panagopoulou | PhD Thesis                                                                                                      The University of Edinburgh, 2020 
15 
 
space (Théry, Zitvogel and Amigorena, 2002) (Denzer et al., 2000). In more detail, it is 
believed that the triggering signal towards vesicles formation is dependent on a protein 
complex, named as the endosomal sorting complex required for transport (ESCRT). This 
machinery enables the budding of the lysosomal membrane to the formation of the early 
multivesicular bodies inside the lumen of the organelle, as well as the scission of the 
membrane so that the MVBs are released into it. Besides ESCRT, there is an alternative EV 
production route which is independent of the sorting complex machinery and involves the 
lipid ceramide that acts as a signalling molecule in the processes of vesicle formation, 
membrane fusion and vesicle trafficking (Bobrie et al., 2011) (Colombo, Raposo and Théry, 
2014).  
The finally formed vesicles are secreted to the extracellular matrix by the process of 
exocytosis, where the MVBs fuse with the interior lumen of the cytoplasmic membrane and 
release their cargo (EVs) out of the cellular space. A complex set of signals are involved in the 
mechanics of secretion and the regulation of the vesicle concentration levels and 
kinetics/frequency of release. The main molecules necessary for the final release are the 
SNARE complex, actin microtubules, and Rab GTPases. The regulation of secretion is 
influenced by multiple biological, chemical and even mechanical stimuli, dependent on local 
factors. In some cases, there is an interesting correlation between diseases and the increased 
levels of signalling molecules which promote vesicle secretion (Hannafon and Ding, 2013). 
This trend is observed especially in various cancer types (Grizzle and Zhang, 2013). 
Monitoring the patterns of secretion or performing more advanced analysis on the content 
of the vesicles could give some evidence about the presence of underlying diseases. 
Next, these vesicles often transfer information to recipient cells, which is achieved by three 
main processes. The first is described as a direct interaction of the transmembrane vesicular 
proteins with signalling receptors on the surface of the recipient cells. The second is the 
fusion of their membrane with the plasma membrane of the recipient, thus, delivering their 
encapsulated material directly and non-selectively into the cytosol and thirdly, whole EVs 
can be taken up in the cell (by endocytosis and/or macropinocytosis), where two possible 
routes can be followed. The internalized vesicles can fuse with lysosomes and undergo 
degradation, or merge with endosomes, move across the cytosol and finally be released out 
again, targeting a new recipient cell. This process is known as transcytosis (Zhang et al., 
2015).  
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As to the functions EVs have, they can be often characterized as “multi-purpose carriers” due 
to their varied cargo profiles. Briefly, their roles are related to cell-to-cell communication 
(transport of secondary messengers to recipient cells), exchange of genetic information (e.g. 
by sharing mRNA and microRNAs) and protection (cells eliminate dangerous substances and 
unwanted metabolites such as chemotherapeutics, caspase 3, oxidized lipids) (Nieuwland 
and Sturk, 2010). However, it is observed that the signals mediated by EVs have multiple 
patterns depending on the cell type, the different tissues and most importantly, on the local 
microenvironment. 
Because of the highly specific cargo, EVs can be considered as disease biomarkers and 
because of their structure, they have some advantages compared to bulk blood biomarker 
samples commonly used. Firstly, using a sample of EVs can be less complex to analyse 
compared to blood or serum sample. This is because separation steps can result in pure 
vesicle samples where no other blood components are present. Consequently, using a 
sample which exclusively contains vesicles without the interference of other components, 
can reduce the noise and set the detection threshold lower. However, the complexity of the 
vesicles’ contents (either encapsulated or on the surface) are still a challenging area and one 
of the main interests for the present project. The stability of the EVs has also been 
investigated and there is evidence that they can be stored without significant loss of their 
properties for a certain period of time (Fendl et al., 2016). However, as described in the next 
paragraphs, a common guideline should be established on storage conditions, as there are 
no common procedures and practices in the community regarding this issue yet. In addition 
to this, in cases where the proteins serving as biomarkers are enclosed by the vesicular 
membrane, they are protected from distortion and proteolytic enzymes, providing a highly 
reliable source of disease marker (Boukouris and Mathivanan, 2015). 
The number of molecules loaded on vesicles can be used as specific cancer biomarkers. The 
largest known family of markers consists of various versions of small RNA (Canella et al., 
2016; Nakamura et al., 2016; Valentino et al., 2017; Salehi and Sharifi, 2018) and there are 
other markers which vary significantly depending on the type of disease or tissue, such as 
glycosylated molecules on the membrane surface (Costa, 2017) and expression of certain 
receptors, oncoproteins and even circulating tumour DNA (Westphal and Lamszus, 2015).  
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Apart from their use as biomarkers, EVs have been investigated as to their clinical functions 
such as therapeutic activity and potential use as vaccines. For instance, administering 
mesenchymal stem cell EVs to cardiac tissue has shown to assist recovery from injury and 
also EVs with pro-inflammatory properties have been effective in triggering immune 
response (György et al., 2015). 
 
1.2. Tumour and extracellular vesicles from apoptotic tumour cells (Apo-EVs) 
Apoptosis is a form of programmed cell death which is thought to have multiple roles in 
physiological processes such as organised removal of cells and tissue regeneration, as well 
as in pathological conditions such as tumour progression, which is of interest in this project. 
Morphologically, it is characterized by cell shrinkage, nuclear fragmentation and plasma 
membrane blebbing, among others. It should not be confused with necrosis where the cell 
dies either accidentally or via a complex signalling pathway and is manifested by swelling of 
the plasma membrane, rupture and release of the cellular contents (Kroemer et al., 2009). 
In cancer, apoptosis is best known as a tumour suppressive process, however, our research 
is focused on other tumour-related effects of apoptosis besides its ability to reduce the 
tumour volume. It is known that apoptotic cells in tumours communicate with the 
neighbouring cancer cells by various signal mediators including soluble factors and 
microparticles or other membrane-associated forms (Gregory and Pound, 2010). The roles 
of apoptosis are not fully understood, but there is increasing evidence that it plays a 
significant role in mediating communication signals within the tumour microenvironment. 
More specifically, it is observed that apoptosis can either induce further apoptosis in the 
neighbouring cells or promote compensatory proliferation in others, depending on the 
signals the apoptotic cells mediate (Gregory, Ford and Voss, 2016). Therefore, understanding 
the impact of apoptosis within the tumour microenvironment can provide useful information 
which could enable researchers to address potential therapeutic approaches against cancer. 
EVs are likely to be important, yet not fully studied mediators of the interactions between 
apoptotic and the nearby cells. It should be here pointed out that apoptotic cells also secrete 
other types of vesicles which can be both apoptosis-related or physiological EVs, although 
the distinction between the two is not well defined (Gregory and Pound, 2011). Apoptotic 
bodies are defined as the largest type of vesicles (1 to 5 μm) resulting from the cellular 
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disassembly process while EVs are smaller in size and usually result from the ESCRT 
machinery, as mentioned earlier (Atkin-Smith et al., 2016). Among the range of vesicles 
involved in tumour progression, this work elaborates on the investigation of the apoptotic 
cancer cell derived EVs (Apo-EVs), as there is early evidence that Apo-EVs could be important 
regulators of the tumour microenvironment (Lynch, Panagopoulou and Gregory, 2017).  
The nomenclature for the different types of particles released from apoptotic cells is a matter 
of discussion, as a standardized terminology has not been defined to date (Gould and 
Raposo, 2013). The general classification of vesicles, although the size ranges suggested by 
different researchers varies, includes exosomes ranging between 30 to 100nm, 
microvesicles/ectosomes that directly bud from the plasma membrane covering the size 
range of 50-2000nm, and apoptotic bodies (50–5,000 nm) (Figure 1-1). Apoptotic bodies can 
be discriminated from other types of vesicles because they are actively released during the 
process of apoptosis (Akers et al., 2013), (Atkin-Smith et al., 2016) and can also encapsulate 
smaller vesicles or organelles (Minciacchi, Freeman and Di Vizio, 2015). At the same time, 
tumour cells release larger vesicles containing tumour-promoting material with paracrine 
activity, often described as oncosomes (1-10μm) (Minciacchi, Freeman and Di Vizio, 2015). 
There is evidence of significant levels of non-constitutively produced proteins loaded on EVs 
prior to the complete dissociation of the plasma membrane due to necrosis and these special 
signals have been associated with the process of apoptosis (Wickman et al., 2013). Apoptotic 
bodies and microparticles can be characterized as metabolically active structures that 
provide the apoptotic cells with the capacity to convey molecular messages over longer 
distances due to their ability to encapsulate functional molecules such as proteins or even 
cellular organelles (Gregory, Ford and Voss, 2016). Moreover, it is shown that apoptotic 
bodies released from tumour cells are responsible for transferring DNA to neighbouring cells 
and induce tumour progression and appearance of p53-deficient fibroblasts (Bergsmedh et 
al., 2001). With signs leading towards the conclusion that the Apo-EVs mediate signals that 
have an impact on tumour progression, it is essential to determine their properties and 
cargo, aiming at the development of therapeutic and diagnostic platforms (Lynch, 
Panagopoulou and Gregory, 2017). 
The effects of apoptotic cell-derived vesicles have been described in a number of studies, yet 
the mechanisms and functions are not entirely clear (Gregory, Ford and Voss, 2016).  
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It has been indicated that cancer cells under stress transfer genetically active material to the 
nearby cells and given that the EVs are loaded with nucleic acids, they possibly play a 
significant role in this communication (Ehnfors et al., 2009). In the case of stromal cells, there 
are data proving that EVs (smaller than 100nm) released from these cells upon a stress 
stimulus transfer signals supporting the neighbouring tumour cells in creating metastatic 
sites, promoting growth and inhibiting apoptosis (Vallabhaneni et al., 2016). In addition, in 
vitro-induced apoptosis to cancer cells by radiotherapy has been shown to have an impact 
on T-cell responses against tumour and this implies the potential of combining radiation with 
immunomodulatory therapies in cancer (Xie et al., 2009). Moreover, apoptotic bodies 
released from tumour cells are responsible for transferring DNA to neighbouring cells and 
can induce tumour and the appearance of p53-deficient fibroblasts (Bergsmedh et al., 2001). 
It is supported that the stress chemotherapeutics cause to cancer cells triggers massive EV 
release directly associated with apoptosis, while in parallel, necrosis does not cause this 
effect to such an extent. This observation has led to the idea that “mild” therapies which are 
not reactive enough to induce necrosis are potentially harmful due to the tumour-promoting 
signals mediated by apoptotic cell EVs (Aubertin et al., 2016). Other research groups have 
also expressed the idea that successful anticancer therapies are associated with reduction of 
EV release from the targeted cells, as those EVs can transfer therapy resistance genes ((Shao 
et al., 2012)-(Mitchell et al., 2009)). 
 
1.3. Burkitt Lymphoma and apoptosis 
Among the most aggressive types of lymphoma, Burkitt Lymphoma (BL) is classified as a B 
cell Non-Hodgkin Lymphoma (NHL), associated with the overexpression of the c-MYC 
transcription factor, caused by the deregulation of the MYC gene (Kalisz et al., 2019). This 
overexpression in c-MYC drives abnormally high B-cell proliferation rates, as well as 
significant levels of apoptosis (O’Malley, Auerbach and Weiss, 2015). Variations of the ‘single 
hit’ MYC-related mechanism are the ‘double’ and ‘triple hit’ cases in which the Bcl-2 and Bcl-
6 are additionally rearranged respectively, which leads to inhibition of apoptosis, therefore 
higher aggressiveness (Kalisz et al., 2019). Histologically, a typical characteristic of this 
particular type of tumour is the starry-sky appearance of the tissue, referring to the large 
extent of macrophage infiltration in the cancerous mass (Berard, C., G. T. O’Conor, L. B. 
Thomas, 1969) (Ogden et al., 2005). BL has been classified among the mature B-cell 
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lymphomas by the World Health Organization, according to the 2016 revision of the 
lymphoid neoplasm classification directive (Swerdlow et al., 2016). There are three main 
variants of the disease which also follow a demographic pattern. The first is the endemic BL, 
mainly occurring in African areas, affecting children around 7 years of age and almost always 
associated with Epstein-Barr Virus (EBV) infection, the second is the sporadic BL which has 
been observed worldwide and affects children as well as adults around 30 years old. Finally, 
there is a Human Immunodeficiency Virus (HIV)-related BL variant observed within the 
endemic HIV African areas, affecting HIV patients and children/adolescents. In African 
regions, the disease is more prevalent in young males, while the cumulative statistics show 
that Eastern Africa holds the highest NHL incidence and mortality rates with 7.5 and 5.7 per 
100,000 respectively (Orem et al., 2007). 
Diagnosis of the disease is currently based on histopathological examination, although the 
morphological pattern of the tissue might not always give a clear answer, therefore it is 
believed that a combination of histology with immunophenotyping and analysis of the 
genetic characteristics is considered to be a more complete approach (Wook Youn Kim, 
Matthew Pugh, Stefan Dojcinov, 2019). For cases in which there is an indication that specific 
genetic mutations are the main cause, Fluorescence In Situ Hybridization (FISH) is 
recommended for the detection of MYC and BCL2 genes (Sesques and Johnson, 2017). The 
above methods require the examination of the cancerous tissue, therefore invasive biopsies 
are needed. There is a clear lack of widely available methods for the evaluation of the stage 
of the disease as well as the success rate of the treatment as reported in the literature, and 
the current options include Positron Emission Tomography (PET) and minimal residual 
disease (MRD) technology, both of which require special and expensive equipment 
(Sandlund, 2012). 
A key characteristic of BL which can serve as a tool for the development of prognostic and 
diagnostic platforms is the high levels of apoptosis, which appears contradictory to the 
established knowledge that apoptosis prevents tumorigenesis. Paradoxically, it has been 
shown that apoptotic cells in BL tumours can have oncoregenerative properties by acting on 
angiogenic, trophic and reparatory pathways, among others (Ford et al., 2015). In addition 
to lymphoma, a similar pattern where increased apoptosis is correlated with aggressive 
progression of the disease is observed in tongue squamous carcinoma, urinary bladder and 
synovial tumours respectively (Naresh et al., 2001a; Jalalinadoushan, M., Peivareh, H., 

Maria Panagopoulou | PhD Thesis                                                                                                      The University of Edinburgh, 2020 
22 
 
the circulation remains a challenge, it is suggested that this dynamic process happens at high 
rates. Interestingly, when liver macrophages were depleted in the animal models, the EVs 
were retained in the circulation for a significantly longer period and therefore the EV 
concentration in the blood was higher (Matsumoto et al., 2020). These results agree with a 
previous study reporting that the clearance of circulating EVs was mainly performed by liver 
and spleen macrophages (Imai et al., 2015). The concentration of EVs in the blood is also 
another matter of discussion, for which there is not a definite answer due to technical 
limitations and differences in the systems under measurement. In an effort to collect the 
relevant literature and compare findings from various studies, Johnsen et al. report high 
variability in the results obtained after several isolation techniques were applied, however 
the authors extracted a mean of 1010 particles/ml (Johnsen et al., 2019). 
The following examples indicate that the cells/platelets found in the blood are releasing EVs 
and that the circulating EVs from various origins interact with those blood cells. To begin 
with, there is evidence that red blood cells release EVs not only physiologically, but also upon 
storage, which is of great significance in blood units intended for transfusion (Almizraq, 
Holovati and Acker, 2018). Leukocyte, platelet and red cell-derived larger vesicles (over 1μm) 
are also a part of the total blood EV population, additionally to the smaller EVs which had 
already been reported to derive from the above cells/platelets (Nanou, Zeune and 
Terstappen, 2019). Interestingly, EVs from various glial neuronal cells have also been found 
in plasma, as they can cross the blood-brain barrier (Saeedi et al., 2019). 
Other studies have provided evidence that red blood cell-derived EVs can interact with other 
blood cells with significant levels of uptake both in vivo and in vitro; in the first case, EVs 
labelled with a radioisotope were injected in mice, subsequently labelling white blood cells 
(Son et al., 2020), while in the second, red cell EVs were co-incubated with isolated 
monocytes, inducing cytokine release and subsequent increase in T-cell response (Danesh et 
al., 2014). EVs from Natural Killer (NK) cells are also interacting with other blood cells, and 
the highest uptake levels were measured for the same cells (NK) and cell lines of T cells and 
macrophages, upon comparison with tumour cell lines (Huyan et al., 2018). 
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Tumour-derived EVs and platelets 
A significant proportion of blood consists of platelets, which are cell fragments responsible 
for the regulation of blood clotting (thrombosis) and hemostasis. They are released by 
megacaryocytes which reside in the bone marrow and regarding their numbers in the blood, 
after red blood cells which are the most abundant type of cells, platelets come next followed 
by white cells (Seyoum, Enawgaw and Melku, 2018). Interestingly, platelets have been shown 
to have functions beyond their well-established hemostatic role, as studies have revealed 
that they can be conditioned by tumour cells. In more detail, tumour-specific RNA has been 
found in platelets isolated from prostate and glioma patients, and it was also shown that 
among a number of mechanisms of RNA transfer, the most prevalent is the uptake of RNA-
containing tumour EVs by the platelets (Nilsson et al., 2011). The term tumour-educated 
platelets (TEPs) has been given to describe the changes in biochemical composition the 
platelets undergo upon interaction with cancer cells which is often manifested by elevation 
of tumour-related levels of RNA. Although the whole range of the mechanisms involved in 
this process are not fully understood, it has been clearly shown that TEPs occur in patients 
bearing a variety of tumours (Best, Wesseling and Wurdinger, 2018). Sequencing of the 
platelet RNA isolated from the blood of breast cancer patients of patients in various stages 
has indicated sequences which can have a prognostic or diagnostic value (Lips et al., 2018), 
while the monitoring of another RNA component in lung cancer patients is a possible 
predictor of resistance to therapy (Nilsson et al., 2016). Further evidence that platelets can 
interact with EVs has been given by Rossaint et al., in a study where platelets and neutrophils 
are reciprocally activated via the release of neutrophil-derived EVs which are subsequently 
internalized in platelets (Rossaint et al., 2016). Those observations, and in combination with 
their high concentration in the blood suggest that in order to analyze the levels of 
biomarkers, instead of isolating the relevant cells -or EVs-, platelets could be a possible 
minimally invasive alternative.  
 
1.5. Analytical technologies applied on the nanoscale for the study of EVs 
In order to answer basic questions about the nature and functions of EVs, it is important to 
apply the appropriate methods of analysis and taking into consideration that EVs are 
nano/microparticles, the range of available techniques is different from the classic 
approaches often used in the field of medical research. In this section, a review on the 
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methods used in this work is given, with emphasis on the specific applications on EV analysis 
and the limitations or strengths of the measurement outcomes of each (Figure 1-3). 
 
Figure 1-3. Methods of analysis for EVs: A: nanoparticle tracking analysis, B: flow cytometry, C: fluorescence 
anisotropy, D: fluorescence microscopy, E: cryoEM and tomography and F: quantitative PCR  (adapted with 
permission from (Panagopoulou et al., 2020)). 
 
CryoEM 
A technique to directly image EVs is Electron Microscopy, which offers high resolution images 
for structures sized in the range of a few nanometres. Electron microscopy has been 
successfully used for biomedical purposes such as imaging of tissues, cells and even 
subcellular organelles (Mielanczyk et al., 2014). The basic difference from optical microscopy 
is that for optical observation, the source of illumination is visible light (or fluorescence) 
photons passing through the specimen which are viewed directly across the sample, while in 
electron microscopy the source of radiation is electrons. This is of great significance because 
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as the resolution limit is determined by the radiation wavelength, the shorter the 
wavelength, the higher the resolution which in case of visible light is between 4000 to 7000 
Å, while the electron beam has a wavelength of approximately 0.02 Å (for an electron beam 
operating at 300kV). The electrons are produced by an electron gun usually containing a 
lanthanum or tungsten source and are accelerated under vacuum in a voltage of 80-300kV 
towards the fixed, sputter coated or vitrified specimen (depending on the variation of EM, 
see below). Their interaction with the second is detected in two ways, dividing electron 
microscopy techniques in two main subgroups: transmission electron microscopy (TEM) and 
scanning electron microscopy (SEM) (Williams and Carter, 2009). In SEM, the electrons are 
scattered away from the surface of a specially stained specimen and collected from detectors 
which produce a 3-dimensional image of the surface of the specimen, based on the 
orientations of the scattered electrons. In TEM, the electrons are transmitted through the 
ultra-thin fixed specimen and are captured at the other side, producing a thumbprint of the 
sample. The direct interaction of the electrons with the biologic sample results in extensive 
damage due to the creation of free radicals and breaking of chemical bonds, while at the 
same time the more intense the beam is, the higher the quality of the image obtained. One 
approach used to tackle this issue is to stain the specimen with a material that enhances 
contrast so that the intensity of the electron beam can be reduced, without affecting the 
resolution.  
Another approach followed to avoid staining, to minimize the damage from the electron 
beam and to preserve the vesicles as close to their native state as possible during imaging is 
cryogenic TEM. This technique differs from conventional TEM in terms of the sample 
preparation and the temperature of the system during measurement. The thin specimen, or 
nanoparticle suspension in the case of EVs, is instantly frozen in order to create amorphous 
vitrified ice (glass-like) and non-crystalline hexagonal ice. To achieve vitrification, various 
procedures can be followed (jet freezing, slam freezing, high pressure cooling), yet, in this 
work plunge-freezing is used, which is also one of the most commonly used methods of 
freezing, as described in the literature (Table 1.1). The specimens are applied on a grid, 
usually made of gold or silver, which is a 1 μm mesh, and in case of liquid suspensions (EVs), 
surface tension serves as a force creating a thin film of material on the grid whereas in solid 
materials, sections of the appropriate thickness must be taken (Dubochet et al., 2016). The 
grid is plunged into liquid ethane (-88.5 °C) cooled by liquid N2 (-196°C) and upon vitrification 
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it is preserved in liquid N2. While under the electron beam, cryogenic conditions must be 
preserved so that the specimen is not damaged from heating and the ice does not melt 
(Figure 1-4). 
An advanced variation of cryoEM is cryogenic Electron Tomography, where 3D 
reconstructions of the specimen can be obtained. From one single particle, multiple images 
can be taken in different spatial orientations and are then projected on a 3-dimensional 
model yielding the structure of the particle with high resolution (Figure 1-4) (Nudelman, de 
With and Sommerdijk, 2011). 
 
 
Figure 1-4. Cryo electron microscopy workflow: Preparation of sample by plunge-freezing in liquid ethane (left): 
a grid on which the sample has been deposited is instantly dipped in liquid ethane and vitrification of the specimen 
is achieved by the formation of amorphous ice. Imaging configuration for 2-D and 3-D structures (right): a 2-D 
image of the specimen is generated by the transmission of electrons through the sample when the grid is at 0o tilt 
on the axis of the transmitted electrons; a 3-D image of the specimen can be reconstructed by recording a series 
of images of the sample when the grid is tilted. 
 
CryoEM has been successfully applied to the study of EVs derived from various human fluids 
as well as animal, plant tissues, microbes and viruses (Turpin, Kruglik and Curie, 2012) (Zeev-
Ben-Mordehai et al., 2014) (Renelli et al., 2004). A brief overview of the most interesting 
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collect the scattered photons from a forward and side position, reflecting the size and 
granularity of the particle, respectively. Finally, the signal from the scattered light is 
converted into a digital signal by the electronics system, which can be then illustrated by a 
variety of plots of several parameters on a computer (Macey, 2007) (Wilkerson, 2012).  
As flow cytometry has been long considered a technique mainly applicable to large entities 
such as cells, its use on EVs is a controversial topic. Although the light scattering method has 
been reported for EVs only following a polystyrene bead calibration step (Lacroix et al., 
2010), this technique has been criticized for its validity (Nolan, 2015). The scattering method 
introduces limitations concerning the refractive index and the dependence of the scattered 
intensity on the r-6 of the particles, while fluorescent sensing is independent of these 
parameters (Nolan, 2015). For conventional instrument setups, EV detection and 
phenotyping using fluorescent markers for flow cytometry has been reported for vesicles 
with a diameter below 600nm (Menck et al., 2017) (Vagida et al., 2017) as well as larger 
apoptotic bodies (Atkin-Smith et al., 2017).  
To overcome the sensitivity issues with conventional instruments, a commonly used 
approach for EV characterization involves the selective binding of the vesicles on large 
magnetic particles, forming a larger complex which can be detected within the conventional 
detection limits of cytometers (Vagida et al., 2017), (Wiklander et al., 2018). The principle 
behind immunomagnetic bead-based isolation is to use magnetic beads whose surface has 
been functionalized with vesicle-specific probes (antibodies) to capture vesicles with high 
selectivity (Figure 1-5). Efficient capturing of EV on the surface of the magnetic particles is 
essential to ensure the total population can be analysed and some of the most common EV 
markers used for this purpose are CD9, CD63 and CD81 (Théry, Zitvogel and Amigorena, 
2002). Staining all particles with non-specific membrane dye can discriminate between the 
magnetic particles carrying vesicles and the unconjugated particles which only appear on the 
scatter plots. Further labelling of the compartments of interest can bring up the positive 
populations.  
 




Figure 1-5. Schematic overview of immunomagnetic bead-based EV isolation and phenotyping by fluorescent 
labelling and flow cytometry. Magnetic beads coated with antibody against an EV surface molecule are incubated 
with EVs and the excessive unbound EVs are finally removed by the collection of the beads on a permanent magnet 
and washing off the EV-containing supernatant. Labelling of EVs with fluorescent or other probes can be 
performed on the bead-bound EVs and washing can be achieved again by the use of a magnet. The labelled bead-
bound EVs can be measured by flow cytometry. 
 
Examples of magnetic beads being used to isolate EVs and investigate their phenotype by 
flow cytometry can be found in various studies. Anti-MHC class II antibody coated magnetic 
beads (dynabeads) were used to isolate EVs from breast milk (Admyre et al., 2007) and 
antigen-presenting cells (Clayton et al., 2001), secondary antibody-coated beads 
(dynabeads) are also used for reticulocyte EV coupling, after conjugation with the 
appropriate antibody (Rabesandratana et al., 1998). Streptavidin beads have been the 
vehicles to carry melanoma-derived EVs after being coated accordingly (Sharma et al., 2018) 
and protein G beads were coated with Herceptin (anti HER-2 antibody used in cancer 
immunotherapy) to capture HER-2 positive vesicles (Koga et al., 2005). 
Although this method cannot provide data about the diameter or number of EVs, staining 
with fluorescent antibodies or other dyes enables EV phenotyping and is used for a large 
variety of molecules of interest (Oksvold, Neurauter and Pedersen, 2015), (Tauro et al., 
2012), (Koliha et al., 2016). Another consideration about this method is that the results do 
not provide information about individual vesicles, but only an average of the population 
(Admyre et al., 2003), (Morales-Kastresana and Jones, 2017).  
Acknowledging the limitations of the bead-based cytometry and coming back to the 
cytometric analysis of free EVs in suspension, significant efforts have been made towards the 
development of flow cytometers specifically designed for smaller particles (Stoner et al., 
2016), (Pospichalova et al., 2015), (van der Vlist et al., 2012). In the case of direct EV 
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measurement, the quality of EV staining is crucial, as dye aggregates are a major cause of 
noise and artefacts. More recent advances enable the detection of particles with a diameter 
of 100 nm (Kormelink et al., 2016), while variations of the conventional method such as 
imaging and high-resolution flow cytometry have introduced new potentials in EV 
measurements (Lannigan and Erdbruegger, 2017), (Erdbrügger et al., 2014) and (Maas et al., 
2015). 
Flow cytometry measurements are fast and offer the ability for analysis of multiple markers 
simultaneously. Despite the advantages, however, its use on EVs raises issues related to 
sensitivity for the smaller particles. In a comparison between flow cytometry and 
nanoparticle tracking analysis (NTA), it is a fact that NTA is by definition designed for particles 
smaller than 1 micron, therefore ensures higher sensitivity (Dragovic et al., 2011), as there 
are parts of the total EV population which are not readable by flow cytometry due to the 
scattering signal from EVs being of intensity comparable to noise (Akers et al., 2016). 
Although some custom-built instruments can bring the resolution down to approximately 
100nm, for the phenotyping of even smaller vesicles, other techniques can be considered 
(Erdbrügger and Lannigan, 2016). 
 
Dynamic Light Scattering (DLS) 
Dynamic Light Scattering (DLS), also known as photon correlation spectroscopy, is a 
commonly used technique to characterize micro- and nano-particles and since the resolution 
range of the technique is 1 nm to 6 μm, it is particularly useful for different biologic samples 
which usually show a variety of size profiles. The results obtained with DLS are the mean 
hydrodynamic radius of the particles, polydispersity index and size distribution curves. The 
physical principles behind the method are the Brownian motion (particles moving in a fluid 
on random trajectories due to interaction with other particles) and the Tyndall effect 
(scattering of light by particles in colloidal suspension) (Dejan Arzenšek, 2010). When 
monochromatic light (laser beam, for example 633nm He-Ne laser (Lawrie et al., 2009)) 
passes through a cuvette containing suspended particles, it interacts with them and is 
scattered to different directions. Because the particles are also moving due to Brownian 
motion at the same time, collection of the scattered beams from various angles can show 
significant intensity fluctuations. Larger particles diffuse more slowly in the solvent 
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compared to smaller ones and this is measured, which is reflected in the intensity curve of 
the detected signal (Bhattacharjee, 2016). 
More practically, EVs derived from airway epithelial cells as well as from blood plasma have 
successfully been studied with DLS in two different studies. The results showed a mean 
hydrodynamic radius of approximately 300nm, with medium polydispersity index values 
(0.400) (Kesimer and Gupta, 2015). There have also been references to a highly sensitive 
method of determining the sample concentration when combining DLS with Bradford 
protein assay, achieving detection levels such as 0.01 mg/ml (Palmieri et al., 2014) (Lawrie 
et al., 2009).  
DLS is one of the methods of choice for monodisperse colloids, however in the case of EVs 
where a broad size distribution is observed, this technique is facing a serious limitation. This 
is due to the fact that the intensity of the scattered light is dependent on the sixth power of 
the radius of the particles, meaning that a small population of large particles in the 
suspension contributes massively to the intensity readout, reducing the resolution for the 
smaller particles (Bhattacharjee, 2016). 
 
Nanoparticle tracking analysis (NTA) 
NTA is a recently developed (2006) technique, commercially known as NanoSight (Malvern 
Panalytical Ltd., United Kingdom) with many applications on nanoparticles ranging from 
30nm to 1μm and especially on EVs (Filipe, Hawe and Jiskoot, 2010) . 
The instrumentation and working principle of the measurement are as follows: the sample 
is a colloid enclosed between an optical prism and a glass window. A laser beam is focused 
through the prism into the solution and particles in the beam path scatter light. The 
illuminated particles are visualized directly by an optical microscope, and a CCD camera 
captures videos over a period of time (usually 30-60s with 30 frames per second) defined by 
the user. Particle movement is recorded in real time and the video can be furtherly analysed 
by the software in order to yield concentration and size distribution of the particles in 
suspension. The velocity of each particle is measured throughout the recorded frames, as 
the software can track an individual event over the recorded time. Next, the two-dimensional 
Stokes-Einstein equation (Equation 1) is solved for diameter, given the measured velocity 
and all other parameters related to the conditions of the measurement. 
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<x,y>2  = 
𝐾𝐵𝑇𝑡𝑠
3𝜋𝜂𝑑ℎ
                                                                                                                         Equation 1 
Where <x,y>2 stands for mean square displacement, KB for the Boltzmann’s constant, T for 
temperature of the system (Kelvin), ts for sampling time, η viscosity and dh for the 
hydrodynamic diameter (Dragovic et al., 2011). 
In the biomedical field, NTA has been successfully used in the characterization of drug 
delivery systems with pharmaceutical interest (liposomes), protein aggregates and most 
importantly for this project, EVs (Filipe, Hawe and Jiskoot, 2010) with some of the most 
representative studies being described below. The number, size distribution and phenotype 
have been determined using a monochromatic laser beam at 405 nm in vesicles secreted 
from ovarian cancer cells isolated from blood by multiple centrifugation steps and 
chromatographic purification (Gercel-Taylor et al., 2012). Another study proves the 
application of the technique on vesicles derived from immune cells isolated from T cell line 
cultures by sequential centrifugation and suggests that NTA is more accurate when particle 
concentration ranges between 2*108 and 20*108 particles per ml (Soo et al., 2012). 
The NTA method can also be used in fluorescence mode, where the particles are labelled 
with a fluorescent dye and the laser beam used is appropriate for the excitation of the 
fluorophore. In this case, the selection of the fluorophore plays an important role in the 
stability of the fluorescence signal, as the long exposure to the laser beam can cause 
bleaching. Quantum dots are considered to be among the most suitable probes, as they offer 
photostability and sensitivity for particles under 1 micron (Table 1.2) (Dragovic et al., 2011).  
An example of how the NTA can be also used for analysis of a surface marker, but without 
fluorescent labelling has been reported for EVs from Jurkat cells which were captured on 
magnetic beads coated with anti-CD45 antibody and the levels of the CD45 positive EVs were 
determined by subtracting the EV number of the post-capture measurement from the pre-
capture concentration (Soo et al., 2012). The following table (Table 1.2) summarises a 
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Fluorescence – The basics of lifetime 
A physical phenomenon that has numerous applications in analytical techniques is 
fluorescence, the mechanism of which is illustrated in Figure 1-6 on the simplified Jablonski’s 
diagram. 
 
Figure 1-6. Simplified Jablonski diagram. S0, S1 and S2 represent the electronic states of the atoms in 
the ground (S0) and excited states (S1 and S2). The thin lines on every electronic state depict the 
vibrational levels and the dotted lines are the virtual energy states. When photons are absorbed by 
electrons found on S0, they cause their deformation to higher energy levels. Depending on the amount 
of the energy initially absorbed by the electron, and the energy released as the electron is returning to 
one of the ground states, several types of light emission can be defined: Rayleigh, Stokes and anti-
Stokes and fluorescence. Each type of energy conversion mechanism is used in different analytical 
methods, for example Rayleigh scattering for NTA, Stokes for Raman and fluorescence for a variety of 
other techniques discussed in this thesis. 
 
In this illustration, the electronic states of the atoms are depicted as S0 for ground state and 
S1, S2 for excited states. Within the electronic states, thinner lines represent various 
vibrational states. There are also virtual energy levels (virtual states) which play an important 
role in the processes described below. Photons from the beam are transferred to the 
molecules of the sample, deforming them to higher vibrational levels.  
When photons are absorbed, the atom is excited to a higher electronic state S1 or S2 and the 
excitation is followed by a rapid relaxation to the lowest vibrational level of S1 which is a 
process named internal conversion. Fluorescence is the radiation emitted when returning to 
a vibrational state of the ground electronic state. The recording of fluorescence can be 
performed in two manners, which categorize the analytical methods in two large groups: the 
steady state and time-resolved mode. In the steady state measurement, the intensity of the 
emitted light is recorded upon excitation of the fluorophore with a continuous light source, 
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averaging the emission intensities from the total time period required for the phenomenon 
to be completed. In contrast, the time resolved mode uses a pulsed light beam and the 
emission from each pulse is recorded separately over time, resulting in a decay curve (Birch, 
Chen and Rolinski, 2015).   
In lifetime measurements, depending on the approach followed, there are two main sides 
that can be explored. As for the time domain, the technique is named pulse fluorometry and 
in the frequency domain there is phase-modulation fluorometry. Although these two 
approaches are equivalent in theory, the experimental set up and data analysis reveals some 
differences. In pulse fluorometry a sharp excitation beam is interacting with the sample and 
the decay is recorded, while in phase-modulation method, the excitation light is modulated 
as to its phase or cropped as to the wavelength and is compared to the wavelength shift or 
level of modulation in the emitted light. The most common lifetime recording technique in 
the time domain is the Time-Correlated Single Photon Counting (TCSPC) in which the 
fluorophore of interest is excited by a pulsed laser beam (short pulses in the range of 
picoseconds or femtoseconds). The delay between the excitation and detection of 
fluorescent photons is measured, resulting in a decay curve of the dye, which illustrates the 
fluorescence intensity over time. Experimentally, in the TCSPC setup a pulsed laser provides 
a short excitation beam to the sample while a signal synchronized with the light pulse is used 
to trigger a timing system such as a time-to-amplitude converter (TAC). The TAC records an 
analogue signal proportional to the time difference between the reference pulse and the 
fluorescent photon detected and converts it to voltage, which is then stored as an event in a 
multichannel analyser (MCA). The decay photons are filtered and captured by a fast detector 
such as a photomultiplier tube able to detect single photons, after which the technique Single 
Photon Counting (SPC) is named. The completion of multiple circles as described above yields 
the decay curve. The initially simplex form TCSPC systems which allows recording of the 
fluorescent decay of one wavelength at a time can also be developed in multiplex systems 
enabling the recording of multiple dyes in the same sample and has facilitated microscopy 
and lifetime imaging (Gerritsen et al., 2009). 
 
Time-resolved Fluorescence Anisotropy (Depolarization) 
Fluorescence anisotropy is a term that describes the diffusion of a fluorophore due to 
rotation and the migration of energy to other components of the microenvironment and is 
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measurable thanks to the ability of the fluorescent light to be polarized. The basics of this 
process involve the use of polarized light to excite the fluorophore (i.e. from all possible 
planes the excitation light can oscillate on, only one is allowed, excluding all others) which 
only excites the fluorescent molecules found parallel to the same plane at that moment. As 
the excited molecules rotate back to randomized positions due to Brownian motion or other 
energy transfer phenomena in the suspension, the emitted photons are recorded in a time-
resolved mode, generating a depolarization curve. This curve illustrates the rotational 
behaviour of the fluorophore and gives information about the degrees of freedom of the 
molecule in the particular microenvironment (Birch, Chen and Rolinski, 2015). 
Steady state and time resolved anisotropy can be determined by the same basic 
configuration of geometric planes of the polarized light and the molecular orientations. For 
time resolved depolarization measurements, the lifetime instrumentation is used (as 
described in the previous section ‘Fluorescence – The basics of lifetime’), with the only 
addition of polarizers on the excitation and emission arm. Recording a series of decay curves 





                                                                                                                  Equation 2 
where IVV(t) and IVH(t) are the fluorescence decay curves recorded vertically (V) and 




) is a factor used to correct the difference in the transmissions of fluorescent signal 
between the vertical and horizontal positions that result from the parts of the 
instrumentation (Birch, Chen and Rolinski, 2015). 
By further calculations, Equation 3 arises, where r0 stands for the initial anisotropy at t=0 and 
τc for the rotational correlation time, which is the rate of depolarization due to isotropic 
rotation. The maximum value for r0 is 0.4 from the literature (Birch, Chen and Rolinski, 2015), 
(Lakowicz and Knutson, 1980), (Bisby and Birch, 1989). 
r(t) = r0 exp (-
𝑡
𝜏𝑐
)                                                                                                                              Equation 3 
Equation 3 can be altered into binomial (Equation 4) when the fluorophore is present in two 
or more different environments, for example the molecules incorporated within the lipid 
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bilayer of the membrane and the free dye molecules. Both species have different rotational 
correlation time values which reflect their freedom to rotate within the microenvironment. 
A useful value that should be defined at this point is the membrane order parameter (S) 
which describes how strictly the membrane components are ordered. Membrane order is a 




                                                                                                                                              Equation 4 
Anisotropy has been long used to study the fluidity properties of biological membranes in 
their physiological state or after changes of pH, temperature, mechanical stress or other 
physical parameters. Model membranes such as liposomes with known lipid composition 
have been initially used (Birch, Holmes and Imhof, 1988) to prove that fluorescence 
depolarization can detect even subtle changes of the fluorophore’s rotational behaviour 
under a variety of stimuli (Bisby and Birch, 1989), (Holmes et al., 1991), (Holmes et al., 1997). 
This method has been extensively applied on cell membranes for the examination of lipid 
rafts, with the first references dating back to the 70’s (Shinitzky and Inbar, 1976a; Schachter 
and Shinitzky, 1977), continuing up to recently (Troup et al., 2006; Ben-Dov and Korenstein, 
2013). The membrane of EVs is a topic studied to a smaller extent because of the challenges 
associated with their heterogenous size, however, fluorescence anisotropy is a method 
sensitive enough to detect changes in nanovesicles and give information about the 
membrane integrity, a critical factor when it comes to cargo transfer and exchange of 
biological materials. EVs isolated from dendritic and mast cells were stained with DPH 
(diphenyl-hexatriene) and the steady state anisotropy was determined for a range of pH and 
temperature values. The results showed that the membrane fluidity rises for pH 5-7, 
indicating that the membrane is potentially rearranged as the EVs migrate from the acidic 
multivesicular bodies to the neutral environment of the extracellular matrix (Laulagnier et 
al., 2004). DPH with steady state measurement was applied on a similar setting for the study 
of epididymosomes, EVs found in the epididymal fluid, showing that there are changes in the 
levels of sphingomyelin and increased microviscosity as the EVs are transferred to the final 
compartments of the organ (Rejraji et al., 2006). One more application of the above setup 
has been described for EVs from ovarian cancer, showing that the phase transition point of 
those membranes is found around 37oC (Shenoy et al., 2018). The examples reviewed here 
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use steady state anisotropy measurement systems, and it is observed that there is a lack of 
studies on depolarization using time-resolved instrumentation (TCSPC) and therefore, one of 
the goals of this thesis is to analyse the EVs in the time domain. 
 
Fluorescence microscopy and super resolution microscopy 
Visualizing EVs directly in tissues or organisms is a topic on which a lot of attention has been 
drawn, as live imaging can answer basic and remaining questions about the biogenesis, 
trafficking, interactions and clearance of EVs. Several groups have reported the imaging of 
EVs by fluorescence microscopy, either by conventional confocal setup or super resolution 
methods, extracting information from a resolution which depends on the limits of each 
imaging modality. As EVs range from a few nm up to microns in diameter, it is acknowledged 
that detailed brightfield imaging is not possible for the smaller fractions of EV, as the 
resolution of a conventional microscope is limited by light diffraction to approximately 200-
300nm. However, by attaching a fluorophore on EVs and using a configuration which 
eliminates out-of-focus light and ‘sharpens’ the emitted signal such as a confocal, EVs and 
their interactions with live biological systems can be studied. As confocal microscopy offers 
the option of live imaging, there are several examples of its use in localizing the EVs in cells. 
To name a few,  EVs with a dimeter around 50 to 80 nm were imaged within the Golgi 
complex (Nakano, 2002), or inside cellular compartments upon uptake (Lai et al., 2015; 
Lerner, Avissar and Beit-Yannai, 2017). The mechanism of uptake of EVs by cancer cells was 
also investigated (Koga et al., 2005), while CD63-labelled EVs have been tracked in zebrafish 
live (Verweij et al., 2019). In addition, individual EVs attached on a solid surface can be 
directly imaged for the purpose of phenotyping by appropriate staining (Hisada et al., 2017), 
while a number of articles refer to the use of multiphoton microscopy for direct imaging in 
live tissue (see (Panagopoulou et al., 2020) for a review of applications). 
Given the small size of the EVs, confocal microscopy has by definition limitations in imaging 
the whole range of sizes and therefore, super resolution microscopy is considered the most 
suitable approach, as it breaks the diffraction limit. This general category of microscopy 
techniques includes, among others, the direct Stochastic Optical Reconstruction Microscopy 
(dSTORM), which is based on the chemical induction of ‘blinking’ of a fluorophore so that not 
all molecules emit simultaneously, allowing precise localization of each isolated emitter. By 
taking a series of frames in which different molecules blink randomly at different locations, 
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the final reconstruction gives a detailed representation of the image with a resolution at even 
20 nm (Rust, Bates and Zhuang, 2006; Van De Linde et al., 2011). Examples of the application 
of STORM on EVs is the imaging of CD9-labelled particles inside dendrites of cells from 
Alzheimer’s animal tissue (Polanco et al., 2018), or the study of interactions of CD63-labelled 
EVs from breast cancer with other cell types (Chen et al., 2016). In this work, confocal 
microscopy has been mainly applied on EV live tracking and phenotyping, and STORM has 
been used to a smaller extent, for the structural imaging of the particles. 
Both microscopy strategies have strengths and limitations which are inherent to the working 
principle, thus the selection of the appropriate setup depending on the scientific question of 
the experiment is crucial. For confocal microscopy live imaging is possible, while a wide range 
of fluorophores is available for EVs and other tissues. On the contrary, STORM is mainly 
performed on fixed samples and the list of suitable dyes is significantly shorter, as they need 
to be chemically suitable for ‘blinking’ (Godin, Lounis and Cognet, 2014). Recent advances in 
the field promise super resolution tracking of EVs intracellularly, as well as simultaneous size 
profiling, as alternative to NTA (ONI, 2019). 
 
qPCR for RNA 
Most of the methods discussed earlier in this chapter refer mainly to the detection of specific 
protein cargo on the vesicles, especially by fluorescent or immunogold labelling. However, 
as mentioned earlier in the Introduction, some very distinct EV biomarkers are nucleic acids 
and especially various types of RNA. There is a large number of studies in which mRNA, 
miRNAs or other small RNA sequences have been shown to give EVs special functional or 
phenotypic properties and the method of choice for analysis of these macromolecules is 
quantitative Polymerase Chain Reaction (qPCR) after reverse transcription of the RNA in DNA 
(RT-qPCR) (Liu and Lu, 2015), (Sun et al., 2018). Apart from RNA, DNA has been also reported 
in EVs, especially from vesicles secreted from apoptotic cells (unpublished data, Gregory lab) 
or other EV types (Momen-Heravi, Getting and Moschos, 2018; Wang et al., 2018). The 
working principle of this technique is the use of a fluorescent probe which only fluoresces 
upon hybridization with the product of each cycle of the polymerase reaction, therefore, the 
kinetics of the fluorescence intensity indicate the levels of the existing sequence of interest. 
As the fluorescence intensity gives only relative levels of expression, but does not reflect the 
absolute quantity of the initial sample, it is essential to apply endogenous controls of stable 
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expression of an RNA, in order to normalize the values of each run, as well as controls on the 
sequence of interest so that the final result is expressed in -fold increase or decrease in the 
levels of the sequence of interest compared to the control (Jo Vandesompele et al., 2002; 
Bustin et al., 2009; IRIC, 2017). Practical considerations in the performance of qPCR for the 
EV samples are discussed in the relevant chapter (Chapter 4). 
 
Fluorescent labelling technologies 
As the majority of methods discussed and used in this thesis use fluorescence, it is important 
to give a brief overview of the range of labelling probes for EV components. Also, given the 
small EV diameter, taking into consideration the size of the fluorescent probes is in some 
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Other methods of analysis 
The methods discussed in the previous paragraphs are some of the most well-established 
approaches for overcoming the challenges of analysing EVs and are applied to this doctoral 
project on different levels. However, it is essential to acknowledge that there is a long list of 
other technologies, most of which are currently under development and promise to simplify 
EV procedures and bridge the distance between laboratory research and clinical use. A 
characteristic example of platforms for isolation and analysis of EVs in one device is the 
microfluidics chips and microarrays, which miniaturize laboratory procedures on a cartridge 
with several functional compartments. For example, serum can be processed on a chip and 
the EVs have been analysed for a pancreatic mRNA biomarker using a nucleic acid 
hybridization and signal amplification reaction (Hu et al., 2017). A more simple setup involves 
the immobilization of EVs on a CD63 binding surface and after staining with the fluorescent 
probes of interest, the signal can be read by other instruments such as a plate reader or a 
confocal microscope (Kanwar et al., 2014).  
Research is also moving towards the improvement of the currently used methods, for 
example by the addition of an autosampler for automation of Nanosight measurements (van 
der Pol et al., 2013b). Novel commercial platforms are also being developed for the purpose 
of phenotyping using fluorescent tags on microfluidics compartments (Bachurski et al., 
2019), (Lee et al., 2018). Finally, there is a variety of spectroscopic methods which have been 
applied on EVs or similar systems including mass spectroscopy for lipid, protein and nucleic 
acid sequencing, Raman spectroscopy, micronuclear magnetic resonance (microNMR) and 
small-angle X-ray scattering (SAXS), however are not discussed in more detail for the purpose 
of this thesis. 
 
1.6. Extracellular vesicle isolation, purification and storage 
The International Society for Extracellular Vesicles (ISEV) has identified the lack of 
standardized isolation workflow and are making efforts towards the establishment of  
protocols for isolation and enrichment of EV samples (Gardiner et al., 2016; Clayton et al., 
2019), so that EVs can be used more widely and reliably in both research and clinical settings 
(Ramirez et al., 2018). 
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Among the most common isolation methods are gel permeation chromatography, 
immunoaffinity capture or polymer-facilitated precipitation or ultracentrifugation among 
others (Lane et al., 2018). The different isolation strategies are taking advantage of distinct 
EV properties such as size, surface charge, density, affinity for biological targets and 
hydrophilic interactions with solvents (Konoshenko et al., 2018). More recent approaches 
based on microfluidics promise both capture and analysis of EVs on the same device as 
mentioned earlier. Some of the most popular isolation methods are presented in Figure 1-8. 
Due to the heterogenous nature of EV populations, combinations of methods are often used 
in order to overcome the limitations of each strategy. Moreover, each method yields slightly 
different EV populations or with different levels of enrichment in proteins or nucleic acids 
etc, therefore a common point authors often make when comparing different techniques is 
that the isolation protocol needs to be carefully selected, taking into account the purpose 
the EVs will be used for (Tauro et al., 2012; Patel et al., 2019). For example, EVs from spin 
column chromatography are preferred for RNA analysis over other methods (Mussack, 
Wittmann and Pfaffl, 2019). 
 
 
Figure 1-8. List of most commonly used methods in EV isolation (extracted from literature search, see main text 
for a description). 




One of the historically first and very classical ways of preparing an EV suspension from cell 
culture supernatants or biological fluids is ultracentrifugation (UC). This approach separates 
EVs using their density and was established in 2006 in a protocol where the EV suspension is 
centrifuged at 100,000g for 70min (Théry et al., 2006). UC has been a popular method for a 
number of research groups (Willms et al., 2018), while a survey is showing over 80% of the 
EV researchers are routinely using it (Bu et al., 2019). However, there is a theoretical 
background in the optimal centrifugation conditions for maximum EV recovery and while it 
is essential that the centrifugation conditions are calculated and adjusted to each rotor type, 
this step is often overlooked by researchers, resulting in variations in the EV preparations 
among the different studies (Cvjetkovic, Lötvall and Lässer, 2014; Livshts et al., 2015; Zhang, 
Yeo and Lim, 2019). As ultracentrifugation can lead to other types of particles being pelleted 
with the EVs, a variation of classical UC is the density gradient UC, in which the EVs are 
ultracentrifuged in a density cushion, resulting in the EVs being retained in the appropriate 
layer, while other particles of different densities such as mitochondria are found in other 
levels (Webber and Clayton, 2013; Campoy et al., 2016). 
However, this technique has not been the method of choice in this thesis, as there are 
concerns about the quality of the EV preparation and enrichment in proteins of interest. In 
a comparison among ultracentrifugation, immunomagnetic bead isolation and density 
gradient centrifugation, the Transmission Electron Microscopy images of the EVs showed 
vesicle aggregation and structural distortion, while the EV protein recovery after 
ultracentrifugation was lower than the other two methods (Tauro et al., 2012). In another 
study in which ultracentrifuged EVs were compared with EVs isolated from commercial 
immunocapture or density gradient kits, the EV specific proteins and RNA levels were 
significantly lower for the UC EVs than other kits (Patel et al., 2019). 
Another series of isolation methods involves different versions of filtration of EV. There are 
several types of ‘filters’ through which the EVs are separated by size such as through a 
membrane filter, a dialysis compartment or gel chromatography. In more detail, filtration 
through a membrane with small pores has been used as a stand-alone method or in 
combination with other steps such as UC or gel chromatography. Typical pore sizes range 
from 0.8 μm to 0.1 μm and the EVs can be fractionated as per size by the application of 
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multiple filters sequentially (Konoshenko et al., 2018). A very promising filtration approach 
which recovers the majority of EV is based on the use of 100kDa centrifugal filters, where 
the separation is assisted by centrifugation at 3,000g (Cheruvanky et al., 2007). It is expected 
that this method also has limitations in the EV yield and quality, because for large pore sizes 
the smaller EVs are filtered through, while for small pores such as the 100kDa, some 
contaminating proteins might be retained in the EV fraction. The latter was shown in a 
comparative study between UC and 100kDa filtration, where the EV contained lower levels 
of EV-related proteins and higher contaminant levels (Rood et al., 2010). An additional 
drawback is that EVs tend to bind and aggregate on the surface of most membranes (even 
on the low-protein-binding membranes) and in order to reduce the EV loss, more 
centrifugation or vacuum steps are often followed, the impact of which on the structural 
integrity of EVs is yet to be investigated (Taylor and Shah, 2015). 
Within the filtration category, a similar principle separates EVs from particles of different 
sizes by dialysis driven by hydrostatic pressure, called hydrostatic filtration dialysis. The EV 
suspension is retained into a 1000kDa membrane and all soluble components are dialysed 
to the buffer outside the membrane. This is a method that allows large volumes of dilute EV 
samples such as urine to be cleared from proteins, although one of the disadvantages is that 
some small vesicles can be dialyzed off the EV preparation (Tataruch-Weinert et al., 2016). 
Size exclusion, or gel filtration chromatography (SEC) is a filtration-type separation 
technique, although the EVs are passing through a gel rather than a porous membrane. In 
this method, a chromatography column is stacked with filling material which is often 
sepharose. This material consists of microscopic beads which have grooves and 
interdigitations that trap the smaller particles of the suspension. The impure EV sample is 
allowed to run through the column and the particles of smaller diameter or proteins and 
soluble factors are interacting with the filling material, delaying their elution. On the 
contrary, the larger entities such as the EVs exit the column first and therefore, by collecting 
sequential fractions during elution, the separation of EVs from soluble components can be 
achieved. Analysis of the EV and protein content of each fraction has shown that for a column 
of the appropriate dimensions, the EV-containing fractions do not overlap with the protein-
containing fractions (Böing et al., 2014; Welton et al., 2015). More recent efforts to optimize 
the performance of SEC have been made in order to determine the most efficient filling 
material and elute. The EVs obtained from comparing various parameters were analysed for 
Maria Panagopoulou | PhD Thesis                                                                                                      The University of Edinburgh, 2020 
47 
 
their protein content by a sensitive technique based on mass spectroscopy and it was 
concluded that Sepharose CL-4B in combination with PBS ensures the highest resolution in 
EV-protein separation (Lane et al., 2019). 
One disadvantage of this technique is that chylomicrons or large lipoproteins from plasma 
samples might be eluted together with the EVs (Taylor and Shah, 2015) , and besides, the EV 
suspension is diluted after elution which often means that a concentration step is needed. 
The next range of isolation methods includes several techniques based on the change of 
solubility or precipitation. Separation between the soluble materials and organic particles 
such as EVs takes place by the addition of a hydrophilic polymer (often polyethylenoglycol, 
PEG) in the aqueous EV suspension. The molecules of the suspension medium (i.e. water) are 
used to solubilize the polymer and therefore, they become less available to the EVs, leading 
to the reduction of their affinity for the solvent. As a result, the EVs can be removed from 
the suspension by a centrifugation step at relatively low speed, often 1500 g. The basic idea 
of this method has been described since 1970, when it was used to isolate viruses 
(Yamamoto et al., 1970). However, it has been successfully applied in the EV field and is 
currently in use, especially after the commercialization of relevant kits dedicated for EVs and 
although EVs have been isolated in high yields (Antounians et al., 2019), the working principle 
reveals one significant drawback of this method. This is the co-precipitation of large particles 
such as albumin aggregates or other (eg blood) components, leading to compromised purity 
of preparations, especially for plasma derived EVs. In a comparative study among SEC and 
precipitation by a commercial kit, and precipitation coupled with a chromatographic device, 
it was shown that the SEC column results in the highest purity of plasma derived EVs, 
followed by chromatography-coupled precipitation and finally precipitation alone (Lobb et 
al., 2015). 
The methods listed above are some of the most widely used and extensively studied 
techniques which are based on the physical properties of EVs. However, some biological 
features can be also used for effective isolation and purification, such as immunoaffinity 
binding on surfaces or beads. Surfaces coated with antibodies specific against EV surface 
molecules are trending mainly in microfluidic systems, however, in this work, 
immunomagnetic beads have been used to perform selection and characterisation and are 
discussed in more detail. Besides selectivity, immunomagnetic beads are a gentle means of 
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handling EVs as their coupling on larger entities allows the performance of various processing 
steps by the use of low force magnetic attraction. Chemical modification of the bead surface 
with antibodies adds the property of versatility and makes this platform the method of 
choice for a number of applications (Ruffert, 2016).  
This approach has been especially useful for plasma-EVs, as plasma comprises of a large 
number of components with a size similar to the vesicles of interest. This results in the 
contamination of the vesicle population with large protein aggregates (mostly lipoproteins), 
cell and platelet fragments and most interestingly, chylomicrons, a type of micelles of lipids 
and proteins that cannot be reliably removed by common purification methods such as 
centrifugation or size exclusion chromatography (Sódar et al., 2016; Simonsen, 2017).  
 
Storage 
As the EV field has seen rapid expansion over the past few decades, researchers have been 
focusing on their properties and functions, however, the EV stability under storage 
conditions has been investigated to a smaller extent. Some key facts regarding storage and 
handling have been recently shared by Clayton et. al., indicating the need for the 
establishment of common procedures among different research units so that results can be 
compared and validated (Clayton et al., 2019). 
Because either human or animal blood is collected usually according to specific clinical 
protocols or guidelines, time becomes a significant parameter in plasma handling. This 
means that it is often necessary to store plasma for future use or store aliquots of the same 
donor’s plasma for further research, or until a trial is completed and samples from all 
timepoints have been collected. Some research has been conducted on the optimal 
conditions of storage and quality of plasma derived vesicles and the common storage 
method is freezing at -80oC after removing the platelets, which would otherwise become 
activated during the freezing-thawing procedure (Kriebardis et al., 2016), (Witwer et al., 
2013). Also, depending on the components of interest in EVs, the conditions can differ; for 
example, it has been shown that DNA content remains generally intact after freezing and 
thawing cycles or after 7 days at different temperatures (Jin et al., 2016). Also, the use of 
cryoprotectant is another variable which can have an effect on the EV properties such as 
increased secretion of pro-coagulant vesicles from frozen platelet preparations (Tegegn et 
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al., 2016). It is therefore important to identify the appropriate method to ensure maximum 
recovery of the molecules of interest. 
Among the publications discussing the optimal conditions of storage for EVs in general, only 
a small number refer to cell culture supernatant-derived EVs, possibly due to the urgent need 
to study biological fluid- derived EVs (Jeyaram and Jay, 2018). From this limited number of 
articles, it is indicated that, similarly to blood plasma, freezing at -80oC results in the smallest 
reduction in EV number and RNA content compared to +4 oC or -20 oC (Witwer et al., 2013; 
Lorincz et al., 2014).  
 
1.7. Hypothesis and Aims of the project 
Based on previous studies showing the effects of apoptotic tumour cells in disease 
progression, and with preliminary evidence supporting the notion that Apo-EVs are involved 
in the oncoregenerative network, it is hypothesized that the detection of Apo-EVs in patients 
can serve as an indication of the stage and aggressiveness of a malignant disease. As 
discussed earlier in this chapter (1.2) for BL, the diagnostic and monitoring protocols can be 
invasive and often lacking important information, which is one reason behind unsuccessful 
therapeutic attempts. It is also known that the levels of apoptosis play a significant role in 
the patient’s clinical outcome and can be used as indicators of stages of the tumour, 
metastatic tendency and overall survival prognosis not only for BL, but for other highly 
aggressive tumours such as squamous carcinoma, synovial sarcoma and bladder cancer for 
example (Naresh et al., 2001b), (Kawauchi et al., 2000), (Lara et al., 1999)(Leoncini et al., 
1993).  Therefore, the development of a minimally invasive analysis which would offer the 
ability for continuous monitoring and the collection of multiple samples could provide 
clinicians with a useful platform which could enable early detection and more efficient 
planning of the appropriate therapeutic strategy.   
The main aim of this project is to explore the nature of apoptotic tumour cell-derived EVs 
and reveal their potential as blood biomarkers in BL, but also in other tumours where the 
apoptotic index offers prognostic value (see above).  
To achieve this goal, there are two points to be addressed: 
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a) as the field of Apo-EVs is currently emerging, the information about these vesicles is 
limited, and especially in the case of lymphoma, the existing knowledge about their 
biochemical properties is insufficient. Therefore, in order to use Apo-EVs in analysis, 
it is essential to understand the molecular and structural differences of those 
populations in comparison to other tumour-derived, non-Apo-EVs.  
b) the detection of Apo-EVs in the blood highly depends on their availability and the 
potential cross-talk they have with the circulating components of the blood. It is 
important to assess whether the Apo-signals are maintained in the EVs or are 
transferred to cells including platelets in the blood, as this information will drastically 
shape the analysis procedure. 
For the first point, which is the largest part of this thesis, emphasis has been given on the 
methods which can be used to answer those basic questions about Apo-EVs. Acknowledging 
that the EVs are significantly smaller than cells, the techniques suitable for detection and 
analysis are lying in the area of nanometrology or can be methods used for cells which have 
been adapted for the detection of vesicles. Of special interest is the application of a variety 
of methods for Apo-EV analysis, each of which targets a specific subset of the EV spectrum 
and can give different sets of information. A comparison between similar methods will also 
be an important part of this process, in an attempt to set the bases for standardisation of 
future analyses. The features where differences between Apo-EVs and non-apoptotic 
tumour cell EVs will be sought are the physical structure, the membrane fluidity properties, 
size distribution and secretion patterns, protein and RNA markers. A schematic example of 
how the available techniques should be critically examined and how multiple methods could 
be used for the confirmation of results is shown in Figure 1-9. 
 





Figure 1-9. Size scale of EVs and resolution of available analysis methods. The methods of analysis can be grouped 
in those which can measure intact EVs, such as the NTA, cryoEM, anisotropy, DLS, microscopy and flow cytometry 
and the techniques in which the EVs can be lysed, such as qPCR and  Western blotting. Each of the above methods 
can examine a specific range of EV sizes, therefore they need to be selected with respect to the research question. 
 
For the second part where the Apo-EV are examined in blood, platelets, erythrocytes and 
leukocytes from the blood of healthy volunteers are treated with EVs and this interaction is 
measured in terms of quantity and quality. The levels of uptake are assessed and the nature 
of EV-cell interaction is also studied in order to determine whether the Apo-EVs are only 
binding on the surface of the cells or can be internalized and possibly deliver their cargo 
intracellularly. An initial examination of potential Apo-EV marker transfer in treated platelets 
is also performed, as platelets are less complex structures compared to the cells and those 
observations can assist in optimising the procedures for further studies. 
Both parts of this study are performed on in vitro generated vesicles from Burkitt’s 
lymphoma cell lines, and more details on the practical objectives of each section are 
presented in the relevant results chapters.  
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2. Materials and Methods  
2.1. Cell culture 
Two human Burkitt Lymphoma (BL) cell lines were used for EV isolation in vitro, the BL2 and 
BL2-Bcl-2. This is because in order to assess the uniqueness of the Apo-EV characteristics 
compared to non-apoptotic tumour cell EVs, a control physiological vesicle population is 
required. For this purpose, a special cell line was used, which is a BL2 apoptosis-resistant line 
transfected with the apoptosis-suppressing gene Bcl-2. The BL2-Bcl-2 cells are resistant to 
apoptosis and have been previously generated by colleagues in the Gregory group by 
transfecting BL2 cells with the Bcl-2 gene using an existing protocol (Wang et al., 1996). All 
cells have been cultured in serum-free media (RPMI 1640 and X-Vivo 20) at 37°C, 100% 
humidity and 5% CO2. 
 
2.2. EV preparations in vitro 
2.2.1. From cultured cells 
BL2 and BL2-bcl-2 cells were exposed to apoptosis inducing factor (UV treatment) and next, 
Apo-EVs and the corresponding Bcl-2 control vesicles were isolated from the culture 
supernatants. The process involved UV irradiation of the cells at high concentration (20*106 
cells/ml) followed by incubation in standard culture conditions while apoptosis was being 
monitored hourly. In more detail, apoptosis was induced on cells by UV-B irradiation using a 
CL-1000 Ultraviolet Crossslinker instrument and a total dose of 3,000 mJ/cm2 as 6 doses of 
500 mJ/cm2. The conditions for the UV irradiation regarding the dose and the concentration 
of the cells have been established by Margaret Paterson in the Gregory group in order for 
the cells to undergo apoptosis but not proceed to necrosis by the end of the incubation 
period. Because there is a time-dependent relationship between apoptosis and subsequent 
secondary necrosis, both apoptosis and necrosis were measured every hour after UV 
treatment.  Annexin V assay is a well-established method for assessing the level of apoptosis 
and is based on the translocation of the phospholipid phosphatidyl serine (PS) from the inner 
side of the cell membrane where it is physiologically found, to the outer part when the cell 
becomes apoptotic (van Engeland, M., Nieland, L. J. W., Ramaekers, F. C. S., Schutte, B. and 
Reutelingsperger, 1998). Annexin V conjugated with Alexa Fluor 488 (Table 2.2) binds 
selectively to PS and can be detected by flow cytometry. Necrosis was measured by the 
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addition of a DNA stain, Sytox Blue which is a cell impermeable dye for non-necrotic cells, 
but manages to stain the DNA when the membrane is permeabilized (sign of necrosis). The 
aim was to isolate EVs from cells being Annexin V single positive with the minimum 
percentage of necrotic cells possible. At the time point when the Annexin V single positive 
cells count for at least 80% of the population (with Sytox Blue positive and double positive 
cells not exceeding 5%), the cells were harvested and the EVs isolated (Figure 2-1). The 
process of isolation requires the collection of the culture supernatant with mild 
centrifugation force (25g) for 1h followed by sequential filtering through a 5μm mesh filter 
and finally through a 1.2μm syringe filter. The force of centrifugation was kept low (therefore 
the duration of centrifugation was longer) in order to avoid fracture and uncontrolled 
particle release from the fragile apoptotic cells, which would result in a contamination of the 
EV preparation. During the filtration steps no external force was applied, as this could 
possibly result in damaging the vesicles’ structure and unlike other protocols reported that 
involve density gradient centrifugation and ultracentrifugation (Kalra et al., 2013), gentle 
handling was preferred, so that the final material remains structurally intact for the series of 
analyses that will follow. Diluents and culture media during the isolation procedure and 
possible dilution steps were always 0.1μm filtered so that any impurities do not interfere 
with the EV studies due to similar size. 
 
 
Figure 2-1. Apoptosis progression for BL2 and BL2-Bcl-2 cells after UV treatment, as measured by Annexin 
V/Sytox Blue staining by flow cytometry. The cells are treated with UV-B irradiation at 20*106 cells/ml for a total 
dose of 3,000 mJ/cm2 as 6 doses of 500 mJ/cm2. The levels of apoptosis are measured in hourly intervals after UV 
treatment and the graphs represent the average of three independent experiments. The BL2 cells undergo 
apoptosis, whereas the apoptosis-resistant BL2-bcl-2 cells remain AxV- during this time-frame (protocol developed 
by Margaret Paterson). 





2.2.2. From blood plasma 
EV isolation from blood is a process more complex than isolation from culture supernatants 
and the literature offers a number of studies on blood vesicles, but what is firstly observed 
in all these references is the lack of common experimental procedures on plasma handling 
for vesicle isolation. In some cases, significant discrepancies are observed as to which 
fraction of plasma contains the vesicles or which method of isolation is less harmful to the 
final sample (Baranyai et al., 2015), (Witwer et al., 2013), (Yuana, Bertina and Osanto, 2011). 
The first approach to examining the use of blood as a source of vesicles was to identify the 
differences between blood serum and plasma, so that the appropriate source could be used 
for all the procedures to follow. According to ISEV, serum which results from spontaneous 
blood clotting contains approximately 50% platelet derived vesicles, due to platelet 
activation during the clot formation process. Plasma, on the other hand, which is collected 
after the addition of anticoagulants has a lower percentage of platelets and their side-
products. In this study, the material of interest was the Apo-EVs from cancer cells, thus, 
plasma was the most appropriate source (Witwer et al., 2013). There are also studies using 
sera as a source when the isolation of specific type of vesicles is desired (Kim et al., 2005). 
Because either human or animal blood can be collected only within specific guidelines and 
often with limited access to the donor, time becomes a significant parameter in plasma 
handling. This means that it is usually necessary to store plasma for future use or store 
aliquots of the same donor’s plasma for further research, once enough knowledge is 
obtained from the preliminary experiments. Some research has been conducted on the 
optimal conditions of storage and quality of plasma derived vesicles and the common storage 
method is freezing at -80oC after removing the platelets (Kriebardis et al., 2016), (Witwer et 
al., 2013). 
The protocol applied for blood-derived EV isolation has been designed by comparing multiple 
protocols described by other groups, excluding all procedures which might cause structural 
distortion such as ultracentrifugation, and was the following: 
Blood was collected in 3.8% sodium citrate and centrifuged at 300g for 20min without brake 
in order to obtain plasma, followed by a second centrifugation at 2,300g for 15 min to 
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remove all platelet and cell debris residuals. To avoid activation of platelets with subsequent 
vesicle release, the temperature was maintained above 20oC and shear forces were 
minimized until the platelets were removed with the first centrifugation. 
The supernatant from the second centrifugation could be collected fresh and analysed 
immediately, or rapidly frozen at -80oC and stored for future use. 
The frozen plasma aliquots could be used by rapid thawing in a 370C water-bath and 
centrifugation at 2,300g for 15 min at 4oC to remove all impurities resulting from vesicle or 
protein aggregation caused during the freeze-thaw cycle. 
The above procedure applies for animal and human samples with the only difference being 
that the volume of mouse blood is less than 1ml, while human samples can be up to 150ml 
or more. 
 
2.2.3. Chromatography columns preparation, validation and use for EV purification 
For experiments where the EVs needed to be purified from proteins and other soluble factors 
in which they were suspended, size exclusion chromatography was used. For this method, 
chromatography columns were prepared in-house, using Sepharose CL-6B as a filling 
material, to ensure EV-sized particles are separated from proteins.  
To pack the columns, empty columns were filled with Sepharose CL-6B suspended in DPBS. 
In order to validate the separation and identify the fractions which contain the eluted EVs, 
1ml of EV sample from cell culture was added to the columns and DPBS was added in order 
to collect several 1ml fractions. 
All fractions were measured by Nanosight to determine the EV concentration, while protein 
content was measured by Bradford Protein Assay with a procedure described in detail in the 
Western Blotting section of this chapter. 
The results for EVs and protein fractions are presented in Figure 2-2. 
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2.3. Platelets isolation from blood plasma 
The platelets used for all relevant studies have been isolated from blood of healthy 
volunteers within the Centre for Inflammation Research Blood Donor Register after informed 
consent. The blood was drawn into a 50ml centrifuge tube containing 4ml sodium citrate 
3.8%, and platelet rich plasma (PRP) was prepared by centrifugation of whole blood at 350g 
for 20 min, according to the internal CIR protocol (Davidson, 2015). After the PRP was 
collected, the method followed for the isolation and washing of platelets has been described 
by Abcam and has been adjusted to the following procedure:  
The PRP was diluted 1:1 in HEP buffer (140 mM NaCl, 2.7 mM KCl, 3.8 mM HEPES, 5 mM 
EGTA, pH 7.4) and 1 μM prostaglandin E1 was added to prevent platelet activation. The 
contaminating red and white blood cells were removed by centrifugation at 100g for 20 min 
at room temperature and next, the platelets were pelleted by centrifugation at 800g for 20 
min at RT. The platelet pellet was washed with wash buffer (10 mM sodium citrate, 150 mM 
NaCl, 1 mM EDTA, 1% dextrose, pH 7.4) and the platelets were finally resuspended in 
Tyrode’s buffer (134 mM NaCl, 12 mM NaHCO3, 2.9 mM KCl, 0.34 mM Na2HPO4, 1 mM 
MgCl2, 10 mM HEPES, pH 7.4) containing 5 mM glucose and 1 μM PGE1. The platelets were 
counted and the concentration was adjusted at 1-3*108 platelets/ml in the above medium. 
The suspension was kept at room temperature with gentle shaking. 
Phenotyping of platelets was performed using CD42b staining (Abcam #ab119496 - CM405F, 
and isotype BD #562438 BV421) by flow cytometry (details about all antibodies in Table 2.2). 
 
2.4. Red and White blood cells isolation from whole human blood 
Similar to platelet isolation, red and white blood cells have been isolated from blood of 
healthy volunteers within the Centre for Inflammation Research Blood Donor Register after 
informed consent. The protocol based on Percoll cell isolation was internally validated and 
used by the CIR ((Davidson, 2015), based on previously described methods (Dooley, Simpson 
and Meryman, 1982)).  
Whole blood was drawn into a 50ml centrifuge tube containing 4ml sodium citrate 3.8% and 
platelet rich plasma (PRP) was prepared by centrifugation at 350g for 20 min. After this 
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centrifugation, the red cells were pelleted and the white cells formed a layer (the buffy coat) 
on the red cell pellet. To further purify the red cells, a quantity of the red cell pellet was 
removed and 9x saline volumes (0.9% NaCl) were added. The red cells were washed with 9x 
saline volumes 3 times by centrifugation at 300g for 5min and were stored in saline at 4oC. 
For leukocyte isolation, the remaining red cell pellet with the buffy coat were used after the 
PRP has been removed. 6% dextran solution was added to the cells at a ratio 1:4 to the initial 
whole blood volume, topped up with 4 volumes of saline and incubated at RT for maximum 
30min. Dextran was added in order for the red cells to precipitate, allowing collection of 
leukocytes from the supernatant. The collected cells were pelleted by centrifugation at 350g 
for 6min. A Percoll gradient was prepared with three layers; the top, middle and bottom, 
with stock Percoll solution diluted as 81%, 70% and 55% in PBS respectively. The cell pellet 
was suspended in the top layer and was added on the top of a gradient formed by the bottom 
and middle layer. The layers were centrifuged at 720g for 20min and the PMNs 
(polymorphonuclear cells) were found in the bottom/middle interface, while the PBMCs 
(peripheral blood mononuclear cells) were isolated from the middle/top layer interface. The 
cell populations were washed in PBS at 230g for 6min followed by centrifugation at 300g for 
5min. The cells were finally resuspended in X-Vivo 15 (Ogden et al., 2001) and stored at 37oC 
+ 5% CO2 for a maximum of 2 days. 
 
2.5. Immunomagnetic beads for selective EV capture – preparation 
A variety of magnetic beads coated with antibodies against several EV surface molecules 
were used for EV studies, and each type of beads was functionalized with the appropriate 
surface antibody by different strategies (e.g. streptavidin-biotin interaction, formation of 
covalent chemical bond etc., see below). In more detail, the beads used here were prepared 
as follows: 
• CD9, CD63, CD81 and W6/32 beads: Streptavidin magnetic beads and biotinylated 
anti- CD9, CD63 and CD81 antibodies were obtained by MBL (Exocap kit). In addition 
to the three antibodies, anti-MHC class I-biotin antibody was used on the beads of 
the same kit, for comparison. The anti-MHC class I antibody was produced in-house 
from hybridoma cells [ECACC (#84112003) mouse anti-human HLA A, B, C hybridoma 
cells, clone W6/32] and was purified from culture supernatants by affinity capturing 
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on Protein A chromatography column. It was biotinylated following the protocol of 
a commercially available biotinylation kit (Sulfo-NHS, ThermoFisher), according to 
the manufacturer’s guidance. The attachment of the biotin-antibodies on the beads 
was performed according to the bead kit manufacturer/s protocol. 
• CD19 beads (Ø4.5μm) were used without further modification. 
• CD20 beads (Ø10μm) were prepared by conjugation of anti-CD20 antibody on 
Protein A beads, following the manufacturer’s protocol. 
• -COOH surface activated beads: beads of Ø1μm with surface carboxyl groups were 
purchased from ThermoFisher and were activated with a reagent alternative to 
EDC/NHS reaction, the Mix n’ Go Micro without further functionalization of protein. 
These beads will be added to the EVs and the attachment will take place by the 
formation of amide bond between the activated -COOH group of the beads and the 
primary amines present in the EV proteins. 
• Anti-PS beads were purchased as a kit, MagCapture (FUJIFILM Wako), and used 
without further processing, with the buffers and reagents contained in the kit. 
After coating with the antibodies, all beads (except for -COOH activated beads and anti-PS 
beads) were washed and resuspended in 2mM EDTA + 0.5% BSA in PBS to minimize particle 
aggregation during storage. All bead handling was performed on a permanent magnet. 
The assessment of the antibody coupling efficiency was conducted by flow cytometry, using 
a fluorescence labelled antibody specific against the coupled protein. All anti- CD9, CD19, 
CD20, CD63, CD81 and W6/32 mouse anti-human antibodies are of the IgG isotype, therefore 
a goat anti-mouse secondary immunoglobulin IgG-FITC antibody (Sigma #F0257) was used to 
stain the beads.  
 
2.6. Analytical methods for the characterisation of EVs 
All buffers were filtered through a 0.1μm filter. 
 
2.6.1. Nanoparticle Tracking Analysis 
EV concentration and size distribution was measured by Nanoparticle Tracking Analysis for 
Rayleigh scattering (Nanosight, Malvern, UK) on a Nanosight LM14 with a cMOS Hamamatsu 
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Orca Flash 2.8 camera and processed with NTA 2.3 software (capture settings: camera 
level=16, video recorded for 60s, imaging threshold=15015, T=24oC, viscosity=water and for 
video processing: screen gain=12, minimum expected particle size=30nm, particle detection 
threshold=8).  
 
2.6.2. Dynamic light scattering 
In vitro Apo-EVs from BL2 and BL2-bcl-2 cells were prepared in phenol red negative culture 
media (50% RPMI 1640 and 50% phenol red negative X-Vivo 15). The size and zeta potential 
measurement were performed on the Zetasizer (Malvern Nano ZS) and the EV suspension 
diluent was complete culture media, diluted with DPBS as needed. For size measurements, 
the instrument settings were adjusted to refractive index equal to 1.45, temperature 25oC, 
measurement angle at 173o, absorption 0.001, 20 runs for each measurement and 10s pause 
between different measurements. Similarly, liposomes were measured in PBS suspension 
with the same settings, with the only difference being the refractive index equal to 1.40 with 
3 measurements. The zeta potential was measured on the same instrument at 25oC. 
 
2.6.3. Cryo Electron Microscopy and Tomography 
EVs isolated from BL2 and BL2-Bcl-2 cells in vitro have been successfully imaged with 
cryoTEM, following the plunge-freezing in liquid ethane method (discussed in Introduction 
and described in detail below). Apoptotic cell-derived vesicles were harvested from cells 
undergoing apoptosis after 5 to 6 hours post-UV treatment, according to the already 
described protocol (Section 2.2.1). A biological fluids concentrator based on blotting water 
away from the EV suspension while retaining larger materials in a membrane (15kDa cut-off 
size) was used to increase the concentration of the sample before freezing. The desired 
concentration of EVs needed at the point of freezing was over 2,000*108 particles/ml as 
measured on Nanosight.  
CryoEM grids (Lacey carbon films, copper) were plasma-cleaned in a vacuum glow discharger 
to render the carbon film on the grids hydrophilic. 4μl of the EV concentrate was loaded on 
the grid and the excess material was blotted away using a Vitrobot™ (FEI) under 100% 
moisture conditions at room temperature and immediately plunged onto liquid ethane, 
which was maintained in the liquid phase by the presence of liquid N2 on the outside walls of 
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the freezing vessel. The frozen grids were transferred and stored in liquid N2 while special 
precautions should be taken so that the vitrification of the sample was rapid and without any 
crystalline ice contamination which would make imaging impossible. The transfer and 
storage of the frozen grids must be done in liquid nitrogen, avoiding contact with the 
atmosphere and consequently with moisture. The grids were inserted in the microscope (F20 
FEI Tecnai Cryo) on a special cryo-holder which consists of a metal rod connecting the grid 
edge with the opposite side of the holder, where a tank of N2 ensures that the heat is being 
conducted away from the frozen specimen and the grid is maintained at low temperature. 
Images were acquired with SerialEM software (SerialEM, Colorado) setting the exposure 
times ranging from 0.2s to 2s maximum, usually at 1s, with “low dose mode” activated on 
the instrument, so that the electron beam causes no harm on the vitrified material, and at 
200kV. Different magnifications were used during image acquisition (up to 62,000x).  
To obtain a series of different angles of the same image for the 3D tomography, the grid-
holding stage was tilted to certain degrees in both directions and a series of images was 
recorded, with the electron dose low enough so that the specimen remains intact throughout 
the imaging. The samples intended for tomography were mixed with gold nanoparticles 
(10nm, stabilized 0.1 mM PBS, reactant free, Sigma) at a 1:1 ratio before freezing. These 
particles do not interact with the specimen, however it is necessary that those appear in the 
imaging plane so that they act as reference points to align the different tilt images during the 
tomogram reconstruction. 
Image analysis was performed with Digital Micrograph (Gatan) and Photoshop (Adobe) and 
tomogram reconstruction was done on eTomo (Imod) and Avizo (FEI). 
 
 
2.6.4. Immunogold labelling of EV surface markers for TEM 
The immunogold complexes were prepared in-house using 15nm gold nanoparticles with -
COOH surface modification and antibodies against the following antigens were attached on 
the nanoparticles surface (details about all antibodies in Table 2.2):  
• CD19 (Serotec #MCA1940EL) 
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• MHC class II, clone W6/32 (produced in-house from HLA A, B, C hybridoma cells 
[ECACC #84112003]) 
• MHC class II, clone HC10 (Origene #AM33035PU-N) 
• Ro (TRIM21) (Thermo #pA5-22294) 
• La (SSB) (Thermo #MA5-24921) 
The final preparation of immunogold nanoparticles was suspended in Tris/0.1% BSA and the 
concentration was adjusted to 20-30*1010 particles/ml. Particle concentration was measured 
by optical absorption at 520nm, with known extinction coefficient ε=3.67*108 M-1 cm-1 and 
given that at O.D=1, the suspension contains 1.64*1012 particles/ml. 
EV staining with immunogold took place on TEM grids (Formvar carbon films on Copper, Agar 
Scientific). Sepharose column-purified EVs were allowed to settle and adhere on the grids for 
3h at RT. The excess of EVs was washed away with PBS and the grid surface was blocked with 
5% BSA in PBS for 1h at RT. The immunogold suspension in Tris/0.1% BSA was added on the 
EVs for 30 min at RT, at a ratio determined experimentally (1:100 nanoparticle suspension of 
25.6*1010 particles/ml initial suspension). The grids were washed in PBS, air-dried and 
imaged on a TEM microscope (F20 FEI Tecnai Cryo) operating at 200kV. Images were acquired 
with SerialEM software (SerialEM, Colorado). Image analysis was performed with Digital 
Micrograph (Gatan) and Photoshop (Adobe). 
 
2.6.5. Fluorescence microscopy 
The EVs were purified from soluble factors and proteins from the cell culture by size exclusion 
chromatography using in-house prepared sepharose columns. The purified EVs suspended in 
0.1μm filtered PBS were stained with Alexa Fluor 568 NHS ester (AF568) with a covalent 
attachment of the dye on the EV proteins, according to the manufacturer’s protocol. To 
remove unbound dye, the EVs were purified again by size exclusion chromatography through 
sepharose columns. The AF568 labelled and purified EVs were added on H1.0 coverslips 
which have been previously treated with Mix&Go™ Biosensor in order to activate the surface 
and increase EV binding. The EVs were allowed to adhere on the coverslips for 3h at ambient 
temperature. The EVs were washed with 0.2um filtered PBS and the surface was blocked 
using 5% BSA in PBS for 1 hour at ambient temperature. Next, the EVs were washed with 25 
mM MES pH 6.0 and were stained with the antibodies in 5% goat serum for 15min at 4oC. 
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finally, the EVs were washed with MES buffer and mounted on a glass slide using ProLong 
Antifade mountant (ThermoFisher). Table 2.2 in section 2.6.7 contains all the reagents used 
to label EVs for confocal microscopy. 
Imaging was performed on an SP8 microscope (Leica) and the quantification of EV markers 
was performed on Fiji/Image J software. 
 
2.6.6. Fluorescence depolarization spectroscopy 
Liposome preparation for fluorescence anisotropy measurements 
The liposomes aimed for the anisotropy study were Single Unilamellar Vesicles (SUVs), which 
means their diameter ranges within the nanometre scale and mainly below 500nm. The 
method applied to achieve such populations has been described several years ago, but is an 
effective protocol which yields liposomal populations of relatively small sizes (Pons, 
Foradada and Estelrich, 1993). Ethanol injection is based on the hydrophobic properties of 
the lipids which spontaneously form vesicles when rapidly injected in an aqueous solution. 
The fluorescent probe used in the initial anisotropy measurements on liposomes was 
diplhenylhexatriene (DPH) (Figure 2-3), a lipophilic molecule practically non-fluorescent in 
aqueous environment, which emits fluorescent signal when incorporated in a lipid bilayer 
(Nelson et al., 2012), (Troup et al., 2006).  
The lipid mixtures used to prepare the liposomal formulations as dictated by Table 2.1, were 
Dipalmitoyl-phosphatidyl-choline (DPPC) with a Tm=41 oC, Dimyristoyl-phosphatidyl-choline 
(DMPC), Tm= 24oC and Cholesterol.  
Lipid and DPH stock solutions were prepared in methanol. For cholesterol only, a mixture of 
MeOH + 5% CCl3 was used to improve solubility. Appropriate volumes of lipid and DPH 
solutions were mixed and rapidly injected with a syringe into PBS while the process takes 
place a few degrees above the transition temperature (Tm) of the lipids, where they are in 
“liquid” state, so that they can align and self-assemble on a bilayer. The suspension was 
allowed to cool down to room temperature.  
The appropriate dilution of the liposomal dispersion in PBS intended for anisotropy 
measurements was found by trial and error, adjusting the concentration so that the 
absorption maximum is 0.1 (Upstone, 2006). Emission spectra and anisotropy measurements 
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were all taken for the same concentration, as defined by the absorption peak maximum 
value.  
A “prompt” sample was required for every anisotropy measurement, which is a non-
fluorescent scatter solution used to measure the system’s response and is co-calculated by 
the software when the data are being fitted to exponential curves, to exclude the 
interference of electronics and instrumentational artefacts in the signal detection. For the 
liposomal samples the prompt was a liposomal preparation of DPPC without the fluorescent 
agent, and was used at the same dilution as the stained material. 
The exact lipid composition and lipid to dye ratio for the liposomal formulations prepared 
are shown in Table 2.1. 
Table 2.1. Composition of liposomal preparations. 
Lipid composition with lipid:DPH ratio 200:1 
DPPC DPPC:DMPC 1:1 DPPC:Chol 2:1 DMPC:Chol 2:1 
 
Size, zeta potential and size distribution properties of the liposomal preparations were 
measured with Dynamic Light Scattering (Zetasizer, Malvern) and Nanoparticle Tracking 
Analysis (Nanosight). 
 
EV preparation for fluorescence anisotropy measurements with DPH and TMA-DPH 
DPH was dissolved in THF at a final concentration of 2mM to prepare the stock solution which 
was next injected in well-stirred PBS at room temperature at a final dilution of 2,000x. The 
solution was stirred for 2h until all THF evaporates and the solution becomes non-fluorescent 
(DPH in water is non-fluorescent). This working solution was mixed at a 1:1 ratio with EV 
suspension and incubated at room temperature for 1h (Shinitzky and Inbar, 1976b), 
(Schachter and Shinitzky, 1977).  
TMA-DPH is a derivative of DPH which consists of the parental molecule and a polar head 
(Figure 2-3), allowing for more specific localization on the surface of the lipid membranes (do 
Canto et al., 2016). For EV staining, TMA-DPH was dissolved in DMSO to a stock solution of 
1mM stock and used at a 1:1000 ratio in the EV suspension (1μm final concentration in 
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sample). The EVs were incubated at RT for 30min prior to measuring (Sutter, Fiechter and 
Imanidis, 2004). 
 
Figure 2-3. Molecular structure of DPH and TMA-DPH (PubChem). 
 
Fluorescence depolarization was measured at room temperature, 37oC and 45oC for EVs, 
using Apo-EVs as scatter solution (prompt) at the same concentration as the stained working 
suspension. All fluorescence depolarization measurements were performed on a TCSPC 
lifetime kit (DeltaFlex Hybrid, Horiba) with 10,000 counts peak difference for the vertical and 
horizontal polarization planes and 10 cycles of measurements to determine the G factor 
(Equation 1 in Introduction). The sample was illuminated by a pulsed Delta Diode 374nm 
(Horiba) at 80MHz and the photons were collected by a detector tbx-850c 250-850nm 
(Horiba IBH). Data were recorded with DataStation v2.7 software (Horiba) and processed on 
DAS6 v6.8 by data reconvolution. 
 
2.6.7. EV immunomagnetic capture and flow cytometry  
In order to perform flow cytometry on EVs, the vesicles were attached on magnetic beads, 
which allows better measurement sensitivity and also easy staining, washing and isolation of 
EVs. Beads coated with the appropriate antibodies (commercially available or prepared in-
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were pelleted by centrifugation at 300g for 5min after washing in PBS and were 
similarly frozen at pellets containing 1*107cells. 
Lysis of platelets or cells for protein extraction: the frozen pellets of samples were thawed 
on ice and lysed in 150µl cell lysis buffer (10 mM HEPES, 1 mM EDTA + 1% Triton-X-100) with 
10µl protease inhibitor cocktail. 
Lysis of EVs: the frozen pellets of 50*108 EVs were thawed on ice and lysed in 60µl cell lysis 
buffer with 6µl protease inhibitor cocktail.  
All samples were vortexed and allowed to lyse on ice for 30min before further lysing by 
syringing 10x with a 23G needle and syringe. Samples were left to lyse for a further 30min 
on ice.  The lysates resulting from this procedure were used in Western blotting. 
Protein concentration measurement by Bradford protein assay: Bradford reagent was 
diluted 1:4 in water and was mixed with the lysates in a range of dilutions. For calibration, a 
standard curve using 0.5% BSA solution was plotted. The optical absorption was measured 
at 595nm at a Varioskan Flash plate reader (ThermoFisher) (Bradford, 1976). 
Gel electrophoresis: for platelet and cell lysates, 10µg protein was made up to 10µl of final 
loading sample with water, NuPAGE™ Sample Reducing Agent (10X) and NuPAGE™ LDS 
Sample Buffer (4X). For EV lysates which are more dilute, the loading samples were made up 
to the maximum volume allowed per well, to maximize the protein quantity. The samples 
were heated at 70oC for 10’ and loaded on 4-12% Bis-Tris 1.5mm thick 10-well gel, with the 
addition of a protein ladder (SeeBlue™ Plus2 Pre-stained Protein Standard). The gel was run 
in MES SDS buffer at 170V constant for approximately 1h. 
Membrane transfer: the electrophoresis gel was dismantled and allowed in NuPAGE transfer 
buffer for 10min in order to equilibrate the gel into the new buffer. The PVDF membrane 
used for the transfer was treated with pure methanol for 30s and incubated for 10min in 
transfer buffer with 10% methanol. The transfer cassette was assembled using NuPAGE 
transfer buffer with 10% methanol to hydrate all parts (blotting paper, foams) and the 
transfer was performed at 30V for 1h 20min. 
After transfer, the membrane was washed 3x in PBS+0.1% tween-20 for 10min and was 
blocked for 1h at RT in 5% milk/PBS+tween-20 or 5% goat serum/PBS+0.1% tween-20. The 
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primary antibody was added in the appropriate solution (goat serum or milk) and the 
membrane was incubated at 4oC overnight. 
After the primary antibody incubation, the membrane was washed 3x in PBS+0.1% tween-
20 for 10min. The secondary antibody was added in 5% goat serum and the membrane was 
incubated for 1h at RT. Finally, the membrane was washed 6x in PBS+0.1% tween-20 for 5min 
and the signal was developed with standard ECL prime. The signal was visualised with 
Amersham™ Hyperfilm™ ECL film. 
Primary antibodies used in Western blots (details about all antibodies in Table 2.2): 
• Histone-3: rabbit anti-human 15kDa, used 1 in 1000 in 5% milk (Abcam #ab47297) 
• Beta actin: mouse anti-human 43kDa, used 1 in 5000 in 5% milk (Sigma #A1978)  
• CD19: rabbit polyclonal anti-human 95kDa, used 1 in 1000 in 5% milk (Bioss #BS-
0079R) 
Secondary antibodies: 
• Goat anti-rabbit-HRP, used 1 in 5000 in 5% goat serum (Sigma #A6154)  
• Goat anti mouse-HRP, used 1 in 5000 in 5% goat serum (Sigma #A3673) 
 
 
2.6.9. RT qPCR 
The samples intended for RNA extraction and hY4 RNA study were prepared as follows: 
• EVs: EVs prepared in vitro were centrifuged at 20,000g for 30min at 4oC and the 
pellets were snap frozen at -80oC. 
• Cells: HUVEC cells were incubated with EVs 2*1011 nm3/ml of cell media for 18h at 
37oC in 75cm2 flasks. The volume of EVs was calculated by the following procedure: 
the particle diameter histogram of each EV sample was obtained by Nanosight 
measurement; the diameter was divided by 2, to obtain the radius and the EV volume 
of each radius bin was calculated assuming EVs are spheres by V=(4/3)*πr3; the sum 
of the volumes from all radius bins gives the total volume of EVs in nm3/ml. After 
incubation, the cells were washed in order to remove any unbound EVs and they 
were detached from the container by trypsin digestion, washed with PBS and 
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pelleted by centrifugation at 300g for 5min at room temperature. The pellets 
containing 1*107 cells each were snap frozen at -80oC. 
RNA was extracted from the frozen EVs or cell pellets according to the manufacturer’s 
protocol for the RNeasy RNA isolation kit. The concentration of the extracted RNA was 
measured by spectrophotometry (NanoDrop, ThermoFisher) and was adjusted to the 
appropriate dilution for the performance of reverse transcription reaction. The RT was 
performed with Reverse Transcriptase using a commercial kit (miScript II RT Kit), for a 10μl 
reaction with maximum 1μg RNA per reaction. In most cases, the concentration of RNA 
extracted from EVs was not as high as required for the performance of the reaction, 
therefore the maximum permitted RNA volume was added per reaction. The RT reaction was 
performed on a thermocycler (Applied Biosystems Veriti 96 well thermal cycler) for 60min at 
37oC, followed by a 5min incubation at 95oC and final storage at 4oC. The cDNA generated 
from the RT cycle was used for the performance of quantitative PCR using SYBR Green dye 
and with materials and protocol provided by the miScript SYBR Green PCR Kit. The quantity 
of cDNA used for a 25μl reaction was a dilution of 1 in 10 for EV cDNA and 1 in 100 for cell 
cDNA as produced by the RT reaction.  
As described in detail in section 4.5,  the forward primer sequence for hY4 RNA  was: 5’ -
GTCCGATGGTAGTGGGTTAT- 3’. The universal reverse primer from the miScript SYBR Green 
PCR kit was used for the hY4 RNA, while the normalization gene primers were commercially 
available for RNA-U6 and miR-21. 
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3.1. Aims of the chapter 
The model of Apo-EVs which is mainly studied in the present work is the in vitro prepared 
vesicles from BL cells. As these EVs are secreted from cells under special conditions (i.e. 
apoptosis), they are expected to show distinct characteristics compared to other EVs 
released from the same cells which are not related to apoptosis. These differences can 
appear in multiple levels such as the pattern of release from cells, their structural phenotype 
and physicochemical characteristics, as well as their biochemical phenotype and functions. 
In this first section, the secretion pattern and basic structural features of Apo-EVs will be 
discussed, using a range of techniques to examine their size distribution, surface charge, 
morphology and membrane fluidity properties. Biochemical and functional differences will 
be discussed in the next chapters. 
Apo-EVs have been defined as the sum of the vesicles released from a cell throughout the 
process of apoptosis, however the mechanism of biogenesis or the extent to which this 
mechanism shares common machinery with other, non-apoptotic, EV biogenesis 
mechanisms is unknown. The kinetics of their release from cells can indicate the differences 
between the Apo-EVs and the non-apoptotic, Bcl-2-EVs and offer a starting point for further 
studies. For this purpose, the size and concentration of EVs as released by cells in hourly 
intervals after triggering of apoptosis were measured with DLS and NTA.  
Once the EVs were released from the cells, direct imaging by cryoEM was performed in order 
to confirm the presence of vesicles and study the structural characteristics of the two 
populations under examination, exploring their potential differences. Conclusions can be 
extracted qualitatively from the images, as well as quantitatively regarding particle size and 
number of enclosed structures. 
Finally, in order to determine the rigidity or fluidity of the EV membranes, a spectroscopic 
technique was applied, which can sensitively detect differences in the order of the lipid 
bilayer. This method was fluorescence anisotropy and although several types of vesicles have 
been studied using a basic configuration of steady state fluorescence, the analysis using a 
time-resolved system has not been reported for EVs and especially Apo-EVs. Fluorescence 
anisotropy was used to compare the physical properties of the vesicle membrane which can 
be expressed as its overall microviscosity, often corresponding to different intracellular 
membranous compartments. In other words, the comparison of the findings of this work on 
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Apo-EVs with values from the literature can suggest the origin of the membrane, for example 
plasma membrane or subcellular organelles (Montaudon et al., 1986). Acknowledging the 
sensitivity of this method and the fact that statistical errors can appear due to sample 
heterogeneity, EVs with a narrow size distribution from blood plasma were used as a 
comparison to the in vitro prepared EVs. 
 
3.2. Study of kinetics of EV secretion upon stimulation of apoptosis  
A fundamental property of a nanoparticle suspension is its size distribution. Especially for a 
diverse population such as the EVs, the range of sizes can be considerably broader compared 
to other artificially prepared particles such as liposomes or labelling nanoparticles. It is 
therefore important to know the diameter of the smallest and the largest vesicle present in 
the sample, as the selection of methods of further characterization depends heavily on those 
values. For example, very large particles are not suitable for cryoEM imaging, or very small 
vesicles cannot be measured with conventional flow cytometry.  
The method which was most frequently used in this work to assess the quality of each EV 
preparation and also measure their concentration was NTA. In Figure 3-1, the size graphs of 
in vitro prepared EVs from BL2 cells are presented, while the EVs isolated from healthy 
human and mouse blood are shown for comparison. The in vivo - derived EVs are significantly 
smaller than the BL2-derived vesicles, possibly due to the clearance larger particles undergo 
by homeostasis mechanisms such as collection in the liver and spleen, or phagocytosis before 
or while they circulate in blood (Peinado et al., 2012) (Imai et al., 2015). For the purpose of 
this study, the properties of Apo-EVs in the cancerous tissue as well as in the blood were 
examined, therefore larger vesicles have not been excluded from the preparation, as these 
possibly contain material mediating signals leading to the alteration of the processes in the 
tumour microenvironment. Looking into the characteristics of Apo-EVs, the most evident 
difference from the control Bcl-2 EVs is that the first show a higher diameter around 300nm 
and there are also vesicles found in the range over 500nm, while the Bcl-2 EVs are mainly 
located in the peak around 170nm, which is common for both populations. 
Another characteristic of suspensions consisting of lipid particles such as the EVs is the zeta 
potential, which is an expression of the surface charge. The value of this parameter is 
determined by the presence of charged moieties on the surface of the vesicles, usually polar 
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heads of lipids and DNA and it is an indication of the expected stability of the colloid. In other 
words, the zeta potential can range from negative to positive values, and the higher the 
absolute value, the stronger the repellent electrostatic forces between the particles, leading 
to smaller tendency for aggregation which subsequently offers higher stability. The surface 
potential of the BL2 cell-derived vesicles is presented in Figure 3-1, showing a value of 
approximately -10mV for both apoptotic and non-apoptotic EV samples. Some indicative 
charts correlating stability and voltage have been extracted from experience and suggest 
that those values correspond to poor stability (Kumar and Dixit, 2017). 
 
Figure 3-1. Size distribution of in vitro prepared EVs from BL2 cells (top), in vivo derived EVs from healthy human 
and mouse blood plasma (middle) and table of zeta potential values for in vitro prepared EVs (bottom). Size 
measurement  performed by NTA and zeta potential recorded by DLS and the curves show the average values from 
3 independent experiments.  
 
The EV sizes shown above are referring to the final preparations after the parental cells have 
been incubated for 5h post apoptosis stimulus by UV, therefore the size properties measured 
correspond to the sum of the EVs generated in this time window. However, it is also 
interesting to investigate the kinetics of EV secretion in real time during the process of 
apoptosis and this is performed by isolating the EVs every hour after the UV treatment of 
Maria Panagopoulou | PhD Thesis                                                                                                      The University of Edinburgh, 2020 
77 
 
cells, in order to measure the concentration and sizes of the vesicles generated at each time 
point. As a reminder, the progression of apoptosis for the BL2 cells upon UV treatment has 
been shown in Figure 2-1. In Figure 3-2, the size and concentration for Apo- and Bcl-2 EVs 
are shown for every hour post UV with filtering through 1.2μm filter, as the method of 
analysis (NTA) is suitable for particles under 1 μm in diameter. Regarding the change in size, 
it is observed that a mixed population of smaller and larger particles are present in the 
sample in all time points, with the Apo-EVs peaks appearing in higher diameters than the 
control EVs. The biggest difference, however, is in the concentration, as the Apo-EVs are 
secreted in larger amounts and this rate is increasing over time, resulting in almost double 
the concentration from 3h to 5h. In contrast, the Bcl-2 EVs have a steady secretion rate up 
until 3h and also mark a significant increase until 5h, although the final concentration is 
approximately 3 times lower than the Apo-EVs, suggesting that the process of apoptosis 
triggers the release of a potentially different EV population. There is also a population of EVs 
present at t= 0h, which reflects the constitutive levels of particle expression within the few 
minutes of cell processing before EV isolation at t= 0h. 
 
Figure 3-2. Nanosight measurement for size (left) and concentration (right) for EVs isolated hourly post UV cell 
treatment and filtering through 1.2um syringe filter Average values from 2 EV preparations; the error bars 
represent standard deviation values. 
 
The observation of an apoptosis-related EV population secreted from apoptotic cells leads 
to the need for measuring the whole continuum of vesicles up to 5μm in diameter, in order 
to understand whether the apoptotic bodies can overlap in size with the smaller Apo-EVs. To 
answer this question, a method less sensitive than the Nanosight but with a broader 
measurement window regarding particle diameter was applied, the DLS. This technique 
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tends to point out the larger particles of a suspension, which is explained by its working 
principle (as described in the Introduction). It can therefore magnify the differences of Apo-
EVs versus the control, and this is indeed shown in Figure 3-3, where EVs isolated hourly post 
UV treatment were filtered through 1.2μm or 5μm. In these graphs, the peaks of Apo-EVs 
towards the larger diameter (over 1 micron) are even more obvious than the Nanosight 
measurements, and it is also shown that the larger particles only appear in the period of 3-
5h post apoptosis initiation, confirming the Nanosight results and indicating the presence of 
apoptosis-specific vesicles, which are not present in the non-apoptotic conditions. For both 
EV samples, the polydispersity index (PDI) value for the 5h time-point was in average 
0.604±0.15 for Apo-EVs and 0.77±0.14 for Bcl-2 EVs. The PDI expresses the sharpness of the 




Figure 3-3. DLS size measurement for the cumulative BL2 cell-derived Apo-EVs in hourly intervals after UV 
treatment and with filtering through 1.2μm or 5μm filter. 
 
The EVs collected every hour after the UV treatment of cells showed in this figure correspond 
to the cumulative EV amount of all vesicles produced from the beginning of the incubation 
up to the collection time. This means that for example, the 4h post UV vesicles measurement 
contain all EVs produced in 1h plus 2h and 3h since time zero. As a comparison, and in order 
to dissect the EV hourly production in more detail, the measurement was repeated for EVs 
harvested only during the period of one hour, for all time points. For instance, in order to 
collect the 4h time point, the cell media was replaced with fresh EV-free media after the 3rd 
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hour of incubation, so that the EVs collected within the 4th hour only correspond to this time 
window and do not contain EVs from the previous times.  
 
 
Figure 3-4. DLS size measurement for BL2 cell-derived Apo-EVs in hourly intervals after UV treatment with 
removal of EVs from previous time points and with filtering through 1.2μm or 5μm filter. 
 
The trend of Apo-EVs towards larger diameters is maintained especially for 5h post UV, and 
it is also seen that especially for the 5μm filtered vesicles, there is an increased size of 
particles secreted from the cells after the first hour of incubation, which can indicate an initial 
‘burst’ of particle release from the cells, which is followed by a more linear pattern. 
The above measurements were quantitatively analyzed as per the peak center and the 
amount of EVs per time point which is expressed by the area under the curve (AUC). The 
results for Apo- and Bcl-2 EVs are presented in Figure 3-5, where is shown that both the peak 
of the size distribution, as well as the quantity of Apo-EVs are higher than the control vesicles, 
and also that this increase is more apparent for times after 3h, as discussed earlier.  
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while for the Bcl-2 EVs these peaks are less apparent. This is another piece of evidence that 
the production mechanism of Apo-EVs contains more complex pathways which result in a 
broader spectrum of particles compared to the control vesicles. In the next sections, other 
characteristics of the Apo-EVs are being discussed, focusing on the structural, phenotypic 
and functional properties, as well.  
 
3.3. Structural study of Apo-EVs with CryoEM imaging and tomography 
In order to examine the structure of the individual EVs in further detail, cryoEM imaging was 
performed in two and three dimensions (tomography). As mentioned in the Introduction and 
the Methods sections, the EVs were rapidly frozen in their suspension media and imaged in 
a layer of amorphous ice, in order to maintain their spherical properties and to avoid 
distortion due to dehydration which is a necessary preparation step in dry TEM. 
The following images have been recorded with a 62,000x or 50,000x magnification and the 
EVs are defined by the lipid bilayer which appears as a dark circle. Dark spots, either spherical 
or irregular, stand for crystalline ice contamination from the freezing procedure and for both 
apoptotic and non-apoptotic cell-derived EVs, the population includes unilamellar and 
multilamellar vesicles.  
Figure 3-6 and Figure 3-7 show a collection of representative Apo-EVs and Bcl-2 EVs 
respectively. 





Figure 3-6. CryoEM 2-dimensional images of Apo-EVs. Vesicles with a single or multiple membranes (indicated 
by arrows) are observed. Scale bar 200nm. 




Figure 3-7. CryoEM 2-dimensional images of Bcl-2 EVs. Arrows indicate non-spherical EVs with multiple 
membranes; scale bar 200nm. 
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The next figure (Figure 3-8) shows a collection of in vitro prepared EVs, both Apo- and Bcl-2 
vesicles which were observed as rare and unusual events in cryoEM imaging, showing the 
potential heterogeneity in the samples. In the top and second row of the images, vesicles 
either appear as ‘empty’, as there are no other characteristics apart from the vesicle 
membrane, or they appear to enclose fibrous-like entities inside the main membrane and 
also other structures on the surface which result in a ‘hairy’ appearance. The identity of these 
structures cannot be confirmed unless biochemical assays are performed, however the 
literature suggests that membrane and intravesicular proteins have been detected on 
several types of EVs, with similar electron microscopic appearance (see Introduction for 
references). Moreover, a vesicle with a double external membrane is depicted in the right 
image of the middle row, and the presence of this second membrane is evident by the 
increased thickness and also by the area where the two layers are locally separated for 
unknown reason.  
Finally, the bottom row shows some special cases of EVs with more elongated shape and/or 
attached to each other similarly to ‘beads on a string’. This effect has been also observed by 
I. Poon and group, in a study where these structures were suggested to be protrusions of the 
apoptotic cells, named apoptopodia (Atkin-Smith et al., 2015). 




Figure 3-8. CryoEM 2-dimensional images of selected Apo-EVs and Bcl-2 EVs, to illustrate rare cases of vesicles 
with unusual shape and structure (indicated by arrows) 
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Following the visual observations on structure, some quantitative parameters were 
measured from the images. Firstly, the thickness of the vesicles’ membrane was found at an 
average value of 7nm for both EV populations under examination, which is in agreement 
with the findings of another study on sperm-derived EVs where the double membrane was 
found to be around 15nm thick (Yuana et al., 2013). 
Image analysis for diameter measurement of all recorded bodies has been used to generate 
a density histogram (Figure 3-9). The differences observed in size using NTA or DLS cannot 
be examined in these histograms, as both populations appear very similar, with the main 
body of the sample located around 100-200nm. Because the layer of ice is only 200-300nm 
thick, some soft specimens such as the EVs are flattened, and therefore the diameter 
measured for some of the larger particles might not precisely reflect the size, as it has 
possibly been distorted (Yuana et al., 2013). However, what this technique revealed, not 
detectable with either NTA or DLS is a population of vesicles as small as 25nm, for both 
samples.  
Another quantifiable parameter from the 2-D images is the lamellarity of the individual EVs, 
which stands for the percentage of particles that have a simple structure with a single 
membrane in contrast to EVs with multiple other membranous vesicles enclosed in the main 
particle, as seen in the images earlier. The occurrence of multilamellar particles over single 
membrane vesicles for Apo- and Bcl-2 EVs is graphically shown in Figure 3-9. The Apo-EVs 
appear to be more simple than the Bcl-2 EVs, as their tendency to enclose multiple structures 
is 10% lower than the latter. 




Figure 3-9. Size histograms for EVs as measured by cryoEM images (top row) and percentages of single and 
multilamellar EVs (bottom graph). The graphs have been generated by single EV analysis for n=100 or n=95 for 
ApoEV and Bcl-2 EV respectively, which derive from a summary of  n=4 independent EV preparations. 
 
Moving to a more advanced variation of two-dimensional imaging, cryoEM was used to 
record 3-D tomograms of the EVs. As shown in Figure 3-10, the smaller vesicles observed in 
the raw data are located inside the larger ones and are not compressed on the outside, 
something which would result in similar images as the electron beam penetrates the 
specimen. A second finding from these images is the presence of amorphous structures 
inside the vesicles, which is suggested to be proteins. Similarly to the previous 2-D images, a 
large variability is observed between the individual particles regarding the presence of other 
vesicles or proteins inside the main vesicle. 
 




Figure 3-10. Raw images of a representative plane and 3-D reconstructed models of vesicles recorded with 
cryoEM; scale bar 200nm. 
 
As a summary on cryoEM imaging, there were no major structural differences between the 
apoptotic and non-apoptotic cell-derived EVs, with the exception of the number of enclosed 
membranes which appears higher for the Bcl-2 EVs by 10%. Measuring the size for particles 
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larger than 200-300nm is not reliable with this method, as there are physical limitations 
attributed to preparation technicalities. This is due to the limited thickness of amorphous ice 
in which the particles are frozen, which also results in loss of the majority of EVs larger than 
300nm during preparation. What can also be concluded, however, is that since the 
membrane thickness is around 7nm, and the smallest particle recorded in this study was 
around 25nm, it can be suggested that the formation of a spherical lipid bilayer - delimited 
vesicle with a diameter smaller than 15-20nm would be geometrically and 
thermodynamically unstable. This is a relieving finding, as it indicates that only a small part 
of the population is undetectable by NTA (minimum particle size 30nm). Finally, some EVs 
have a structure more complex than expected, and it can be speculated that these structures 
reflect the various biogenetic pathways through which those vesicles have been produced, 
albeit this hypothesis would need to be investigated with other methods, as well. 
 
3.4. EV membrane study by fluorescence depolarization (anisotropy)  
Fluorescence anisotropy is a spectroscopic method in which fluorescent dyes with specific 
affinity to the lipid bilayer can give information about the membrane fluidity and order. For 
the purpose of this work, the information expected to be obtained from this technique is the 
extracellular vesicles’ membrane integrity and viscosity, which can reveal potential 
differences among the vesicles derived from different cellular paths (apoptotic and non-
apoptotic cell-derived vesicles). The incorporation of an appropriate fluorescent molecule in 
the vesicles’ membrane such as DPH and its derivative, TMA-DPH allows the measurement 
of depolarization of these molecules under different conditions. The experiments are 
focused on comparing Apo- and Bcl-2 EVs as to the membrane fluidity at different 
temperatures. In a more general frame, membrane integrity measurements can be applied 
to EVs from clinical samples in order to determine the effect of various storage conditions 
on the EV stability (for example temperature, freeze-thawing, addition of cryoprotectant). In 
this section, human plasma-derived EVs will be measured alongside the BL2 cell-derived EVs, 
setting the baseline for further clinical sample analyses. 
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3.4.1. Fluorescence depolarization measurements on liposomes 
Acknowledging that the vesicles’ membranes are complex systems that not only consist of a 
wide variety of lipids, but also macromolecules such as proteins, nucleic acids and even 
saccharides, simpler liposomal model vesicles were first prepared and analysed in order to 
obtain a set of data which can be used for comparison to the EV measurements. 
Liposomes are spherical colloidal particles which form lipid bilayers, often one inside 
another, alternating with aqueous parts. The building blocks of those structures are lipids, 
phospholipids, and cholesterol. Because of the amphiphilic nature of the lipids, the presence 
of aqueous solution leads to a thermodynamic formation of a self-assembled lipid bilayer, 
which finally forms a spherical membrane, encapsulating the aqueous solution. The 
literature shows an extended interest in the anisotropic properties of the liposomal lipid 
bilayers from the past few decades until recently, and these systems have been studied as 
to the behaviour of the membranes under different conditions, usually altering the 
temperature, pH and lipid composition of the membrane (Birch, Holmes and Imhof, 1988). 
The results prove that depolarization measurements are sensitive to minor changes in the 
system under the impact of physical conditions and even the presence of chemical 
substances (Bisby and Birch, 1989), (Holmes et al., 1991), (Holmes et al., 1997). 
Different liposomal preparations involved combinations of phospholipids and mixtures with 
cholesterol, as seen in Figure 3-11. The liposomal suspensions were characterized as to size 
distribution and colloid stability by zeta potential. Figure 3-11 shows the values of the size 
distribution peak along with the poly-dispersity index (PDI) for all preparations with different 
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liposomal types seem to have increased fluidity up to 37oC, albeit the pattern is altered for 
higher temperatures. However, there is a general trend indicating that the fluorophores in 
the non-cholesterol liposomes rotate faster than the cholesterol-containing samples, 
confirming the increased membrane rigidity caused by cholesterol. 
The results obtained by liposomes stained with DPH have overall showed the dependence of 
the anisotropy and the rotational correlation time on the membrane microviscosity, and in 
addition have revealed a potential structural deformation of the particles for temperatures 
higher than 45oC, which becomes evident by the decrease in membrane fluidity and the 
possible re-arrangement of the lipids or particle fusion. 
 
 
3.4.2. Fluorescence depolarization measurements on in vitro prepared Apo-
EVs and blood plasma-derived EVs stained with DPH 
 
In this section, the anisotropy measurements were applied for DPH-stained EVs, for which 
the staining protocol is different from the liposome staining. Because EV staining with DPH 
requires the initial stock dye solution in THF, the spectra of absorption and emission for DPH 
in THF are presented Figure 3-16. 





Figure 3-17. Anisotropy decays (red) and fitting curve residuals (green) for DPH in THF, Apo-EVs (at 46.4*108 
particles/ml) and Bcl-2 EVs (at 17.7 *108 particles/ml) (Ex374nm Delta Diode, Em450nm). The curves have been 
extracted from one measurement, and are representative for all experiments. 
 
The presence of the ‘spike’ on the beginning of the decay curve for all EV samples is due to 
detection of scattered excitation light due to the refractive index difference between the 
solvent and vesicle. However, by applying fitting equations to the lifetime and anisotropy 
decays for all samples and temperature points, cumulative data were extracted and the 
parameters which appear to be the most significant and statistically reliable have been 
plotted in the following graphs. 
Figure 3-18 shows the anisotropy values and the membrane order parameter as calculated 
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with SD for rotational correlation time; for membrane order, the value was calculated using the average values 
from e experiments) 
. 
As seen in the graphs above, the rotational time drops rapidly from room temperature to 
37oC and the difference is smoother for up to 45oC. Interestingly, the membrane order seems 
to be stable for both types of EVs up to 37oC, but there is a significant decrease between 37 
and 45oC, indicating that the phase transition temperature of the membrane (the 
temperature point where the membrane loses its rigidity and becomes more fluid) is found 
between those temperature points. 
 
 
3.4.3. Anisotropy measurements for EVs stained with TMA-DPH 
In order to compare the findings of the DPH anisotropy on EVs, and in an attempt to examine 
the fluidic behaviour of the vesicle membranes in more detail, the measurements were 
performed with a second fluorophore, as an alternative to DPH. TMA DPH (trimethylamine 
DPH) is a derivative of the parental molecule with a polar head, which is localized only on the 
polar groups of the lipids and is therefore internalized to a lower extent compared to the 
parental molecule, remaining selectively on the membrane (Montaudon et al., 1986). 
The fluorescence lifetime decays for the free dye in solvent and for Apo- and Bcl-2 EVs are 
shown below. 


































Figure 3-21. TMA-DPH fluorescence decay curves for free dye in DMSO at 2μM (top), Apo-EVs (middle) and Bcl-
2 EVs (bottom) in a range of temperatures. The table following the graph presents all values extracted from fitting 
analysis. 
 
In the decay curves in Figure 3-21, it would be expected that the increasing temperature 
would result in shorter decays, however this is only observed for the Bcl-2 EVs and not for 
free dye and Apo-EVs, which show an irregular decay pattern for the different temperatures. 
The values extracted from the mathematical fitting of the decays are presented in the next 
figures. For comparison, EVs from the blood plasma of healthy individuals is also analysed 
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From the values extracted for rotational correlation times in Figure 3-22, it is observed that 
TMA-DPH in DMSO is practically insensitive to the increase of the temperature, while 
irregular trends are seen for Apo-EVs and Bcl-2 EVs. Plasma-derived EVs seem to maintain a 
trend for decreasing T as the temperature rises, especially for T2. 
Anisotropy and membrane order values are not presented, due to unacceptable values of 
the standard deviations. 
From the graphs above, it is observed that TMA-DPH exhibits a rotational behaviour different 
to the parental molecule DPH, as some values change irregularly over the effect of 
temperature. The rotational correlation times of the two most dominant moieties decrease 
as the temperature increases for free dye in DMSO and for plasma-derived EVs, however the 
data for Apo-EVs and Bcl-2 EVs do not show a specific pattern and would be considered 
rather unreliable. This behaviour can be attributed to the fact that the TMA-DPH is bound 
more preferably on the outer surface of the EV membrane, thus its rotational behaviour can 
be more susceptible to EV coalescence, which would significantly alter the dye’s 
microenvironment. In addition, TMA-DPH is considered to be less temperature dependent 
on the anisotropy of more rigid membranes, as shown on a study where plasma membranes 
of cells were compared to intercellular compartments (Montaudon et al., 1986). 
In this case, DPH would be considered a more suitable dye for anisotropy studies on time-
resolved anisotropy studies, as it is located deeper in the lipid bilayer and therefore the 
impact of other particles interacting with the surface of the vesicles. The literature shows 
examples of EVs and similar particles studied with DPH and TMA-DPH, however only using 
steady state anisotropy and not time-resolved instrumentation (Laulagnier et al., 2004), 




To summarize the findings of this chapter, DLS is commonly used for particle suspensions, 
although there are some clear limitations for samples with broad size distributions, such as 
the EV suspensions. Polydispersity index values suggest that the sample is possibly more 
heterogenous than the technique ideally analyzes, and the software gives information for a 
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limited number of peaks (up to 3). From the data acquired, there is an agreement with the 
NTA method, but with fewer details on the shape of the histogram. What distinguishes DLS 
from NTA is the practically unlimited range of sizes (with biological interest) the instrument 
can detect and interestingly, both for Apo- and Bcl-2 EVs, a peak around 8nm was detected, 
which may, though, be an artefact of the data fitting analysis, as the presence of vesicles of 
such small size have not been confirmed by cryoEM. DLS also offers zeta potential data with 
the values suggesting poor to moderate stability for the suspension.  
Translating these results in a biological dimension, both techniques showed that the Apo-
EVs include a population of larger vesicles and that the cells release a higher amount of Apo-
EVs as they go into apoptosis, compared to the non-apoptotic cells. This trend suggests that 
the Apo-EVs can be potentially released via alternative routes or by taking advantage of the 
existing machinery, affecting the type of cargo and the messages they can deliver. 
Phenotypic characterization promises to give more information on the possible mechanisms 
of secretion and functions. 
Next, imaging EVs under cryoEM offers the high resolution of TEM alongside the benefit of 
maintaining the sample closer to its native state, minimizing distortion from fixation. As 
shown in the results, the size distribution is generally similar to the size measured by NTA 
and DLS, although this method is less reliable for particles larger than 300nm. It is also shown 
that among other techniques, cryoEM is possibly the only tool that can provide detailed data 
on the shape, number of enclosed structures, tendency to aggregate or coalesce, presence 
of subcellular organelles and membrane thickness. CryoEM and tomography have so far 
provided high quality images of the structure, dimensions and the spatial arrangement of 
multilamellar particles, in which smaller vesicles are included in a main membranous 
structure. Another observation from the EM images is the high degree of heterogeneity 
among the vesicles of both populations, as they can range from single to double membrane, 
with or without membrane and intraluminal proteins. 
Finally, fluorescence anisotropy decay curves can reveal details of the membrane structure 
and its viscosity, undetectable with other techniques. However, because of the high 
sensitivity in those measurements, the recording of meaningful sets of data can be a 
challenge for systems such as extracellular vesicles, where the variety of different 
components (membrane proteins with fluorescent amino acids) and the broad size 
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distribution increase the level of complexity. The results suggest that there are differences 
in the membrane rigidity of the two EV populations, as the DPH measurements revealed. In 
more detail, the Apo-EVs appear less rigid than the Bcl-2 EVs, which is an evidence that these 
vesicles are generated from different cellular compartments. This observation can be a 
starting point for further considerations about the potential biogenetic routes of these 
vesicles, as it can be correlated with other studies in which the plasma membrane was found 
more rigid than subcellular compartments (Montaudon et al., 1986). In addition, looking at 
the effect of temperature on the fluidity of the membranes, it is evident that there are 
significant alterations in the rotational correlation times and anisotropy of samples as the 
temperature rises from ambient to 37oC, which reflects the proportion of cholesterol in the 
membranes. Comparing the EV data with the results from the anisotropy measurements on 
liposomes, it has been overall shown that the less rigid Apo-EVs resemble the formulations 
without cholesterol, while the Bcl-2 EVs follow a pattern similar to the cholesterol-containing 
liposomes, which is an additional indication that the two EV populations have differences in 
the lipid composition. Finally, regarding the technical aspect, DPH proved more suitable than 
TMA-DPH for this system and the vesicles derived from blood plasma seemed to be more 
suitable for this method than the in vitro prepared Apo-EVs, as they have a narrower size 
distribution, therefore lower degree of variability. Therefore, it was shown that fluorescence 
anisotropy is suitable for EVs from clinical samples and can be a useful method for the 
assessment of the vesicle stability under routinely used storage and isolation methods of the 
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4. Study of EV cargo 
 
4.1. Aims of the chapter 
This chapter describes how the EVs can be analysed as to their surface receptors as well as 
internal proteins and nucleic acids. Some of the methods discussed here are mostly applied 
for basic research purposes, however, as it will be shown, there are techniques with potential 
applications on the clinical diagnostic practice, offering rapid results using clinically available 
equipment. 
To begin with, one of the most commonly used methods for the analysis of disease-related 
markers is flow cytometry. In the case of EVs and due to their small size, this technique is 
being pushed beyond its resolution limits since conventional instruments are mainly 
designed for larger particles >200-500nm, depending on the cytometer (Lacroix et al., 2010), 
(Nolan, 2015). As discussed in the Introduction, an adaptation of flow cytometry which can 
overcome the size limitations is the capturing of EVs on larger magnetic beads. In this work, 
the most effective bead capture probes for EVs were investigated, as the availability of 
surface molecules on the vesicle membrane affects the efficiency of binding. Starting from 
surface markers which would be expected to be highly expressed on EVs, the beads were 
coated with antibodies against those molecules and the binding efficiency was determined 
by flow cytometry with fluorescently stained EVs. The surface receptors of choice are: CD19 
and CD20, as these are two classical B cell lymphoma markers (Kelemen et al., 2010), MHC 
class I, as indicated by proteomics analysis on EVs (study performed by Gregory group 
members, results not shown here), PS which is generally expected to be exposed on EV 
membranes (Shih et al., 2016) and the well-established ‘exosome’ markers CD9, CD63 and 
CD81 (Exocarta.org). 
Phenotypic analysis was also performed with confocal fluorescence microscopy in order to 
visualize the EVs attached on a surface without using magnetic beads and finally, a number 
of surface molecules were examined by immunogold labelling and TEM imaging, providing 
high resolution visualization of individual particles. 
All techniques discussed above concern the study of proteins and surface receptors as 
potential Apo-EV specific markers. However, nucleic acids and especially micro RNAs are 
biomarkers which are often used to identify EVs arising from a specific condition. RNA 
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sequencing of Apo-EVs has been performed by colleagues and the most significant results of 
this study will be verified in vitro in this thesis. The upregulation of a non-coding RNA species, 
the human Y4 RNA (hY4 RNA), was taken as a starting point from the RNA sequencing data, 
and reverse transcription quantitative PCR was performed on EVs and also on EV-conditioned 
endothelial cells in order to confirm the potential of this marker as an Apo-EV-specific 
molecule. 
Finally, the findings from the techniques applied for phenotyping are critically discussed, 
highlighting the power of each method regarding the sensitivity and the potential use in a 
clinical setting. 
 
4.2. Immunomagnetic bead-based EV capture and flow cytometry 
Magnetic beads can be a powerful tool to isolate a targeted biological component of interest, 
while the magnetic properties of these particles enable purification of the material simply by 
using a magnet. Chemical modification of the bead surface with antibodies allows for high 
selectivity and makes this platform the method of choice for a number of applications 
(Ruffert, 2016).  
As part of the process of identifying the most efficient capture probe for EVs, a variety of 
magnetic beads were coated with several antibodies against EV surface molecules. As some 
types of beads were coated in-house and using different chemistry platforms (Protein A-
antibody affinity, or Streptavidin-Biotin interaction), the saturation of the beads’ surface with 
each capture antibody was assessed by flow cytometry. In every case, a fluorescent 
secondary antibody against the capture antibody was added to the beads and the 
fluorescence readout from the flow cytometer was used to confirm the effective coating. 
The following figures (Figure 4-1 and Figure 4-2) show the coating validation results using a 
fluorescent secondary antibody against the coating antibody. 





Figure 4-1. Validation of antibody coating efficiency on Protein A beads. Measurement was performed by flow 
cytometry for beads coated with antibody and stained with secondary antibody (error bars indicate standard 
deviation from n=3 independent experiments). 




Figure 4-2. Validation of antibody coating efficiency for streptavidin magnetic beads from Exocap kit. 
Measurement performed by flow cytometry and staining with secondary antibody (bar chart shows the values from 
n=2 independent experiments). 
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Comparing the fluorescence intensity of the beads in the graphs above, it can be seen that 
the majority of the particles have been successfully coated with the capture probe, both the 
Protein A and Streptavidin beads from the Exocap commercial kit. 
Besides the in-house coated beads against CD9, CD19, CD20, CD63, CD81 and MHC class I 
(W6/32 antibody), beads capturing PS and beads with surface -COOH groups which capture 
-NH2 protein groups were used from commercially available sources (validation of protein 
binding capacity of -COOH beads is presented in supplementary Figure 4-22).  Figure 4-3 
shows the EV binding performance for every type of bead collectively, with large quantities 
of EVs and incubation of EV/beads at 4oC for 24h. The amount of EVs used to investigate the 
maximum binding capacity of the beads was the technically maximum possible quantity (due 
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the MHC class I (W6/32 antibody) and also the EV marker CD63 fail to capture the EVs 
effectively. On the other hand, the EV markers CD9 and CD81, as well as anti-PS and protein-
binding -COOH beads are the most efficient capture probes for the EVs of this study. 
Apart from the type of capture antibody which shows the most efficient EV binding, there 
are other parameters to be considered in order to establish the capturing protocol, which 
are schematically presented below in Figure 4-4. Strategy of EV-bead binding for flow 
cytometry analysis. The variable parameters under examination are the type of capture 
antibody, the ratio of beads:EVs and the time required for sufficient interaction between the 
beads and the vesicles.Figure 4-4 (EV: bead ratio and time required for incubation before 
washing). For the analyses to follow, the two most efficient bead types were selected in order 
to study the kinetics of the binding over time and also the range of bead:EV ratio which 
ensure maximum binding saturation. Figure 4-5 and Figure 4-6 include a summary of how 
EVs bind to anti-CD81 and anti-PS beads over a range of time and ratios. 
 
 
Figure 4-4. Strategy of EV-bead binding for flow cytometry analysis. The variable parameters under examination 
are the type of capture antibody, the ratio of beads:EVs and the time required for sufficient interaction between 
the beads and the vesicles.   




Figure 4-5. EV binding kinetics for anti-CD81 beads from Exocap kit. The EVs were added to the beads at a range 
of concentrations or for a range of time points for Bead:EV 1:5000. Measurement performed by flow cytometry 
with EV staining with Annexin V-AlexaFluor488 (error bars indicate standard deviation from n=3 independent 
experiments).  




Figure 4-6. EV binding kinetics for anti-PS beads from MagCap kit. The EVs were added to the beads at a range 
of concentrations or for a range of time points for Bead:EV 1:1000. Measurement performed by flow cytometry 
with EV staining with Annexin V-AlexaFluor488 ((bar chart shows the values from n=2 independent experiments). 
 
Maria Panagopoulou | PhD Thesis                                                                                                      The University of Edinburgh, 2020 
117 
 
The kinetics of EV binding on anti-CD81 and anti-PS beads indicate that there is rapid 
interaction from the first hour of incubation which increases up to 3 hours and remains 
relatively stable for longer incubation times up to 24h. From these figures it is concluded that 
>3h incubation at room temperature provides sufficient binding for both types of beads. In 
addition, it is shown that anti-CD81 beads require a ratio of 5000 EV/bead, while the anti-PS 
bead can be sufficiently saturated with approximately 1000 EV/bead. This study was 
essential in order to ensure that the binding conditions used for the experiments to follow 
provide the desired binding. It is, however, important to mention here that an additional 
factor which might affect the EV binding efficiency is the volume in which the EV:bead 
interaction takes place. This means that in order for an EV to encounter a bead which can 
lead to a binding event, the volume of incubation can facilitate or hinder this interaction. It 
is logically expected that when a small volume of beads is diluted in a very large volume of 
dilute EVs, the binding might be less efficient. The volume factor has not been examined in 
detail in this work, as this would require the adjustment of the concentration of EVs (usually 
by increasing their concentration), which has been a technical challenge faced throughout 
this thesis. However, empirical ratios of volumes have been used, avoiding extremely small 
or large volumes of both components. 
In order to visualize the EVs bound on beads and understand whether this is a 1:1 binding, 
anti-PS beads were saturated with EVs and were imaged by TEM (Figure 4-7). 
 




Figure 4-7. TEM images of EV bound on anti-PS magnetic beads from MagCap kit (mean bead diameter ~200nm). 
A representative bead and a bound EV are indicated by arrows. A variety of EV and bead sizes are shown, with 
larger and smaller EVs binding to larger or smaller beads respectively. 
 
It is shown that the beads have a broad size distribution [in contrast to the manufacturer’s 
product specifications (200nm monodisperse bead suspension)]  and that the interaction 
with the surface of EVs is strong, indicated by the fact that EVs are not bound on a bead by 
a single-point interaction, but there is a rather extended surface of EV membrane coming in 
contact with the bead. An interesting observation is that the majority of EVs are bound on a 
bead on one side and some larger EVs attract multiple beads which seem to be binding on 
one domain of the membrane, indicating potential spatial selectivity in PS exposure. If PS 
would be exposed homogeneously on the surface of the membrane, then EVs would have 
multiple beads binding all around their perimeter, which is not seen here. Another EV 
characteristic highlighted by these images is the large size heterogeneity of EVs, however 
showing that binding on the anti-PS beads is independent of size, as both large and small EVs 
are attracted to one or more beads. At this point it is important to stress that in the above 
images, only the bead-bound EVs are present on the TEM grid, as the non-bound EVs had 
been washed off in the previous processing steps. This is a reminder that it is possible that 
there are EVs which are not expressing PS, but have been excluded from this imaging due to 
the preparation procedures. 
Maria Panagopoulou | PhD Thesis                                                                                                      The University of Edinburgh, 2020 
119 
 
The above imaging was performed on TEM, as the bead size was suitable for this type of 
microscopy, however, other beads such as the anti-CD81 or anti-CD19 have a larger diameter 
and therefore the EV binding has been visualized by fluorescence microscopy (Figure 4-8). 
 
 
Figure 4-8. Fluorescence microscopy images of EVs bound on and-CD19 magnetic beads. EVs are stained with 
Annexin V-AlexaFluor488 (bead diameter 4.5μm, scale bar 20 μm). Arrows indicate beads with multiple EVs or 
with only one EV or EV cluster. 
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The findings of this phenotypic study are in general suggesting that there are no significant 
differences in the levels of expression of proteins in Apo-EVs compared to the control 
vesicles. In more detail, the highest expression (over 40%) is marked for the proteins Ro, 
active caspase-3, MHC class I (clone W6/32) and CD9. Lower levels are observed for the rest 
of the markers studied.  
Interestingly, comparing the protein levels found for CD81 bead-bound EVs in Figure 4-9 with 
the efficiency of EV binding for beads in Figure 4-3, there are contradictory results for W6/32 
and CD81, as in the first case the W6/32 is detected on the EV surface but fails to capture 
the EVs, and in the second case the CD81 is the best capture probe but is not detected in 
high levels by flow cytometry. These differences can be attributed to poor antibody-antigen 
affinity which does not permit effective capturing, or in the case of CD81, a potential 
explanation involves the spatial arrangement of the CD81 antigen in such a way that all 
molecules are grouped together at the binding site of the anti-CD81 bead, therefore there 
are no available molecules for a second anti-CD81 antibody used for phenotypic 
measurement. In addition, for some markers it is observed that the Bcl-2 EV have higher 
levels of expression, as for example in active caspase-3 and CD63. While the levels of CD63 
have not been validated by other methods, for active caspase-3 the flow cytometry results 
contradict other methods (see microscopy below), which poses the question of reliability of 
this method on smaller EVs. 
 
4.3. Fluorescence microscopy on EV 
Another phenotyping method for EVs is labelling with a fluorescent antibody and performing 
direct imaging on a confocal microscope. As discussed in the Introduction, it is acknowledged 
that the resolution for this type of microscopy is physically limited to approximately 250nm, 
therefore the smaller EVs are not possible to be visualized as individual particles. However, 
the larger EVs and/or clusters of particles are can be imaged. Since EVs are not detectable by 
brightfield illumination, the imaging has been performed by staining the EVs with a general 
protein stain (AF568), to ensure the total population is ‘lit up’, followed by the addition of a 
primary fluorescent antibody. The following images show representative examples of 
imaging for a ubiquitous marker, PS, and for CD10 which is expressed to small percentages, 
for comparison. Images for other markers are presented in the Appendix of this chapter. 




Figure 4-10. Confocal microscopy for EVs stained with Annexin V-AlexaFluor488. Images acquired on Leica 
SP8 system, 63x magnification.The total population of EVs is pre-stained with a protein dye, AF568. 
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Figure 4-11.Confocal microscopy for EVs stained with CD10-FITC. Images acquired on Leica SP8 system, 63x 
magnification. The total population of EVs is pre-stained with a protein dye, AF568. 
 
The following image (Figure 4-12) shows the staining for active caspase-3 in more detail, as 
this marker exhibited significantly higher expression on Apo-EVs compared to Bcl-2 EVs. The 
results on active caspase-3 contradict the flow cytometry figures which suggest that the 
levels of expression for Apo-EVs are lower than the control vesicles, however, as discussed 
at the end of this chapter, fluorescence microscopy is considered more reliable, as these 
observations have been cross-examined with other methods, as well. 




Figure 4-12. Confocal microscopy for EVs stained with active caspase-3 – AlexaFluor 488. The total population 
of EVs is pre-stained with a protein dye, AF568. Images without and with zoom (top and bottom row of each EV 
type respectively) are shown for better presentation of the labelling. Images acquired on Leica SP8 system, 63x 
magnification. 
 
Quantitative analysis on the confocal microscopy images for all molecules studied is 
presented in Figure 4-13. 





Figure 4-13. Expression levels of selected EV markers as measured by fluorescence microscopy. The values 
represent the % positive EVs double positive for both fluorophores in absolute counts from the analysis of 
multiple images deriving from n=2 EV preparations. 
 
Two markers which appear exclusively on Apo-EVs are the active caspase-3 and the histone-
3 which indicates the presence of DNA. For the rest of the markers expected to be generally 
expressed on EVs, no significant differences in the levels are observed. 
 
4.4. EV surface markers studied by Immunogold on TEM 
A method of phenotyping, alternative to fluorescent imaging, is the labelling of EVs with 
antibodies conjugated with gold nanoparticles followed by TEM imaging. Besides super 
resolution microscopy, this is perhaps the only method which allows single vesicle imaging 
and studying of the spatial arrangement of the target molecules on the membrane surface. 
However, it needs to be acknowledged that the spherical 3D morphology of EVs cannot be 
maintained intact by dry TEM (in contrast to cryoEM where the vesicles are frozen in their 
natural shape). In this measurement, the EVs have been attached on TEM grids and have 
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been labelled with in-house conjugated immunogold complexes against several surface 
markers and some of the most representative examples are shown in the following figures 
(Figure 4-14 and Figure 4-15).  
 
 
Figure 4-14. Immunogold TEM imaging of EVs labelled with 15nm anti-CD19 immunocomplex. 




Figure 4-15. Immunogold TEM imaging of EVs labelled with 15nm anti-Ro immunocomplex. 
 
The figures show indicative results for EV labelling with a marker with low and high 
expression (CD19 and Ro respectively), and more images of all markers can be found in the 
Appendix of this chapter. The next graph shows the quantification of TEM immunogold 
imaging for all markers. The quantification has been performed using the following exclusion 
criteria for the particles appearing in the images: as determined by cryoEM in Chapter 3, the 
minimum vesicle diameter has been found at 25nm, therefore all particles smaller than 25nm 
in the immunogold images have been excluded from the analysis. 
 






4.5. Quantitative Reverse Transcription PCR for Apo-EV specific hY4 RNA 
detection 
 
Small RNA species are often abundant in EVs and as mentioned in the introductory chapter, 
they are often selectively expressed in certain conditions, serving as highly reliable disease 
markers. In an effort to identify RNA-based characteristics of the Apo-EVs, RNA sequencing 
was performed on EVs and EV-producing BL2 cells upon UV irradiation and apoptosis 
triggering. This study was performed by Dr Margaret Paterson in our laboratory in 
collaboration with Dr Amy Buck at Ashworth laboratories, University of Edinburgh. For the 
purposes of this study, the following samples were prepared for RNA sequencing: BL2 and 
BL2-bcl-2 cells isolated 5h after UV irradiation (therefore the BL2 cells were apoptotic), Apo-
EVs and Bcl-2 EVs purified from in vitro preparations, and finally HUVEC (human umbilical 
vein endothelial cells) cells after an 18h treatment with or without the two types of EVs. The 
HUVEC study was performed in order to examine the angiogenic effects of Apo-EVs, which 
concerns a different project of our laboratory. The isolated RNA from the above samples was 
sequenced and analyzed by Dr Amy Buck, and an initial screening of miRNAs indicated 
increased levels of human Y RNA for the Apo-EVs. Some more specific bioinformatics analysis 
was performed on all species of hY RNA (see next figure), comparing two samples at a time, 
for example BL2 cells versus BL2-bcl-2 cells, or Apo-EVs versus Bcl-2 EVs etc. 
The most significant outcome of this analysis was the identification of a small non-coding 
RNA, the RNA-Y4 or hY4 RNA which is upregulated in Apo-EVs when these are compared with 
Bcl-2 EVs, however the apoptotic versus the non-apoptotic cells do not seem to follow the 
same trend. hY4 RNA is one of the four hY RNAs which were first discovered by their 
association with the autoimmune disease lupus erythematosus (Lerner et al., 1981). The hY 
RNAs are parts of the Ro protein complex and have physiologically been linked with the 
initiation of DNA chromosomal replication (Christov et al., 2006), while in disease they have 
been associated with apoptosis (Rutjes et al., 1999; Hizir et al., 2017) and tumour (Christov, 
Trivier and Krude, 2008), among others.  
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Figure 4-17 presents a summary of the RNA sequencing results which shows that hY4 RNA is 
overexpressed in Apo-EVs (please note the scale numbers). 
 
 
Figure 4-17. RNA sequencing data indicating RNA-Y4 levels for cells and EVs upon stimulation of apoptosis (top 
row) and hY4 RNA sequence counts in all samples (bottom graph). Data provided by Amy Buck, Ashworth 
laboratories, University of Edinburgh (the scales are not the same for all axes; therefore for the cells graph, hY4 
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RNA is more than 15fold higher in apoptotic cells, while in EVs, hY4 RNA is expressed 100 times more in the Apo-
EVs!). The bottom image shows the hY4 RNA sequence in the bottom line (the 5’ and 3’ ends of the 96 nucleotide 
sequence are highlighted by arrows) and the number of ‘hits’ of the two ends of the sequence on all individual 
samples. 
 
In order to confirm the above results in vitro, traverse transcription quantitative PCR (RT 





The two ends of this sequence were shown to match the majority of reads in the RNA 
sequencing data (results shown above) and were therefore examined for the potential 
selection of primers. The primer sequence was extracted from the underlined part of the 
sequence shown above and therefore the forward primer was: 
Forward primer: 5’ -GTCCGATGGTAGTGGGTTAT- 3’ 
The following paragraphs describe the various parameters which the qPCR measurement of 
the RNA levels is dependent on and need to be optimized as a preparation before the 
experiment. 
 
Selection of normalization genes 
For the performance of RT qPCR, some normalization controls are required for the reaction. 
The normalization genes are usually housekeeping genes of the biological system, the 
expression of which remains stable under the conditions of the experiment. The expression 
levels of these genes are used in the data analysis procedure for setting the baseline for the 
relative measurement of expression of the genes of interest. It is therefore crucial to select 
housekeeping genes for which the expression has been shown stable for Apo-EVs and Bcl-2 
EVs. A helpful tool for this decision is the data obtained by RNA sequencing of the EVs, 
performed and analysed by Amy Buck and lab group, Ashworth laboratories, University of 
Edinburgh (unpublished data). From this analysis, the miRNAs and the -fold change between 
the EV populations were listed, and the miRNA-21 was identified as a species with 0.0074-
fold change of expression between the Apo- and the Bcl-2 EVs. An additional gene, the RNA-
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The primers amplifying the hY4 RNA and miRNA-21 are efficient in the acceptable range (90-
110%), however the RNA-U6 shows lower efficiency. Another point of qualitative control of 
the qPCR performance is the behavior of the primers in increasing temperature, as some 
sequences can fold and form primer-dimers, reducing the quality of the reaction. Figure 4-19 
represents the primer melting curves and shows that there is one main peak for every 
primer, indicative of only one primer configuration (in case of dimer formation, a second 
peak would appear).  
 
Figure 4-19. Primer melting curves after a qPCR cycle with the same conditions used in the qPCR amplification 
of hY4 RNA. 
 
Taking into account the melting curves and the previous efficiency results from the cDNA 
dilution slopes, RNA-Y4, miRNA-21 were both shown to be sufficiently reliable genes, and 
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the RNA-U6 was also included in the measurement, although its efficiency was found lower 
by 10% from the desired. 
 
Data analysis 
The main sample under measurement was Apo-EVs, using Bcl-2 EVs as the control condition 
of the system. Because qPCR is a method of quantifying the relative expression level and not 
the absolute values, some internal controls of the measurement need to be applied in every 
experiment. The measurement outcome of each experiment is the Ct value, which stands for 
the number of reaction cycles needed in order for the fluorescence intensity to exceed a 
threshold limit after the initiation of the reactions. This value is an indication of production 
of the sequence under examination, and the lower this value is, the larger the quantity of 
the RNA template, therefore the higher the expression level. However, in order to normalize 
the Ct values of each reaction and minimize the effects of variations in RNA quantity added 
for each sample, the normalization controls are ‘housekeeping’ genes of the biological 
system, meaning that these genes have been found to have a stable expression for both the 
sample under measurement (Apo-EVs in this case) and the control condition (Bcl-2 EVs). The 
Ct values of those genes are used to set a common baseline for both conditions and ensure 
that only the relative differences due to expression levels can be revealed, eliminating factors 
related to differences in the absolute Ct value of each reaction. The data analysis procedure 
is summarized here: 
For each gene, either the gene of interest (RNA-Y4) or a housekeeping gene (RNA-U6, miRNA-
21), there are two sets of reactions, one for the condition of interest (Apo-EVs) and one for 
the control Bcl-2 EVs, in duplicates. The Ct Values of the duplicates of each sample were 
averaged, followed by the calculation of the difference between the conditions (RQ), setting 
the control Bcl-2 EVs as the baseline expression, at 1.0. The normalization factor of the 
experiment is calculated by extracting the geometric mean value of the RQ of all the 
housekeeping genes for the control conditions (normalization factor =1) and for the Apo-EVs. 
Finally, applying the normalization factors of the control and Apo-EV condition to the 
respective RNA-Y4 RQ values, the level of expression of the Apo-EVs in comparison to a 
baseline expression of 1 for the Bcl-2 EVs is extracted (J. Vandesompele et al., 2002; De 
Spiegelaere et al., 2015). 
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cytometry, microscopy and proteomics data collected by other studies on the Gregory group, 
results not shown here) comes from the mechanistic and spatial interactions between 
protein molecules. This can be because MHC class I is a comparatively “shorter” molecule 
and could be spatially ‘blocked’ or ‘hidden’ by neighbouring larger surface molecules, thus 
providing with a poor capture receptor (Barclay et al., 1997). Another reason which was 
hypothesised as a potential factor contributing to poor MHC class I - mediated capture was 
the absence of beta-2 microglobulin, a molecule involved in the formation of MHC class I 
molecules (Entrez Gene: Beta-2-microglobulin, 2014). In other words, if the EVs lack beta-2 
microglobulin, this could lead to malfunction of the MHC class I. However, the expression 
levels of this molecule were studied by flow cytometry (Figure 4-9) and as it was found that 
both Apo- and control EVs express it, this hypothesis has been rejected. 
Capturing the total population of EVs with a single probe remains a question, since there is 
evidence that a large number of EVs might not express this marker -or any marker-, leading 
to the conclusion that immunomagnetic capture would require the use of multiple capture 
targets and even in this case, there can be vesicles which would not present any of those 
surface molecules, rendering immunomagnetic isolation unsuitable for total vesicle 
isolation. The heterogeneity of the population is strongly evident from this work, but also 
other groups have highlighted the need for multiple probes to successfully recover the 
majority of vesicles (Koliha et al., 2016). For CD81 and CD63 particularly, it has been 
suggested that some EVs associated with early endocytic membranes or plasma membranes 
might lack those two markers (Kowal et al., 2016). 
Applying flow cytometry on EV-bead complexes yielded results which showed no statistically 
significant difference between Apo-EVs and Bcl-2 EVs, however it became evident that cell 
lineage markers such CD19 and CD20 were expressed in lower levels in comparison to the 
classical ‘exosome markers’ CD9, CD63 and CD81 (Figure 4-9). Looking into the individual 
markers measured, Ro/SSA and La/SSB are autoantigens which are exposed on the surface 
of apoptotic blebs playing significant roles in autoimmune diseases and especially lupus 
erythematosus (Lerner et al., 1981) and have also been found on EVs isolated from neoplastic 
cells (Kapsogeorgou et al., 2005). Although the literature suggested the potential over-
expression of these markers on the Apo-EVs, this was not confirmed by flow cytometry. Next, 
previous studies of BL2 derived Apo-EVs on the total proteome have shown significant 
expression levels of CD10, CD45, CD46 and thrombospondin-2 in Apo-EVs compared to the 
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control EVs (unpublished data, Gregory group), therefore flow cytometry was used to 
investigate this result in vitro. However, the immunomagnetic method has not indicated 
differences in the level of expression. Active caspase-3 and histone-3 have been highlighted 
as proteins specifically expressed on Apo-EVs by previous studies by western blotting 
(unpublished data, Gregory group) and from the literature (Böing et al., 2013), (Schiller et al., 
2008), however no differences between the two EV populations were found by flow 
cytometry. Methods used as a comparison to flow cytometry phenotyping are discussed in 
the following paragraphs. 
Next, confocal fluorescence microscopy was applied on Apo-EVs and the findings on active 
caspase-3 and histone-3 indicated that those markers can be selectively expressed on Apo-
EVs, although flow cytometric analysis results did not support this finding. This indicates that 
flow cytometry is potentially less sensitive and selective compared to the counting of 
individual vesicles from microscopy images. Taking a step beyond conventional confocal 
microscopy, super resolution imaging can be an effective tool for investigating the presence 
of fluorescent markers on the EV surface and an example proving the degree of resolution 
achieved by STORM is shown below (Figure 4-21).  




Figure 4-21. Super resolution microscopy imaging by STORM for EVs labelled with covalent protein staining 
AlexaFluor568, scale Bar 500nm. A quantification of the EV diameter for Apo-EV is shown in the bottom graph. 
Images were recorded on Nanoimager and processed by ONI scientists during instrument demonstration (Oxford 
Nanoimaging, Oxford UK). 
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STORM is a mode of imaging which can visualize single fluorescent molecules, therefore, as 
also proved in the figure above, can result in highly reliable and robust data. For the purposes 
of this work, proof-of-concept imaging on EVs was performed on the Nanoimager system 
during demonstration, indicating the suitability of the method for further analyses in the 
future (ONI, Oxford, UK). 
Finally, immunogold labelling on TEM is a very efficient method when details on the 
arrangement and the number of target molecules are needed, however it is a low throughput 
technique which would be unsuitable for clinical applications. In this work, it was used as a 
comparison to flow cytometry, in order to validate the quality of flow cytometric 
measurements where the EVs are bound on magnetic bead complexes. It is generally 
observed that immunogold particles label a smaller number of EVs compared to the 
expression levels recorded by flow cytometry, which is unknown whether it can be due to 
the sample preparation method or due to over-estimation of levels by flow cytometry. In 
addition, accepting the fact that flow cytometry only enables the phenotyping of larger 
vesicles, the differences in measured levels could be a reflection of the actual levels in the 
larger versus the smaller EVs measured by each technique. In other words, a direct 
comparison of the phenotypic results might not be fully relevant, because each method looks 
at a slightly different target group of EVs. 
Moving away from protein targets, the qPCR study for hY4 RNA on Apo-EVs confirmed the 
significant over-expression of the sequence in the Apo-EVs, as those have been isolated from 
EV suspensions. However, when EVs were added in endothelial cells, the increase in the 
levels of this RNA was not detectable, possibly due to the already existing copies of this 
sequence in the cells (Appendix Figure 4-31 shows the EV uptake by HUVEC cells, as 
performed by Dr Margaret Paterson, confirming the interaction of EVs with the cells). 
Overall, the hY4 RNA was proven to be the first non-coding RNA marker which was identified 
for the BL2-cell derived EVs. However, the potential use of this small RNA as a diagnostic 
marker is a matter which requires further investigation with in vivo studies, as it has been 
shown that EVs from several cell types and body fluids contain all types of RNA Y, including 
the hY4 RNA (Driedonks and Nolte-T’Hoen, 2019).  
In conclusion, a range of methods for EV phenotyping have been presented, each of which 
has provided with interesting findings such as the identification of active caspase-3 and the 
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hY4-RNA as unique Apo-EV markers. Comparing the results obtained with each method is 
also another aspect worth considering, as the strengths and limitations of each of them are 
revealed. For example, in the case of active caspase-3, flow cytometry failed to highlight the 
importance of this protein for Apo-EVs, due to non-specific binding of the fluorescent 
antibody on the immunomagnetic bead/EV complexes. When choosing a method of 
phenotypic analysis, the time and equipment required for the measurement need to be also 
considered, as for example in the case of immunogold labelling and TEM imaging, for which 
the speed of measurement for each sample is significantly lower than flow cytometry or 
fluorescent NTA. 
  
Maria Panagopoulou | PhD Thesis                                                                                                      The University of Edinburgh, 2020 
142 
 
Appendix for Chapter 4 
 
 
Figure 4-22. Validation of antibody coating efficiency for -COOH surface magnetic beads. Measurement 
performed by flow cytometry and staining with IgG-FITC (results from 1 experiment). 
 
 
Figure 4-23. Confocal imaging of EVs attached on glass coverslips stained with general protein dye AlexaFluor 
568 and with anti-MHC class I-FITC antibody. 




Figure 4-24. Confocal imaging of EVs attached on glass coverslips stained with general protein dye AlexaFluor 
568 and with anti-MHC class II-FITC antibody. 
 
Figure 4-25. Confocal imaging of EVs attached on glass coverslips stained with general protein dye AlexaFluor 
568 and with anti-CD45-AlexaFluor 488 antibody. 




Figure 4-26. Confocal imaging of EVs attached on glass coverslips stained with general protein dye AlexaFluor 
568 and with anti-CD20-AlexaFluor 488 antibody. 
 
Figure 4-27. Confocal imaging of EVs attached on glass coverslips stained with general protein dye AlexaFluor 
568 and with anti-CD19-AlexaFluor 488 antibody. 




Figure 4-28. Confocal imaging of EVs attached on glass coverslips stained with general protein dye AlexaFluor 
568 and with anti-CD10-FITC antibody. 
 
Figure 4-29. Confocal imaging of EVs attached on glass coverslips stained with general protein dye AlexaFluor 
568 and with anti-CD9-FITC antibody. 




Figure 4-30. Immunogold labelling of EVs on TEM. 





Figure 4-31. HUVEC cells uptake of Apo-EVs after 3h incubation at 37oC in a range of EV concentrations. The 
EVs were pre-stained with AlexaFluor488 and the readout was performed by flow cytometry after washing of 
excessive EVs. This experiment was performed by Dr Margaret Paterson who kindly provided this graph. 
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5. Study of Apo-EVs in blood – the role of platelets and blood 
cells 
 
5.1. Aims of the chapter 
In the final chapter of this work, the analysis of EVs is moving from the characterisation of 
the particles alone to the environment of the blood circulation, aiming to examine the 
potential recipients of the Apo-EV cargo. The conceptual basis of this project is to use Apo-
EVs as diagnostic and prognostic indicators of cancer progression, therefore their behaviour 
in the blood is a crucial factor which can affect their availability for analysis from e.g. blood 
samples. As blood is an organ rich in cells and cellular fragments, the platelets, their 
interactions with the tumour-derived Apo-EVs are examined quantitatively by the degree of 
uptake, as well as biochemically, by the cargo they deliver.  
Red and white blood cells will be examined mainly for their ability to take up EVs, however, 
the delivery of Apo-EV molecules will be primarily studied in platelets. As platelets are the 
most abundant cellular entity in the circulation after erythrocytes, the signal transduction 
from the EVs to the platelets can potentially reveal alternative sources for EV cargo detection 
in blood, which can affect the Apo-EV analysis procedures in the clinical practice. In other 
words, as EVs encounter and interact with platelets or leukocytes in blood, EV material could 
be transferred to the second. From this point, the cells or platelets can bear Apo-EV signals 
themselves, or can release other EVs, which will act as secondary Apo-EV signal mediators. 
This phenomenon (also described in Figure 5-1) can have clinical significance, as for example, 
hypothesizing that the endpoint of Apo-EV signal expression in blood is via platelets after the 
interaction, the isolation and analysis of platelets may prove sufficient as a diagnostic tool 
avoiding all the EV isolation steps which can be impractical for conventional clinical 
laboratories. 
A schematic summary of the rationale of this chapter is presented in Figure 5-1. 




Figure 5-1. Hypothesis of Apo-EV signal transduction to blood cells and platelets. Tumour-derived EVs can 
potentially interact with blood cells and platelets and deliver their cargo to the second. The result of this interaction 
could lead to a secondary expression of EV material by the recipient cells and platelets. 
 
In more detail, this chapter mainly presents flow cytometric studies of EV uptake by blood 
cells and platelets, followed by confocal fluorescence microscopy for the direct visualization 
of the internalization of EVs and finally biochemical analysis for the transfer of Apo-EV cargo 
on platelets or study of the internalization mechanism of EVs in blood cells. 
 
5.2. Platelets and Apo-EVs 
In this section, the interactions of in vitro prepared Apo-EV with platelets derived from the 
blood of healthy volunteers are discussed. The first part of the study involves the platelet 
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isolation and confirmation of their presence on the flow cytometry dot plots. Blood from 
healthy volunteers was used to isolate plasma from which the platelets were extracted and 
suspended in Tyrode’s buffer supplemented with PGE1 to inhibit activation. The following 
graph shows the gating of platelets as dictated by CD42 staining, a platelet surface marker 
(Blair, Michelson and Frelinger, 2018) and Cell Tracker Violet stain, which fluoresces once 
being trapped inside living cells/platelets (Invitrogen) (Figure 5-2). In this figure, the Cell 
Tracker staining appears to form a biphasic curve, which shows that a part of the platelets 
are negative to this dye, although they are positive for CD42. This is an indication of the 
fragility of the platelets, as they tend to collapse and release large vesicles, therefore the dye 
leaks out of their interior, resulting in them appearing as unstained. 
 
 
Figure 5-2. Flow cytometry dot lot and fluorescence histograms for freshly prepared platelets stained with anti-
CD42 antibody or Cell Tracker Violet. 
 
Following the establishment of the platelets gate on flow cytometry, pre-stained AF488 EVs 
are added to the platelet suspension and are allowed to interact at 37oC for 0, 1, 2 or 3h with 
and without the addition of PGE1 during incubation. The results of the measured uptake are 
presented in Figure 5-3. 
 




Figure 5-3. a) levels of EV uptake by non-activated platelets with the addition of PGE1 (left) and platelets without 
PGE1 (right), b) fluorescence intensity histograms for EV uptake in platelets without PGE1.  Study performed by 
flow cytometry for AF-488 stained EVs using 5,000 EVs/platelet (error bars indicate standard deviation from n=3 
independent experiments). 
 
From the above figures, no significant differences in the level of uptake between the Apo-EV 
and the Bcl-2 EV are observed, however, the non-activated platelets in which PGE1 was 
present at all times, during storage, incubation with EVs and measurement, show 
significantly lower percentages of uptake which remains steady up to 3 hours of incubation. 
In contrast, the platelets which were exposed to EVs without the addition of PGE1 were 
almost saturated with EVs by 3 hours of incubation. Interestingly, a strong interaction 
between the platelets and EVs is observed instantly (time 0h, which in reality reflects a time 
period of 15-20min), as 40% of platelets are positive for EVs. 
The observations from flow cytometry will next be confirmed by confocal fluorescence 
microscopy on platelets stained with Cell Tracker Violet and AF488 EVs after an incubation 
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of 3h at 37oC  followed by quantification of the AF488 intensity levels as an alternative 
method to measure the uptake (Figure 5-4). 





As platelets are significantly smaller than cells, it is challenging to visualize them by 
brightfield illumination, therefore the staining with a general fluorescent dye (Cell Tracker 
Violet) is essential in order to study the EV interactions in detail. However, the violet 
fluorophore appears in the emission channel of the AF488 dye, causing a background signal 
in the non-EV treated platelets, which is presented in the quantification graph in Figure 5-4.  
To further examine the localization of the EVs on the surface or inside the platelets, three-
dimensional images were reconstructed and vertical sections of the 3-D models show the 
presence of EVs in the inside of platelets Figure 5-5. 




Figure 5-5. Three-Dimensional representation of platelets (blue) with EVs (green) after 3h incubation at 37oC 
with section on the vertical plane (red lines indicate the plane of sectioning). 
 
Figure 5-5 shows a large number of EVs interacting with the surface of platelets, however, 
the vertical sections highlight the cases where EVs are found inside the main body of a 
platelet. 
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In brief, it has been shown that both Apo-EVs and Bcl-2 EVs interact strongly with platelets 
to which activation inhibitors have not been added, and as flow cytometry measurements 
revealed, this interaction is rapid regarding the time of incubation. The microscopy images 
confirm that the uptake is happening with EVs attached on the outer or inner side of the 
platelet membrane.  
The confirmation of this interaction leads to the next question which is whether the Apo-EVs 
selectively transfer their molecular signatures to platelets, rendering the second a potential 
source of Apo-EV signal in blood. To investigate this hypothesis, some of the known EV 
markers for the in vitro derived BL2 EVs (expression levels shown in Chapter 4) were 
measured on platelets, in order to find candidates with low platelet expression, but 
abundant on EVs. The following graph presents the % positive platelets for BL2 EV markers 
such as CD19, CD20, CD77 (Mangeney et al., 1991) as well as universal EV markers, the CD9 
and CD63. In addition, DNA is a recognized Apo-EV component (Chapter 4 and other 
unpublished data from Gregory lab), therefore the platelets were stained with Hoechst for 
DNA and also with Annexin V for PS (Figure 5-6). 
 
 
Figure 5-6. Study of surface markers expressed on platelets by flow cytometry on freshly isolated platelets in 
suspension. Isotype controls were used for every antibody staining (CD42, CD19, CD20, CD9, CD62, CD77 and 
MHC class II), while unstained platelets were used as a control for Hoechst and Annexin V staining. For Annexin 
V, measurements were taken at different days post isolation, as it was observed that the levels of PS exposure 
increase over storage (error bars indicate standard deviation from n=3 independent experiments). 
 
Maria Panagopoulou | PhD Thesis                                                                                                      The University of Edinburgh, 2020 
157 
 
As expected, platelets have low levels of B cell related markers such as CD19, CD20 and CD77, 
as well as MHC class II, however the EV marker CD9 is detected in the majority of platelets, 
followed by CD63 which shows a smaller percentage. Surprisingly, all platelets were positive 
for DNA as indicated by the Hoechst staining, and this is a finding that was further 
investigated by microscopy, which suggested that this is free circulating DNA attached on the 
outside of platelets, although platelets do not contain DNA themselves (figures in Appendix) 
(Dorsch, 1981). Another characteristic of the platelets was the exposure of PS, especially as 
this increases over storage of non-activated platelets at room temperature. The above 
measurement indicated the selection of three EV markers with low platelet expression which 
can potentially show elevated levels in platelets after their interaction with EVs. Figure 5-7 
shows the collective results of three studies on EV marker expression on platelets after 
increasing time of interaction with the EVs.  
 




Figure 5-7. Levels of expression of EV markers on platelets after interaction of EV-platelets for 3h at 37oC. Study 
conducted by flow cytometry using isotype controls for each antibody (the error bars indicate standard deviation 
from n=3 independent experiments). 
 
It is observed that for all three markers examined here, the number of positive platelets is 
not higher than the isotype control, and overall not higher than 10%. Since no EV cargo 
transfer has been shown by flow cytometry on platelets, a more sensitive method will be 
next used to investigate the presence of the B cell-EV specific marker CD19 and Apo-EV 
marker Histone-3, the western blotting (histone-3 present in Apo-EVs as shown in Chapter 4 
and from previous data from western blots performed by Catriona Ford, Gregory group). 
Platelets were saturated with EVs for 3h at 37oC and after the excessive EVs were washed 
off, the platelets were used for total protein extraction, blotted and probed for CD19 and 
histone-3 (Figure 5-8). 
 




Figure 5-8. Western blotting of platelets after incubation with EVs. a) histone-3 blot for platelets with EVs, using 
BL2 cells as positive control and confirmation of platelets sample protein concentration by probing for actin-β. b) 
probing for CD19 on platelets and EV-treated platelets. 
 
The above blots show that there are no detectable levels of histone-3 transferred to platelets 
from the Apo-EVs, and also there is some reaction of the anti-CD19 antibody with the 
platelets alone, therefore the band of a potential transferred signal is undetectable. 
As a summary, there is a strong interaction of platelets with Apo-EVs and Bcl-2 EVs as 
measured by flow cytometry, however, the quantification of uptake measured by 
microscopy appears lower and this can be partially due to the high background noise from 
the platelet violet staining, masking the signal from small EVs. Three-dimensional microscopy 
showed that the EVs approach the external surface of the platelets but also get internalized. 
Those observations lead to the hypothesis that EV cargo is transferred to the platelets, 
therefore flow cytometry and western blotting were used to examine the presence of EV 
signature molecules such as proteins and DNA on EV-treated platelets, showing no significant 
indication of EV molecule up-regulation, which could also be attributed to low sensitivity of 
the selected techniques. 
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5.3. Blood cells and Apo-EVs 
Apart from platelets, blood contains a large number of erythrocytes and leukocytes, which 
appear in high numbers and their interactions with EVs are also important to examine. The 
white blood cells are generally categorised in granulocytes, monocytes and lymphocytes, 
each of which contain other sub-sets of immune cells, however, for the purpose of this work, 
data on the general populations are sought without details on the exact subtype, as this is a 
preliminary study. The erythrocytes, on the other hand, are a homogenous population and 
can be isolated as a pure set of cells. The flow cytometry dot plots of the blood cells are 
presented in Figure 5-9 and the gating for the leukocytes has been done according to the 
side and forward light scattering properties of the cells (Silva et al., 2013). 
 
 
Figure 5-9. Flow cytometry dot plots for preparations of white blood cells (left) and erythrocytes (right). 
 
Apo-EVs and Bcl-2 EVs were co-incubated with erythrocytes or leukocytes (as a mixture of 
granulocytes, monocytes and lymphocytes) and the levels of interaction are measured by 
flow cytometry, as the EVs are pre-stained with AF488 (Figure 5-10). 




Figure 5-10. EV uptake levels for freshly isolated blood cells when incubated at 10,000 EV/cell for lymphocytes, 
granulocytes, monocytes and 5,000 EV/cell for erythrocytes at 37oC. Study performed by flow cytometry for AF-
488 stained EVs (the error bars indicate standard deviation from n=3 independent experiments). 
 
As a first observation from the uptake levels on EV, erythrocytes are the only type of cells 
which are not interacting with EVs, even after overnight incubation. Figure 5-11 also shows 
the fluorescence intensity histograms for the different categories of leukocytes over time 
of incubation with EVs. 




Figure 5-11. Flow cytometry fluorescence intensity histograms for blood cells interacting with EVs stained with 
AF488 with 10,000 EV/cell at 37oC. The histogram show data from one experiment, which is representative of the 
total number of independent experimental repeats (n=3).  
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As shown in the histograms, the biggest increase in intensity is recorded for overnight 
incubation of EVs with cells, and this change is evident for all cell types (erythrocytes are not 
presented, as there is no apparent interaction with EVs). Although the percentages of uptake 
shown in Figure 5-10 indicate some increase from 5h to 18h incubation, the degree to which 
the intensity of the signal increases is not proportional to this change in the percentage 
value, suggesting that the cells take EVs up continuously, therefore the EVs are accumulated 
in cells over time. A common feature for all the trends above is that there are no significant 
differences in the uptake level of Apo-EVs compared to the Bcl-2 EVs. 
In order to examine the nature of interaction between the cells and EVs, and determine 
whether EVs are internalized or adhered on the outer surface of the plasma membrane, a 
series of studies has been conducted, where the co-incubation conditions are altered. As 
erythrocytes showed no uptake of EVs, the following measurements are made on leukocytes 
only. Lowering the temperature of the co-incubation to ambient (22oC) or even 4oC is used 
to examine the level of passive adherence and internalization, while treating the cells with 
trypsin/EDTA after incubation at 37oC gives the percentage of EV which are adhered on the 
plasma membrane via receptors or non-specific protein binding. The detailed uptake values 
for every condition over time are presented in the Appendix. Figure 5-12 is a summary of the 
calculated percent reduction of uptake of EVs for all conditions, using the uptake values at 
37oC as reference (from Figure 5-10). 




Figure 5-12. Percentage of reduction in EV uptake by white blood cells when EVs were incubated with cells for 5h 
at 4oC and room temperature, or at 37oC with trypsin treatment after uptake. The average of the % reduction of 
three experiments was calculated using the 37oC at 5h uptake values obtained from Figure 5-10 (standard 
deviation bars not shown because the calculation was performed on the average values of the 3 experiments which 
were not paired in the with and without trypsin conditions). 
 
The most significant reduction of uptake is noted for 4oC incubation, as all types of cells see 
a reduction of around 50% of their uptake, with lymphocytes being affected the most. For 
room temperature, only lymphocyte uptake is dropping to about 60%, while granulocytes 
and monocytes are still interacting with EVs without a difference from 37oC. What is also 
obvious is that trypsin/EDTA treatment after uptake has had no impact on the final quantity 
of EVs measured in cells. A positive control of trypsin/EDTA digestion, confirming the 
biological activity of the enzymatic reaction is shown in Figure 5-17 in the Appendix. 
To confirm the localization of EVs and assess whether the vesicles are internalized, 
fluorescence confocal microscopy is used on the mixture of leukocytes incubated with AF488 
EVs for 1h, 2h or 5h. The images from the respective time points are shown in Figure 5-13, 
Figure 5-14 and Figure 5-15, where the different categories of cells can be identified by the 
appearance of the nucleus (Dan, 2012). 




Figure 5-13. Confocal microscopy on white blood cells from 1 donor stained with nuclear stain Hoechst (blue) 
interacting with AF488 EVs (green) after 5h incubation at 37oC. Scale bar 30μm. 




Figure 5-14. Confocal microscopy on white blood cells from 1 donor stained with nuclear stain Hoechst (blue) 
interacting with AF488 EVs (green) after 2h incubation at 37oC. Scale bar 30μm. 
 




Figure 5-15. Confocal microscopy on white blood cells from 1 donor stained with nuclear stain Hoechst (blue) 
interacting with AF-488 EVs (green) after 1h incubation at 37oC. 
 
The microscopy images show that there are fewer EVs in the cells for incubation periods 
shorter than 5h, while for 5h the EVs are located inside the cells and closer to the nucleus. 
These results agree with the previous data on the trypsin-treated cells which imply that EVs 
are rather fused with the plasma membrane or internalized, than bound on the exterior via 
protein interactions. 
 




As a conclusion to the platelet studies, the data support that the EVs interact rapidly with 
the platelets and this interaction is surface binding and also internalization of the EVs, as 
microscopy showed. With this evidence, the secondary expression of markers delivered to 
platelets by EVs was examined, however, neither flow cytometry nor western blotting 
yielded positive results. This observation leads to the hypothesis that the transfer of protein 
markers might be a method not sensitive enough for analysis, therefore other molecules 
such as RNA can be studied, as has been shown for the case of tumour-derived RNA which 
has been found in platelets (Nilsson et al., 2016), (Nilsson et al., 2011), (Del Conde et al., 
2005).  As shown in Chapter 4, Apo-EVs express high levels of hY4 RNA which could be 
potentially measured on EV-saturated platelets as a secondary signal. However, the 
literature suggests that the platelets also express high levels of hY4 RNA, thus, the detection 
of the EV contribution to this signal would not be feasible (Itoh and Reichlin, 1991). At this 
point, future work will need to be focused on alternative detection methods and also on 
potential micro RNA sequences which can be detected on platelets upon their interaction 
with EVs. Another result which shows contradictory data is the presence of DNA on the 
surface of the platelets. Flow cytometry and confocal microscopy (Figure 5-16 in the 
Appendix) for platelets stained with a DNA dye (Hoechst) have indicated the presence of 
large quantities of DNA, while the western blot with histone-3 appears negative, even for 
non-treated fresh platelets (control). This phenomenon can be possibly explained by the fact 
that circulating single-stranded DNA has been found on platelets before, therefore it is 
histone-3 (Dorsch, 1981). Although it is known that platelets do not carry any DNA of their 
own, this unexpected result proved to be of importance because it indicated this potential 
source of DNA contamination in other studies within our laboratory. For example, in cases 
where EV-derived DNA transfer to platelets is examined, it is essential to remove the surface 
DNA in order to avoid false positive results.  
To sum this chapter up, the study of EV uptake from all blood cells has not been previously 
described in the literature as a whole, apart from a small number of examples where only a 
subset of leukocytes have been co-incubated with EVs ((Danesh et al., 2014) have found that 
monocytes internalize red blood cell-derived EVs). Here, it has been shown that both Apo-
EVs and their control vesicles, Bcl-2 EVs are taken up by platelets, granulocytes, monocytes 
and lymphocytes but not by erythrocytes. This observation can be starting point for further 
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considerations about the possible uptake mechanisms which erythrocytes lack. Moreover, 
the reduction in the levels of uptake as the temperature decreases indicates higher 
probability for an active mechanism rather than passive binding of EVs on the cell surface. It 
has also been confirmed that these interactions are not surface binding or non-specific 
attachment of EVs on the surface of a membrane, but the vesicles are transferred in the cells 
or platelets with a mechanism still to be examined. Those early data suggest that the cells 
are receiving the vesicles in an active manner, as the decrease of temperature hinders the 
uptake and the microscopy images show their migration towards the nucleus over time. 
Finally, microscopy revealed that the EVs are internalized in cells, suggesting that the Apo-
EV cargo can be transferred and possibly replicated via leukocytes, providing evidence that 
there can be secondary Apo-EV signals in leukocytes as well as platelets. The biochemical 
analysis on the specific EV cargo transfer to platelets has not highlighted protein markers 
which can be detected as a secondary signal, however, these markers can also be RNAs, 
opening a new area of future studies. Acknowledging these challenges from the platelet 
study, and given the higher level of complexity for cells, the biochemical analyses on EV-
conditioned leukocytes were not performed, as more robust markers need to be established 
before this step. 
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Appendix for chapter 5 
 
Figure 5-16. Hoechst 33342 staining on fresh platelets from 1 donor in 2-D and 3-D confocal imaging. 





Figure 5-17. EV uptake levels for blood cells when incubated at 10,000 EV/cell for lymphocytes, granulocytes, 
monocytes at 4oC or toom temperature (row a) and at 37oC with trypsin treatment after uptake. Study performed 
by flow cytometry for AF-488 stained EVs. c) positive control for trypsin/EDTA efficiency: BL2 cells were attached 
on anti-CD19 magnetic beads followed by trypsin digestion of the bead-cell bonds to remove the cells from the 
beads. Error bars show standard deviation values from n=3 independent experiments. 
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6. General discussion 
6.1. Thesis Objectives and Summary of Findings 
 
The purpose of this study was to examine the distinct features of Apo-EVs derived from 
tumour cells as to their physical and biochemical properties and also regarding their 
interactions with the components of the blood (cells and platelets). Comparing those results 
with the non-apoptotic cell derived vesicles has highlighted some differences which can be 
potentially used in order to distinguish and selectively analyse Apo-EVs in the context of 
diagnosis and therapy. In this section, a summary of the most significant findings is 
presented, followed by a discussion on the future studies needed in order to bring the use 
of Apo-EVs to the clinic.  
To begin with, the mechanism of biogenesis for Apo-EVs remains largely unknown. From the 
findings of this work, it is proved that the secretion pattern of Apo-EVs from cells in culture 
upon stimulation of apoptosis is different from the physiologically released EVs, however, 
the intracellular processes leading to this pattern have not been studied in this project and 
the literature also shows that they generally remain unexplored. One of the few examples 
which show the variety of Apo-EVs and highlight their different nature is the ‘beads on a 
string’ structure of apoptotic monocyte-derived bodies, described by I. Poon’s group (Atkin-
Smith et al., 2015). In this study, the authors came across an unusual apoptotic body 
configuration in monocytes, which was further examined to reveal that the apoptotic bodies 
were connected in a linear structure generated by actomyocin contractions and the 
formation of apoptopodia. Another more recent example is a study on apoptotic bone 
marrow-derived macrophages showing that the Apo-EV formation was dependent on 
S1P/S1PRs signalling in the initial stages of apoptosis, followed by EV maturation in 
multivesicular endosomes where F-actin and CD63 were involved, among others (Park et al., 
2018). These mechanisms can be specifically apoptosis-related and completely different 
from the classical pathways such as ESCRT machinery and the EV formation from the plasma 
membrane, or the Apo-EVs might be formed through those mechanisms, but with different 
purpose and cargo, or can be a combination of all the above. This third option appears to be 
the most credible, as the data have suggested that a part of the Apo-EV population is very 
similar to the non-Apo-EVs, therefore indicating that an apoptotic cell can secrete both the 
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apoptosis-independent EVs (with unknown presence/levels of apoptosis-related cargo) and 
the Apo-EVs (loaded with Apo-related material). More specifically, the structural studies by 
cryoEM as well as the phenotypic investigation of a variety of protein markers (MHC class I 
and II, CD19, CD20 etc.) have shown very few differences between the two types of particles, 
which leads to the above assumption. 
Considering the data acquired for size distribution and kinetics of EV release together with 
the cryoEM imaging and tomography and fluorescence anisotropy, it is shown that once the 
EV have been produced, the physical characteristics of the individual particles are not 
significantly different for Apo-EVs. In more detail, both EV populations under examination 
show similar structure under EM and a similar membrane thickness, however the 
quantification of the bodies with single versus multiple lamellae indicated a 10% difference 
between the two. Apo-EVs seem to be more single-membraned compared to the Bcl-2 EVs 
and this can be a potential indication about their different biogenetic origin. Also, regarding 
the fluorescence depolarization results, it has been observed that the membrane of the Bcl-
2 EVs is less fluid than the Apo-EVs, which is another potential evidence about their different 
biogenesis mechanism. Similarly to the cryoEM studies, the literature shows that there is 
very poor reference to time-resolved fluorescence anisotropy measurements on EVs and 
especially on Apo-EVs, therefore comparison of the results obtained here with other groups 
cannot be made at this stage. Moreover, the heterogeneity of the EVs is a fundamental issue 
which has been faced throughout this study, but also in the general EV field (Sork, H., Corso, 
G., Krjutskov, 2018). It is therefore, expected that although the individual Apo-EVs might 
have a few unique phenotypic signatures, the sum of all EVs which are released from an 
apoptotic cell are probably a mixture of Apo- and non-Apo- related EV types (Figure 1-1). The 
persistent question is whether the Apo-EVs can be clearly discriminated from the non-Apo-
related vesicles in terms of phenotype, but also whether there is a possibility for selectively 
sorting and purifying the Apo-EVs from a mixture of other types of EVs. Looking at the 
findings of this study, and keeping in mind that the differences between the two types are 
mainly evident by intracellular molecules such as active caspase-3 and hY4 RA, some classic 
sorting approaches which would involve binding on a substrate using surface markers do not 
seem to be possible in the near future. For instance, it has been demonstrated that tumour-
derived EVs can be selectively isolated and quantified using a surface receptor the EVs 
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express and its binding to gold nanoparticles (Liang et al., 2017). However, this might not be 
applicable to the Apo-EVs at this stage and with the current knowledge. 
In an effort to identify EV surface targets which could be effectively used for capturing on 
immunomagnetic beads, the results were in some cases unexpected, as it was seen that 
markers abundant on EVs such as the MHC class I are not suitable for the capturing of the 
majority of EVs. This can be potentially explained by the steric conformation of the molecules 
on the EV membrane or the affinity strength of the target with the capture antibody. In 
contrast, although the classic exosome markers CD9, CD63 and CD81 would be expected to 
only capture a smaller fraction of EVs, they appear to be effective for a broader spectrum of 
vesicles, including the Apo-EVs. Regarding those results, as mentioned earlier, one of the 
general conclusions of the present work is the high degree of EV heterogeneity, even from 
the EV preparations which have been released by a single type of cells. The discovery of 
exomeres in EV preparations from B16 melanoma cells has added another level of complexity 
in the analysis of the EVs. Exomeres have been described as non-membranous particles 
which can be seperated from large or smaller EVs and show a distinct biochemical profile. 
Assymetric-flow field-flow fractionation isolation of the exomeres followed by proteome, 
lipidome and nucleic acid analysis identified unique exomere markers compared to the EVs 
derived from the same cell line. These results suggest that the exomeres can play a role in 
diseases such as cancer, therefore, understanding their biology can help the EV field to 
understand the effects of all types of cell-derived particles respectively (Zhang et al., 2018). 
However, flow cytometry using immunomagnetic complexes of EVs showed no difference in 
the expression levels of all markers studied on Apo-EV, although other techniques such as 
fluorescence microscopy (and western blotting from previous studies in the Gregory group) 
could highlight selective expression of markers on Apo-EV. These comparisons suggest that 
flow cytometry does not offer the required level of sensitivity for EV phenotyping when the 
differences in the expression level are small, such as in the case of histone-3. Interestingly, 
confocal fluorescence microscopy has proven the most sensitive method based on 
immunophenotyping by fluorescence, as it has revealed the selective histone-3 and active 
caspase-3 expression on Apo-EVs, as well as the presence of double stranded DNA.  
Within the immunophenotypic studies of EV markers, an approach which does not involve 
fluorescence as a readout is immunogold labelling and imaging by TEM. This method offers 
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the highest resolution when it comes to visualising each target molecule, however the 
quantification of the surface marker levels did not show differences for the two populations 
of interest. 
Finally, small RNAs are often used as EV biomarkers for several conditions and indeed, hY4 
RNA was shown to be expressed in significantly higher numbers in the Apo-EVs than the Bcl-
2 EVs in an RNA sequencing experiment which was also confirmed by RT-qPCR. One of the 
challenges of qPCR is to identify and use the appropriate genes as housekeeping controls, 
and these should be specific for the tissue of the sample. In addition, in the case of small RNA 
sequences such as the hY4 RNA, some of the classic controls such as GAPDH and other genes 
often used for larger RNA sequences might not be suitable, therefore it is important to seek 
for potential small RNAs the expression of which remains constant for all samples. 
Comparative results available from Dr Amy Buck’s lab contributed to the selection of these 
controls and it was shown that upon establishing a standard protocol for the technique, a 
large number of samples can be analysed with the same template, therefore RT-qPCR is 
considered a method of great value to the clinics, especially for EVs. 
The functional studies of Apo-EVs in blood cells and platelets have shown that both types of 
vesicles studied here interact strongly with platelets and white blood cells (monocytes, 
lymphocytes and granulocytes), although their uptake by red blood cells has not been 
confirmed. Interestingly, looking at the mechanisms EVs use to interact with these 
components, fluorescence microscopy showed that both for platelets and white cells, pre-
stained EVs are found internalized and also bound on the surface, which appears to be a 
time-dependent process. In addition, measuring the uptake under the effect of several 
conditions such as reduced incubation temperature and trypsinization of the EVs from the 
surface of cells after uptake have indicated a rather active mode of uptake, therefore passive 
and non-specific binding are considered less likely to occur. Those observations increase the 
probability for transfer of Apo-related material in those cells and opens the field of Apo-EV 
biomarker detection in blood cells and platelets besides circulating EVs alone. Preliminary 
studies on the transfer of Apo-EV markers in platelets have not indicated a clear increase of 
the tested Apo-EV markers in the EV-treated platelets, however this is an area which requires 
additional studies, as the references from the literature mainly focus on non-apoptotic cell 
derived EVs. For example,  it has been shown that neutrophil-derived EVs can cross-interact 
with platelets, orchestrating anti-bacterial immune response (Rossaint et al., 2016), while 
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vesicles released from monocytes or macrophages contain tissue factor which upon fusion 
with activated platelets, enables coagulation (Del Conde et al., 2005). 
A variety of analytical techniques has been used for the analysis of EVs, and by comparing 
the data and the general characteristics of these methods, some conclusions can be drawn 
on the suitability of each approach depending on the desired outcome. A distinction which 
can be immediately made on these methods is their application in the clinical or research 
laboratories. TEM and especially cryoEM, fluorescence anisotropy, western blotting and 
confocal microscopy are methods which are rarely found in the majority of the clinical 
laboratories, while the time of measurement and data analysis is relatively long. In contrast, 
the most rapid measurements can be conducted by flow cytometry, NTA, DLS and qPCR, and 
especially flow cytometry and qPCR are methods which are used more often in clinics. 
A second point for consideration for the selection of the method is whether single vesicle is 
required, or whether bulk analysis is sufficient. Only a small number of methods can provide 
with structural or phenotypic information on individual particles, which are super resolution 
microscopy, electron microscopy and potentially NTA for unstained particles - or as a 
variation of the technique, NTA where EVs are stained with a fluorescent reporter and dual 
imaging determines the levels of the marker on each vesicle. The majority of the methods 
discussed in this work such as qPCR and DLS for example, are applied on a sample consisting 
of a mixture of EVs, therefore the resolution is lower, but they can provide with robust data 
on the general characteristics of an EV population such as the Apo-EVs. 
Moreover, as shown in in the Introduction (Figure 1-9), not all of these methods are 
applicable to the full size spectrum of the EVs, therefore the selection of the mode of analysis 
needs to be studied carefully, considering the subset of EVs of interest.  
In general, it was found that Apo-EVs differ from the non-Apo-EVs in a number of features. 
Their structure reveals a clear difference in diameter, as Apo-EVs are larger than the vesicles 
not related to apoptosis, as well as a tendency for the formation of multiple lamellas in Bcl-
2 EVs. Qualitatively, however, the structure of the vesicles in the two populations appears 
very similar, as shown by cryo electron tomography. The kinetics of secretion from cells is 
another point where Apo-EVs differ from control EVs, as cells rapidly increase the number of 
released vesicles as apoptosis progresses, which can be used as a potential apoptosis 
indicator in the number of EVs isolated from patients’ blood. 
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Biochemical analysis of Apo-EVs has highlighted the presence of active caspase-3, histone-3 
and hY4 RNA in higher levels than Bcl-2 EVs, which can be the first biomarkers to be 
potentially used as a starting point for further studies. 
Functionally, and looking at how EVs interact with the circulating blood cells and platelets, 
there are no apparent indications of effects occurring specifically due to Apo-EV, but there 
is evidence that this area can provide with interesting results, as it has been confirmed that 
EVs are internalized in leukocytes and platelets.  
 
6.2. Future work 
A common point arising from all the analyses conducted in this work is the fact that the 
vesicles used throughout the experiments are prepared from BL2 cells, therefore all the 
results correspond to this particular cell line and it is unknown whether the same trends are 
maintained among vesicles from other tissues. Comparing the findings from several cell lines 
could provide with interesting conclusions about the structural and biochemical 
characteristics of the Apo-EVs. Especially in the case of malignant versus physiological EVs 
and Apo-EVs, the markers or signature nucleic acids can differ, therefore detection for 
diagnostic procedures needs to be tailored to the specific tissue (Kosaka, N., Kogure, A., 
Yamamoto, 2019). Those EVs differ not only on the level of biochemical characteristics, but 
also regarding functional properties, as it is generally believed that physiological EVs can 
have roles within metabolic pathways and signalling crosstalk among cells, while cancer-
derived vesicles mainly facilitate tumour growth by supporting angiogenesis or the formation 
of metastatic niches, for example (Nieuwland and Sturk, 2010; Minciacchi, Freeman and Di 
Vizio, 2015). 
Moreover, this thesis can serve two basic purposes: the first is the use by researchers for the 
continuation of Apo-EV related studies and the second and more translationally important is 
the contribution to the development of a platform which can be applied in the clinic. The in 
vitro findings of this study provide with a variety of information about the nature and the 
behaviour of Apo-EVs regarding their physicochemical, biochemical characteristics as well as 
the degree to which they interact with components of the blood once they are in circulation. 
This knowledge can be used as a starting point for further investigations and assist with the 
process of understanding their function in cancer. In addition, a number of methods and 
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protocols have been adjusted or created de novo for the purpose of EV analysis, such as the 
fluorescence anisotropy measurements, the flow cytometry on immunomagnetic beads, 
fluorescence microscopy and immunogold staining protocols. These methods can be re-used 
on the basis of EV analysis, accelerating the pace of EV studies in the future.  
On the other hand, applying the key results of this study on a healthcare solution which could 
be used for patients would add tremendous value to this research, as it could help tackling 
cancer. For this purpose, future work would include the introduction of patient samples and 
samples from in vivo studies which would provide with information about how the Apo-EVs 
can be eventually detected from body fluids as diagnostic or prognostic markers or how they 
are related to the different stages of the disease. Therefore, it would be relevant to repeat 
some of the analytical procedures presented in the previous chapters, using in vivo produced 
EVs and observe the trends and characteristics of these populations. 
As discussed in the Introduction, for some tumours the levels of apoptosis can suggest the 
staging of the disease and therefore assist clinicians shape the next steps of the therapeutic 
procedures. However, the direct measurement of apoptosis in the tumour tissue cannot yet 
be achieved in a non-invasive procedure, therefore this assessment is currently impossible. 
Measuring the Apo-EVs in blood is a non-invasive method of assessing the levels of apoptosis 
in the tissue, as those would be reflected by the Apo-EV levels throughout the various stages 
of the disease. In order to achieve an analytical platform sensitive and selective for the 
particular tumour Apo-EVs, it is essential to establish robust Apo-EV markers which can give 
reliable results and exclude all other physiological Apo-EVs related to non-cancerous tissue. 
The present in vitro studies have highlighted a small number of potential Apo-specific 
markers, however it is important to acknowledge that these measurements were conducted 
on pure populations prepared by a single cell line, without interference from EV of other 
tissues. Although little is known about how the vesicles and specifically Apo-EVs released by 
solid cancerous tissues enter the bloodstream, given the indications on the rapid clearance 
of smaller EVs by the liver and the lungs, one would expect that the larger the particle, the 
faster it will be removed from the circulation (Matsumoto et al., 2020). With this in mind, 
the significance of Apo-EV study in patients or tumour-bearing animals’ blood is highlighted. 
In vivo, it is likely that the co-isolation of EVs from other cells could alter the degree of 
sensitivity needed, or might highlight other markers besides the ones identified in this study, 
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thus it is important to assess those parameters and evaluate the potential of the Apo-EV 
markers in biological samples. For example, it is possible that active caspase-3 and hY4-RNA 
are loaded on EVs from multiple tissues, rendering the selective detection of the tumour-
derived Apo-EVs more challenging, and the results would depend on the sensitivity of the 
analysis. In such cases, more than one marker would be necessary for the sorting and 
measurement of tumour Apo-EVs (multiplexed platform) in order to exclude interference 
from non-cancer EV.  
Another potential issue could arise from the clearance of EVs from the circulation, which 
could result in significant losses of EV numbers, and depending on the kinetics of this process, 
this could mean that the time of sampling would have an impact on the number of EVs 
available for measurement. In contrast, other markers could be highlighted, or the analysis 
could be even more simple, supposing that the stages of the tumour could be assessed only 
by the quantification of the total EV number. In addition, looking at the uptake tendency of 
EVs by the leukocytes, the question of EV numbers versus cell numbers arises, as if one 
assumes that all circulating EVs get fused with cells, the amount of remaining available EVs 
for diagnostic detection will be insufficient. As mentioned in the Introduction, and although 
the numbers of circulating EVs varies hugely not only between donors but also between 
healthy versus diseased individuals, a very rough estimation of the range of EVs would yield 
around 1010 particles/ml (Johnsen et al., 2019). With the number of leukocytes being around 
5*106/ml and platelets around 300*106/ml in healthy donors (Dean L., 2005), it can be seen 
that there is a 104-fold excess of EVs, which can mean that there is high probability that there 
will be available EVs for measurement, even after interaction with the above components. 
All the above points can only be addressed by the performance of in vivo studies initially on 
animal models and subsequently in the clinics, and those findings will be crucial for the 
design and development of a final diagnostic procedure or device. 
As mentioned in the Introduction, one of the main reasons why cancer management and 
prevention still remain unresolved issues to date is late diagnosis. Such is the case for 
Burkitt’s lymphoma, which is a highly curable cancer when it is diagnosed at early stages 
(Fayad et al., 2011). It is also a fact that there are high rates of this particular type of cancer 
in regions of Africa and a large percentage of the patients are children, as well as elderly 
patients (Orem et al., 2007). With these data in mind, the need for a diagnostic tool with low 
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invasiveness and of low cost, designed to be transported and used in places with minimum 
infrastructure is emerging. 
Microfluidics-based technologies are being continuously evolved over biological and 
analytical applications, and especially in the field of EV detection. In most cases, these involve 
the capturing and separation of EVs on a solid substrate surface localized within a 
microfluidic compartment. The analytes can be detected by a variety of different methods 
depending on the desired readout signal. For instance, nucleic acids can be amplified on-chip 
with PCR-based methods (Chiriacò et al., 2018), (Ko, Carpenter and Issadore, 2016). 
EV enrichment for mRNA recovery and subsequent analysis has been achieved specifically 
for tumour-derived EVs using a mixture of capture antibodies. The device was applied on 
blood-derived EVs from glioblastoma patients and the RNA analysis confirmed the detection 
of EGFRvIII mutation, a glioblastoma biomarker (Reátegui et al., 2018) (Chen et al., 2010). 
The miniaturization of EV capture and detection processes on microfluidic chips has 
promoted research towards the development of hand-held analysis devices, and the 
literature provides examples of the potential utility of these platforms for the analysis of 
(Apo)-EVs (Ko et al., 2016). Below is presented a hypothetical ‘prototype’ of the key 
mechanical parts of a point-of-care blood test device for the diagnosis of non-Hodgkin 
lymphoma (Figure 6-1). Based on the results of the present work, the first compartment can 
be dedicated to the selective capture of EVs of the tumour tissue of interest using the 
relevant cocktail of capture probes (CD19) and the RNA extraction, followed by the second 
compartment where RNA amplification can take place (hY4 RNA) (more details in the figure 
legend). 
 




Figure 6-1. Simplified schematic representation of an EV analysis point-of-care device. The device consists of two 
main compartments: a) the vesicle isolation and RNA extraction cartridge (top left) where the blood sample is 
inserted and processed in order to extract RNA from EVs and b) the RNA to fluorescence conversion compartment 
(top right), where the purified RNA is amplified and measured. The readout from the fluorescence detector is 
transferred to another portable electronic device for further evaluation by the operator. Details on the procedure 
are shown in the perforated boxes at the bottom: the microfluidics compartment (bottom left) and the RNA 
conversion compartment (bottom right). 
 
Besides the direct EV analysis from biological samples, another stream which can be 
potentially followed in order to assess the presence of Apo-EVs in the blood is by utilizing 
their ability to interact with blood cells and platelets. To achieve this, a set of analyses which 
can improve our understanding of the specific molecular patterns occurring on/in cells due 
to their interaction with Apo-EVs includes -omics sequencing for several biomolecule 
categories such as RNA, proteins etc. In this work, data from previous protein and RNA 
sequencing on EVs have been used as a guide to the evaluation of Apo-related markers, 
however, this analysis could be expanded to EV-treated platelets and blood cells. With data 
proving that Apo-EVs strongly interact with all components of the blood except for 
erythrocytes, performing total RNA sequencing on those cells upon EV treatment could 
reveal potential sequences which are altered under the effect of Apo-EV uptake. An example 
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of this transfer of material to components of the blood is the case of tumour-educated 
platelets which receive tumour RNA which can be then be detected in them (Best, Wesseling 
and Wurdinger, 2018). Regarding the Apo-EVs, the respective markers could be subsequently 
used as secondary markers of Apo-related activity in the blood, moving the analysis from 
individual EVs to cells or platelets. In other words, the existence of secondary markers on 
cells can simplify the analytical workflow, as the isolation of cells is a standard procedure 
most clinical laboratories already perform, avoiding the additional step of vesicle isolation. 
Finally, the above platforms for EV analysis in patient samples have been described here in 
the context of apoptosis and its diagnostic/prognostic use in Burkitt’s lymphoma. However, 
similar approaches could possibly apply to other types of cancer with high levels of apoptosis 
or even other diseases which release vesicles related or unrelated to cell death. EVs have 
proved to be versatile carriers of information and with the use of appropriate markers, 
vesicle detection can be useful for a number of purposes. For example, by adapting the 
reaction parts of the microfluidics platform presented earlier to the particular EV reagents, 
the analysis can be expanded beyond lymphoma, ensuring low invasiveness and flexibility. 
 
6.3. Philosophical considerations 
As this thesis has been dedicated to cancer management, it is important to consider that 
there is currently a wide variety of therapeutic approaches for several types of cancer, and 
looking at the lists of available medicinal agents used globally, it could be assumed that those 
solutions would suffice. However, it is observed that cancer continues to be one of the 
leading causes of death and this contradicts the number of the approved medicinal 
treatments. One of the reasons why most medicines are unsuccessful for a large percentage 
of patients is the high degree of heterogeneity of the disease in among individuals. The 
scientific community are increasingly stressing out the importance of precision medicine, 
which highlights the need for individualized assessment of the disease in order to deliver 
personalized therapy supporting that general treatment schemes applied to all patients are 
ineffective or cause adverse responses due to this heterogeneity. The administration of 
therapeutics at an individualized pattern with the appropriate doses and timings could 
improve response and finally overall survival (Whitcomb, 2012). Of course, bringing 
personalized tests to all patients requires the establishment of robust biomarkers, and this 
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is where Apo-EVs can appear useful in order to evaluate the levels of apoptosis and 
subsequently the stage and progression of the tumour. In addition, early detection by non-
invasive means is key to improved outcomes in the community, both with respect to the 
patient’s survival and quality of life, but also financially for the healthcare systems. 
As a final comment on this work, if one focuses on what remains unknown about the Apo-
EVs and EVs in general, those questions lead to the fundamental principles of the physical 
world, to which science has no answers yet. Quantum physicists have long debated about 
how a phenomenon evolves in reality, versus how it appears when it is measured. With initial 
observations that some events cannot be precisely measured, but one can only look at the 
probability that the event will happen in a certain way, Everett - based on Schrödinger’s initial 
work - was one of the first to describe that the physical world is oscillating in ‘many worlds’ 
states, indicating that what the observer measures is only one of the probable states of the 
system. In other words, the famous Schrödinger wave function (fundamental for quantum 
physics) suggests a continuous oscillation for the states of a system which are independent 
from external parameters. However, when the observer decides to measure a variable of this 
system, the system becomes entangled with the observer and the wave function collapses 
to a single point, therefore the observer is only measuring this single point, ignoring the rest 
of the probable states (Everett et al., 1957). Having those theories in mind, it is unavoidable 
to wonder how the quantum effects can exist beyond the sub-atomic world and affect the 
nano-world of vesicles and the measurements of several parameters. If there is no single 
state for a system and it is rather split in ‘many worlds’, then how can science ever make safe 
conclusions about any hypothesis, and if what is measured is only one probable outcome, 
then will we ever able to understand why some systems ‘decide’ to evolve in a certain 
direction, where the probabilities increase for this state and not for others? These 
considerations also bring another issue to the surface, which is the extent to which human 
senses can understand the world.  
Technology has helped overcoming limitations related to measuring nano-sized entities 
which are not noticed by the human sensory organs such as the eyes, but all measuring 
devices, as well as their outcomes have been created for the human standards. Therefore, 
how can one be certain that measuring all these parameters can still give a safe 
representation of what actually exists in the nano-world (not to mention the sub-atomic 
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world)? These thoughts can be summarized in the Greek philosopher Socrates’ saying: ‘I 
know that I know nothing’, or ‘εν οίδα ότι ουδέν οίδα’, as spelled in the original language. 
The answer to these questions is not known yet, but until an explanation is found (if ever), 
the only option for medical scientists is to continue researching with the available means. As 
it has been proven in several occasions, achievements in medical sciences have led to 
significant improvement in the lives of millions of people, and it is one of the scientists’ duties 
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